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Healthcare is one of the most challenging, 
resource intensive and complex areas of public 
sector reform. Many countries have established 
healthcare regulatory systems to provide as-
surance that standards are complied with and 
to improve the quality of care. This research 
focused on the healthcare system in the United 
Arab Emirates (UAE), a young, modern state 
with an ambitious healthcare reform program. 
This study takes an in-depth look at three dif-
ferent methods used to regulate the conduct 
and performance of healthcare professionals 
and organizations. Using a variety of methodol-
ogies, this research offers practical insights and 
recommendations for policy makers, regulators 
and researchers.
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For many governments healthcare is perhaps the most challenging, resource intensive and 
complex areas of public service to manage, control and oversee. Despite huge expenditure 
and ever increasing amounts of investment healthcare systems are bereft with challenges: 
rising consumer expectations, ageing populations, global public health security threats, poor 
access to essential services, overtreatment and patient safety concerns, to name but a few1.
One way by which governments around the world attempt to protect society from harm, 
provide assurances to the public and improve the quality of health services has been through 
the design and implementation of a range of regulatory interventions2. Governments have 
established healthcare regulatory systems to not only assure compliance with legislation and 
standards to protect individuals and communities from harm but also to improve the quality 
of services3.
It is perhaps surprising that there appears to be a lack of scientific evidence that healthcare 
regulation achieves the desired results. Researchers have argued that the main challenge is 
not regulation or oversight per se, but the manner in which regulatory methods are imple-
mented which has resulted in this lack of evidence4.
The notion that governments and their agencies need to strengthen its control and oversight 
over the quality and performance of healthcare is a relatively new concept5. In many coun-
tries, the role of the medical profession in overseeing its own performance has remained a 
powerful and strong oversight method but in many cases there has been a shift towards a 
more independent, centralized, external of accountability and a also mixture of both forms6. 
As Healy7 points out: “a regulatory revolution is underway in the twenty-first century as 
governments around the world to strengthen the regulation of professionals and organiza-
tions in order to ensure better and safer health care”. A number of influential patient safety 
reports, such as a report from the US Institute of Medicine8 which highlighted preventable 
deaths from adverse events and a RAND report9 which found that, on average, only 54% of 
American patients receive the recommended care, contributed to this shift from oversight 
based on professional autonomy to the establishment of independent regulatory agencies.
This study was carried out in the United Arab Emirates (UAE), a federation of states (Emirates) 
in the Persian Gulf region (see Figure 1 below). Until 1971, when the UAE gained indepen-
dence from the United Kingdom, the UAE was known as The Trucial States of the Persian 
Gulf Coast. Today the UAE consists of seven Emirates with an open economy with a high per 
capita GDP10. The broader geographical focus of this study is on the Gulf region. The focus of 
one Chapter (Chapter 4) is on the so-called Gulf Cooperation Council (GCC), a cooperative 
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organization founded by six member states (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and 
the United Arab Emirates) in 1981. The remaining Chapters focus on healthcare in the UAE, 
in particular its main Emirate, Abu Dhabi.
The UAE has changed dramatically since its establishment as an independent country in 
1971. A census in late 1950s estimated that around 50,000 people were living in the area at 
that time11. The latest population estimates indicate that the population has grown to over 
9 million12. Abu Dhabi and Dubai are the largest Emirates within the federation, with a total 
population of around 3 million each13.
Figure 1 A map of the United Araba Emirates (source: World Health Organization14)
The population of the UAE is relatively young: around 60% of the population is estimated to 
be below 34 years of age15 and in Abu Dhabi only 1.8% of the population is over 60 years 
of age16. The vast majority of residents are expatriates (in 2016 around 82% of the popula-
tion of Abu Dhabi were expatriates and 18% UAE nationals13). Furthermore, the majority 
of UAE residents are male (around 64% in Abu Dhabi, in 201616) due to the reliance on 
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male expatriates who work in the construction and service industries. The rapid economic 
growth following the discovery of significant natural resources (oil and gas) in the 1950s 
and the subsequent exploration has had a major impact on the health of the population, 
due to a shift in behaviour and lifestyles from a semi-nomadic and active to an urbanised 
and sedentary lifestyle.17 The lifestyle changes have led to a large and increasing burden of 
chronic disease, such as diabetes and cardiovascular diseases18.
At the time of its foundation in 1971 the UAE had only 7 hospitals and 12 healthcare cen-
tres19. The most recent figures indicate that there are now 130 hospitals in the UAE20 (see 
Table 1 below). At the same time the healthcare spending as a percentage of the overall 
GDP has remained the same since 2005, around 3.5%. A similar increase can be seen in the 
number of healthcare professionals working in the UAE. In 2010 there were around 4,800 
licensed physicians working in Abu Dhabi, by 2016 this had increased to just under 9,00013. 
More importantly, the physician density grew from around 20 physicians per 10,000 head of 
population to 29.5. During the same time period in the US, the ratio had grown from 27.7 
in 2010 to 29.7 in 201621.
Healthcare in the UAE is provided by a mixture of government and private providers. In the 
Emirate of Abu Dhabi healthcare is provided by almost 50,000 licensed healthcare profes-
sionals who work for over 2,400 private and public providers, ranging from pharmacies, 
clinics, rehabilitation centres to primary, secondary and tertiary hospitals13. Since 2001 Abu 
Dhabi has taken charge of its own healthcare system, with a mandatory health insurance 
for all residents and a focus on competition22. Abu Dhabi has its own healthcare regula-
tory authority23 and, despite increased competition, the largest provider is a government 
owned network of health services, SEHA. The role of the regulatory authority for Abu Dhabi, 
the Department of Health (formerly known as the Health Authority Abu Dhabi), includes 
traditional regulatory roles such as setting standards and developing policies, monitoring 
compliance and enforcement, as well as a broader role in terms of defining the entire health 
strategy for the Abu Dhabi population, including a focus on health promotion and research. 
The healthcare regulatory context in Abu Dhabi differs from the other Emirates insofar that 
the service provision and regulatory roles are separated and divided over multiple agencies 
in Abu Dhabi. In Dubai and the rest of the Emirates, the regulator is also the main provider 
of healthcare services (see Table 1 below). The six other Emirates have established their own 
systems of governance, including a number of different regulators22, primarily the Ministry 
of Health and Prevention (Federal level) and the Dubai Health Authority (Dubai). The Govern-
ment of Dubai established a separate healthcare free zone in 2011 including it its own 
regulatory authority, the Dubai Healthcare City Authority19.
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Table 1 Healthcare regulators in the UAE
(source: UAE Federal Competitiveness and Statistics Authority20)












Abu Dhabi 3.1M Department of Health No 56 8983 21735
Dubai
3M
Dubai Health Authority Yes
35 8614 16624
Dubai City






Ministry of Health and 
Prevention
Yes 39 3827 7796
The UAE has embarked on an ambitious reform program, Vision 202124, with an overall 
aim to be ranked globally among the top 20 countries (in 2017 the UAE was ranked 39th 
on the Legatum Prosperity Index25). Vision 2021 also outlines the performance improve-
ment targets for all aspects of health care: service provision, population health, public health 
and healthcare regulation. The current healthcare regulatory landscape in the UAE is quite 
fragmented with a number of different healthcare regulatory authorities responsible for their 
own area26. There have been calls for a more ‘nuanced’ regulatory approach to address 
this fragmentation23 and create an environment that is more conducive to competition and 
private sector growth.
A number of educational, research and regulatory organizations in the UAE participated in 
this research, including the largest and highest ranked university in the UAE (UAE University), 
the Abu Dhabi healthcare regulatory authority and the Behavioural Economics Department 
within the New York University Abu Dhabi. Throughout the period of this PhD study (2010-
2019), I combined these research activities with full time leadership roles with a number of 
healthcare regulators and oversight agencies in the UAE, including the Health Authority Abu 
Dhabi (now known as the Department of Health) and the Ministry of Presidential Affairs. 
This study aims to contribute to a better understanding of healthcare regulation by taking 
an in-depth look at three different regulatory methods used to regulate the conduct and 
performance of healthcare professionals and organizations in the Emirate of Abu Dhabi and 
the UAE.
In this Chapter I will delve into the role, objectives and methods of regulation in the health-
care sector, as well as describe its anticipated benefits and highlight some of its unintended 
consequences. At the end of the Chapter I will also outline the focus of this thesis and 




At its core regulation can be described as the attempt by governments to steer or direct 
events, activities and behaviour.27 Regulation covers a wide range of interventions and has 
been defined as “sustained and focused control exercised by a public agency over activities 
which are valued by a community”28. Put differently, regulation seeks to change behaviour in 
order to produce desired outcomes29.
Regulatory objectives and activities
The objectives of regulation are varied and range from protecting citizens (particularly groups 
that may be viewed as ‘vulnerable’), regulating social problems30, exercising control over 
regulated activities or organizations and improving the quality of public service delivery31. 
Regulations are often designed to address failures or problems that arise from market or 
government failure32. Regulatory agencies aim to provide oversight over the quality of public 
services and provide assurances to the public using a range of regulatory interventions33. The 
public increasingly demands that the regulators ensure that public services deliver positive 
results and improve the quality of service. As a result, the effectiveness of the public sector, 
including the role of its regulatory agencies, has come under increased scrutiny34.
The focus of healthcare regulatory agencies can be on the institutions provider healthcare 
(institutional), the professionals who work in the healthcare sector or the entire healthcare 





Healthcare regulatory systems have been established to achieve these objectives, using three 
types of regulatory activity36:
•	 Directive	measures	(standards,	targets,	indicators,	guidelines,	etc.),
•	 Surveillance	 or	 assessment	 of	 the	 levels	 of	 performance	 (through	 audits,	 inspections,	
investigations, etc.), and
•	 Enforcing	compliance	through	advice,	formal	sanctions,	penalties	and	rewards.
Taxonomy of healthcare regulation
There is no generally accepted taxonomy of healthcare regulatory methods37. The absence of 
a coherent taxonomy of regulatory methods hinders research into the effectiveness as there 
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is a lack of common understanding and classification. The UK based Health Foundation, a 
non-profit think tank, was one of the first organizations to categorize healthcare regulation 
and listed 10 different interventions35. Healy7 lists 33 different regulatory mechanism and 
rates their impact on quality an patient safety, without further explanation upon which these 
ratings are based. Before reviewing the effectiveness of healthcare regulation, it is important 
to clarify and categorize regulatory methods.
In many countries, healthcare regulators have been given a broad and generic remit to 
oversee numerous heterogeneous organizations, markets and professionals. As a result, a 
regulator’s approach often consists of a mix of regulatory interventions33 with high levels 
of variance in context (i.e. the setting), contents (i.e. the characteristics of the intervention) 
and the application (i.e. the methods used and the process through which the intervention 
is delivered).
A dichotomous categorization of regulatory approaches is often used when describing 
regulatory practice. In this categorization regulators are described as either deterrence 
regulators who view the regulated organizations as ‘amoral actors’ out to get what they 
can or compliance regulators, who view the regulated organizations as fundamentally good 
and well intentioned. In practice regulators often use a mixture of the two approaches2,31. 
Reflecting on this dichotomy, Ayres and Braithwaite38 developed a theoretical hybrid model 
of ‘responsive regulation’ asserting that regulatory interventions are more likely to succeed 
if they are responsive to the culture, context and conduct of the regulated organizations 
and individuals. At its core, the responsive regulatory approach is based on trust between 
regulator and the regulated organization. This approach argues that the regulated party is 
intrinsically motivated by social responsibility and therefore regulatory approaches should be 
flexible and based on dialogue. Healthcare regulatory agencies have increasingly adopted 
such a risk-based and responsive approach39. At times this approach has been called into 
question as too soft and ineffective in preventing major failings and high-profile incidents 
such as the Mid Staffordshire NHS Foundation Trust scandal in the United Kingdom40. In or-
der to achieve effective regulatory oversight, many regulatory agencies seek to find a balance 
between assurance and improvement. For example, recent research in the United Kingdom 
described the emergence of hybrid regulatory models being adopted by the UK healthcare 
regulatory agencies31.
Utilizing multiple regulatory mechanisms that respond to the needs of the regulated en-
vironment, with often multiple interventions working at the same time, is a fundamental 
characteristic of ‘responsive regulation’.38 This responsive regulation model has received 
growing criticism as it does not assist in dealing with ambiguity in the regulatory context41. 
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Even though it is argued that regulators should consider all potential tools and instruments at 
their disposal42, the exact manner by which to implement this is less well understood.
The legal academic Professor Arie Freiberg from the Monash Law School in Melbourne, Aus-
tralia has developed a taxonomy of regulatory methods.37 This taxonomy can assist regulators 
in general to focus on day-to-day factors that influence compliance and produce regulatory 
outcomes. Freiberg’s regulatory toolkit is a non-hierarchical taxonomy of regulatory meth-
ods, based on the premise that the responsive regulation model, its gradual escalation from 
persuasion to punishment is not suitable for all situations. Freiberg37 lists six different modes 
of regulating: through economic tools; through contracts (or grants); through authorization; 
through structural means; through information; and through law.
Table 2 below is a summary of the six regulatory methods within the taxonomy developed 
by Freiberg, with a short description of each category and some examples relating to the 
healthcare regulatory system.
Table 2 Freiberg’s taxonomy of six regulatory methods37
Regulatory Methods Description Examples in healthcare
Economic regulation
Taxes, prices, tenders and market 
regulation
Introducing competition into the 
healthcare system by the removal of 
barriers to market entry.
Transactional 
regulation
Contracts, grant and procurement 
contracts
Public procurement process established 






External inspections, accreditation and 
licensing
Structural regulation
Physical design, process design and 
choice architecture




Using information to raise 
awareness, improving decision 
making and change attitudes, 
for example through ratings and 
indicators
Quality ratings, registries and 
performance indicators
Legal regulation Laws, guidelines and rules Standards, clinical practice guidelines
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1.3 Healthcare Regulatory Methods
Effectiveness can be defined as ‘the degree to which the objectives of a program, care, 
services, or system are achieved’43. In this section we will use Freiberg’s taxonomy37 to review 
the existing empirical evidence that describes the effects of healthcare regulation.
Economic Regulation
Governments may seek to create, oversee or influence markets by limiting or preventing ac-
cess to a market or liberalization of a monopoly or duopoly. Other ways to influence a market 
can be by imposing taxes, charges or levies. The main reasons to deploy these method are 
to create efficiencies, improve access to healthcare and establish financial accountability44. 
For example, the recent expansion of health insurance coverage under the Affordable Care 
Act in the United States has resulted in a significant increase in insurance coverage and 
utilization45,46. Economic regulation has been criticized as a crude and largely ineffective 
mechanism in the healthcare sector47, delivering negligible benefits48. When it comes to 
healthcare regulation the focus has often been on so-called social regulation44 that aims 
to change the behaviour and performance of organizations and professionals, rather than 
economic regulation.
Transactional Regulation
Transactional regulation consists of oversight arrangement through contractual and purchas-
ing agreements, as well as grants, between government agencies and third parties37. These 
regulatory arrangements may include stipulations and requirements for the third party, for 
example compliance with privacy requirements, minimum wages for staff or the contractual 
agreement may stipulate that the third party achieve quality accreditation. These terms and 
conditions can be applied to ensure efficiency gains through competition and create greater 
accountability. In healthcare regulation, transactional methods include rate setting35. There is 
some evidence that rate setting can be used as an effective mechanism to contain expendi-
ture and constrain expenditure growth35.
Authorization as Regulation
The effects of one specific form of authorization, accreditation, has been the focus of an 
increasing number of studies across the world49. Most studies have found limited empiri-
cal evidence in support of the widespread use of accreditation as an effective strategy for 
improving performance in healthcare50. In the US for example, researchers compared medi-
cation errors between hospitals accredited by the Joint Commission International (JCI) and 
non-accredited hospitals and found no statistically significant differences51. A randomized 
controlled trials in South Africa52 found no significant effect on performance of accredited 
hospitals compared to the control group. However, in Denmark researchers found an associa-
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tion between hospital accreditation status and 30-day mortality risk for in-patients, with fully 
accredited hospitals having lower mortality risk than partially accredited hospital53. Overall, 
the evidence for accreditation improving patient safety and quality is weak, with no convinc-
ing evidence that accreditation has an overall significant effects on the quality of care54,55,56.
Another regulatory tool that uses an authorization mechanism is an external inspection 
system. Similar to accreditation, there is sparse knowledge of the effects of external inspec-
tions.57 A Cochrane study that looked at the effectiveness of external inspection systems 
found a paucity of high-quality studies and no firm conclusions could be drawn58. In addi-
tion, numerous researchers have demonstrated a lack of reliability in the external inspection 
processes with noticeable variations in the inspection reports59,60.
Other authorization tools, such as professional licensure, certification or registration have 
had a more noticeable impact on the quality of care provided61. For example, studies have 
found an association between a medical team with a higher proportion of registered or 
licensed nurses and lower mortality rates and improved patient outcomes62. Similarly, earlier 
involvement of licensed consultants are associated with better patient outcomes and lower 
levels of involvement, for example during weekends or holidays, have been associated with 
poorer patient outcomes63. However, professional licensure boards in different countries such 
as the US and UK have come under criticism for failing to protect the safety of patients64and 
improve the quality of care65.
Structural Regulation
Structural regulation involves amending the design of the physical or technological environ-
ment with the aim of changing the behaviour of the regulated persons. The idea behind 
this regulatory method is to manipulate the environment or redesign the care processes in 
order to influence behaviour37. This is also often referred to as the choice architecture. There 
are examples of structural regulation in the public health field, including warning labels on 
cigarette packaging, water sanitation or hazardous waste disposal37. There is some evidence 
that choice architecture may have a positive effect on the targeted compliance behaviour, 
for example, presumed consent for organ donations66 or active surveillance and isolation of 
infected patients to prevent transmission67. However, further research is required as this is a 
relatively new field of study in healthcare regulation.
Informational Regulation
Ensuring that patients and their families have access to reliable, timely and accurate information 
is an important healthcare regulatory objective as it empowers recipients to make an informed 
decision. Informational regulation can include requirements to fully disclose side effects of 
certain medical treatment, warning labels and the public release of performance results.
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An effective way to improve quality and contain costs are patient registries that track and 
make available the outcomes various population groups68. A large study comparing 13 
registries in 5 countries concluded that registries can improve patient outcomes at a lower 
costs69. In the Netherlands, the establishment and maintenance of a national colorectal 
cancer surgery registry resulted in a 29% decline in mortality and 20% decline in severe 
complications70.
Another informational regulatory tool is to disclose and release information such as reports 
about the quality of care. Food or menu labelling, for example, can help to reduce overall 
calorie intake.71 A large systematic review also concluded that the public release of perfor-
mance data helps to stimulate change and improve quality.72
Finally, regulators can also use less prescriptive and directive tools and more persuasive tools38, 
such as information campaigns and training. As Gunningham points out73, one of the most 
powerful tools for any regulator is acquiring and expanding its credibility and legitimacy. 
Ayres and Braithwaite’s concept of responsive regulation38 can assist regulators in finding 
the right regulatory strategy with the highest likelihood of success74. For example, many pa-
tients do not adhere to medical recommendations, resulting in lower than expected patient 
outcomes.75 However, when patients are more likely to accept a clinician’s recommendation 
if patients perceive that the clinician is credible and uses fair procedures76. Applying this 
understanding in the regulatory context may also result in greater compliance with regula-
tory requirements.
Legal Regulation
Methods of legal regulation include laws, guidelines and rules. Growing evidence exists 
indicating that Clinical Practice Guidelines (CPGs) can, at times, have positive effects on the 
quality of clinical care77. Clinical Practice Guidelines are often used to support clinicians in 
using best available clinical evidence in their daily clinical practice. There is some evidence 
that by standardizing clinical practice improvements in the quality and safety of care can be 
made78,79. Since the positive effects are widely acknowledged, health care regulatory agen-
cies have often mandated the development and implementation of guidelines80.
Another form of applying regulatory requirements is through mandatory incident and ad-
verse event reporting81. Several longitudinal82 studies reviewing adverse event rates over a 
period of time found limited evidence that these mandatory systems resulted in a reduction 
in incidents or adverse events83.
Finally, many healthcare regulators have attempted to steer the behaviours of organizations 
and professionals by setting standards describing and specifying the compliance require-
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ments and expectations. Standards are considered an essential part of quality improvement84, 
however, the evidence available is sparse and the link between standards and improvements 
in quality are primarily associative rather than causal58.
In summary, many healthcare regulatory agencies have an arsenal of different regulatory 
methods at their disposal with limited insights into the effectiveness of each method and 
how the regulator can maximize the impact of the regulatory methods. This study takes an 
in-depth look at the potential benefits of three methods: Structural (behavioural cues), Legal 
(clinical practice guidelines) and Informational (Legitimacy).
1.4 Effectiveness of healthcare regulation: Measurement 
Challenges
To date limited research has been conducted into how healthcare regulation works in practice 
and, more importantly, what impact it has made33. One of the key conclusions of the empiri-
cal research has been that the research evidence of the impact of regulatory interventions 
on quality of healthcare is sparse85, based on observational studies and research has found 
an associative rather than causal link between regulation and quality improvement.35 As a 
recent RAND Europe review of the regulatory mechanisms of six countries concluded: “The 
overall evidence of the effectiveness of regulatory strategies towards ensuring care quality 
and safety at system level is scarce”.86
There are several explanations for this lack of empirical evidence. First of all, regulatory agen-
cies often are not always able to show evidence that their regulatory methods are reliable, 
accurate and trustworthy. For example, a study undertaken in the Netherlands87,88 found that 
53% of rating by inspectors working for the Dutch Health Care Inspectorate were unreliable. 
The researchers found that in 52% the inspectors had given the service provider a higher 
rating than what, based on the descriptions of the evidence, could have been expected 
(false positives). The remaining 1% were false negatives: the inspectors had given the service 
provider a lower rating than expected. A recent evaluation of the Care Quality Commission 
(CQC) in England89 reported a low predictive value of the risk rating for healthcare facilities 
and the rate of compliance. In other words, there was no statistically significant relationship 
between the risk rating and the performance of the operator. Further research found sig-
nificant variation in CQC assessments59. Similarly, a Norwegian research study of inspection 
reports issued by the healthcare regulatory organization found that none of the reports 
contained any reference to outcomes and in 47% of the inspection reports the observations 
did not explain or display how deficiencies might affect processes in the organization and 
often made no specific reference to the exact standard57.
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A second challenge is that the objectives of healthcare regulation can be poorly defined and 
not specific enough to be measured. For example, improving the quality of healthcare is one 
of the most common objectives for healthcare regulatory agencies. However, quality as a 
construct is difficult to define and even more challenging to measure90. Quality of healthcare 
is multi-dimensional and a consensus appears to be emerging within national governments 
- USA, Australia, Canada, England, New Zealand - and international organizations - OECD, 
World Health Organization - that quality involves a small number of domains91. The US 
Institute of Medicine8 (2001) identified six dimensions through which the overall concept 
of quality is expressed: Safety, effectiveness, patient-centeredness, timeliness, efficiency and 
equity. Other international umbrella organizations, such as the WHO and the OECD have 
taken an active leadership role in defining and measuring quality of healthcare, through 
research, indicators development, performance measurements and conceptual frameworks. 
Notwithstanding this, the lack of unified definition relating to healthcare quality, as well 
as other regulatory objectives, creates additional measurement challenges for a regulatory 
agency.
Thirdly, regulatory agencies often encounter numerous challenges relating to their relation-
ship with the regulated organizations. For example, unnecessary rules are slow to disappear 
and new rules to address new risks are slow in coming (regulatory obsolescence)32; at times 
regulated organizations may find ways to avoid compliance (regulatory escape)5 or they may 
capture influence over the regulator (regulatory capture)33. Attempts have been made to 
address these challenges, through initiatives initiated from central government, with catchy 
titles such as Better Regulation, reducing red tape, regulatory reform, Regulatory Impact 
Assessments, etc. However, many of these initiatives are insufficiently grounded in evidence 
and often based on naïve and overly optimistic view of their benefits36.
Furthermore, considering the complexity of the health care systems overall, including the 
diverse political and cultural contexts within which regulatory agencies operate, it can be 
a challenge to analyse information and ascertain causal or even associative relationships 
between the regulatory methods deployed and the quality of care provided.86 Regulation 
in healthcare does not revolve around one organization and a regulator may not always 
have the authority over a particular area. The regulatory agency often has to consider the 
confounding factors that influence compliance. Scholars in the field of regulation, such as 
Braithwaite and Healy36 and Gunningham and Grabosky92 have advocated for the use of a 
mixture of regulatory strategies, making it even more challenging to ascertain relationships 
between a regulatory intervention and its expected outcomes.
Finally, citizens often have misperceptions and unrealistic expectations when it comes to 
the role, responsibility and influence of regulatory agencies. Public concerns often relate 
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to the direct costs of healthcare regulation93 and the perceived outcomes31. Table 3 below 
offers an overview of the annual costs of institutional healthcare regulatory agencies in 
five countries showing that, for the selected countries, the average direct expenditure for 
healthcare institutional regulatory authorities varied between 4.38 and 7.68 USD per head of 
population. However, healthcare regulatory costs are only make up a really small part of the 
healthcare expenditure per head of population. For example, in Sweden, the total healthcare 
expenditure per capita in Sweden was 5,219 USD in 201494 of which less 0.15% (7.68 USD) 
was spent on healthcare regulation.













Care Quality Commission 
(CQC)
2681 314M USD 5.92 USD
Ireland 4.8M
Health Information and 
Quality Authority (HIQA)
192 21M USD 4.38 USD
Netherlands 17 M
Dutch Healthcare Inspectorate 
(IGZ)




329 32M USD 6.04 USD
Sweden 9.9M
Health and Social Care 
Inspectorate (IVO)
640 76M USD 7.68 USD
A survey in the Netherlands found that the majority of the public assigned a higher degree 
of responsibility for the quality of care to the regulator rather than the care providers97. A 
similar survey in Sydney, Australia, found that, when it comes to the public’s view regard-
ing the responsibility for healthcare quality, respondents allocated the highest scores to the 
regulatory agencies98. Ensuring that the regulatory meets and exceeds the expectations of 
the public plays an important role in creating the right foundation for effective regulation.
To date, the small number of evaluations into the effectiveness of healthcare regulation 
have mostly focused on the regulatory processes and, to a lesser extent, the outputs and 
outcomes. Evaluations have not yet focused on the actual behaviours that regulatory agen-
cies are attempting to change. For example, the effectiveness of the UK regulatory healthcare 
authorities has been reviewed a number of times in the last decade by looking only at the 
governance of the regulatory agencies and the impact on performance.99,100,89
The effect chain
To create a better understanding of the achieving regulatory outcomes, we first need to 
understand the determinants of compliant behaviour. Only a small number of empirical 
studies have looked at why some healthcare organizations or individuals display compli-
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ant behaviours and others do not7. The ability of regulatory agencies to ensure compliance 
with regulatory requirements such as standards, directives, rules, guidelines, etc. underpins 
the study into healthcare regulation.76 Since the extent to which different actors within the 
wider healthcare system comply with regulatory requirements is assumed to impact on the 
quality and safety of healthcare, it is important to conduct further research into the exact 
determinants of compliance.
The Organisation for Economic Cooperation and Development (OECD) has designed a 
generic regulatory framework or effect chain to evaluate whether the regulatory methods 
and interventions have the desired effect and achieve the regulatory objectives29. As a recent 
report from the OECD points out, in order to be effective, healthcare regulators need to 
ensure that their institutional governance arrangements and regulatory instruments are 
evidence based and fit for purpose101 The independent scientific healthcare advisory body 
in the Netherlands, the Health Council102, started to conduct multidisciplinary research into 
the effectiveness of its regulatory system103 around 10 years ago creating the impetus for the 
development of an effect chain framework currently used by the Dutch Healthcare Inspector-
ate85, see Figures 2 and 3 below.
Figure 2 – Effect chain for healthcare regulation, adapted from OECD29
Studies into the determinants of health outcomes have found that the provision of health 
care services has a limited but not negligible role as a determinant of health. Approximately 
five years of the 30-year increase in life expectancy achieved this century can be attributed to 
improved medical care104. Of these 5 years, curative services contribute about 3.5 and clinical 
preventive services about 1.5 years. The greatest share of this gain from health care can be 
attributed to diagnosis and treatment of coronary heart disease, which contributes 1 to 2 of 
these additional years of life. The quality of health care is one of a number of determinants 
of health outcomes, as Figure 3 illustrates. Other determinants include genetic disposition, 
social circumstances, environmental factors and behavioural choices105.
In addition to this, the relationship between the regulatory interventions and the behaviour 
of the organization or individuals is also quite complex and not yet well understood106. Even 
if compliance improves, it does not always lead to improved health outcomes, as Oude Wes-
selink et al107 found when investigating the effects of diabetes guidelines compliance and 
health outcomes. Other studies have found similar results, with a lack of positive outcomes 
from regulatory interventions such as accreditation54,93,106 and external inspection58.
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Figure 3 – Effect chain for healthcare regulation, adapted from OECD29
1.5 Research aim and objectives
This research study aims to contribute to a better understanding of the role and effect of 
regulation in healthcare, including providing new insights into the complexity and inter-
relationships of factors influencing compliance of healthcare professionals.
The central question guiding this research is:
How can regulators utilize regulatory methods to improve healthcare regulatory compliance?
The research objectives are:
Research objectives: Chapter(s)
Review the role and impact of health system reform in the United Arab Emirates 
with a specific focus on Abu Dhabi.
Chapters 2 and 3
Review the current availability, use and effects of a particular healthcare regulatory 
intervention (Clinical Practice Guidelines) in the Gulf region
Chapter 4
Examine the determinants of self- reported compliance by particularly looking at 
the social motivators of behaviour and the relationship between perceptions of 
procedural justice and legitimacy and compliance with regulatory requirements
Chapters 5 and 6





This research study investigates the relationship between regulatory methods and compliant 
behaviour, assuming that the compliant behaviour, in turn, will ultimately lead to improve-
ments in the quality of care and better patient outcomes.
1.6 Study Design
The extent to which different actors, in particular clinicians, within the healthcare system 
comply with the regulatory requirements is assumed to have an impact on the quality and 
safety of healthcare (see Figures 2 & 3, the regulatory effect chain). Conducting research into 
the determinants of compliance is therefore important in order to gain better insights into 
what methods are effective in improving compliance.
In this study, we looked at how a number of regulatory methods – legal (Clinical Practice 
Guidelines, Chapter 4), informational (perceptions of legitimacy, Chapters 5 and 6) and 
structural methods (behavioural cues, Chapter 7), interact with regulatory compliance, using 
a number of different research methods. In addition, we also conducted systematic reviews 
of the existing evidence regarding the healthcare system reform in the UAE.
We selected these study designs for a number of reasons. Due to a lack of research in the 
fields of health policy, management and regulation in Abu Dhabi, the UAE and across the 
broader Gulf region108, the research started with systematic reviews of the healthcare sys-
tems in Abu Dhabi and the UAE, as well as a review of the development, implementation and 
evaluation of one regulatory method (Clinical Practice Guidelines, CPGs) in the Gulf Region. 
We chose CPGs as the topic for our systematic review because of the growing evidence of 
the positive impact CPGs have on the quality and safety of healthcare.80 Since most Gulf 
countries have only recently established healthcare regulatory authorities, it made sense to 
focus our initial research on a relatively well understood regulatory method.
Increasing the number of UAE nationals (Emiratis) in all medical professions forms an impor-
tant part of the UAE’s Vision 2021109 and in our study we focused on this group. The study 
took place in the largest medical and health sciences university in the UAE. We conducted a 
survey with these medical students to measure their perceptions of healthcare regulation and 
their self-reported compliance levels.
We selected a natural field experiment as our third study design because we wanted to 
investigate a regulatory method that could be replicated in other settings. One of the chal-
lenges when comparing effectiveness of regulatory methods is that healthcare regulatory 
agencies are quite unique in terms of their functions, remit and instruments39. Conducting an 
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experiment in a controlled environment allowed us to generate research findings that could 
be applicable elsewhere.
Systematic Reviews – Abu Dhabi, UAE and the Gulf region
Our research started with an investigation into the health system reform with an initial, 
specific focus on the regulatory context in the Emirate of Abu Dhabi. This was followed by 
a more general review of the healthcare system in the entire UAE to review the progress 
against its strategic reform program, Vision 2021.24 Finally, the research focused on the de-
velopment, implementation and evaluation of a specific regulatory method, Clinical Practice 
Guidelines within the Gulf region.
Each systematic literature review was conducted using a variety of databases, such as 
Medline, PubMed and the Cochrane Library, as well as publicly available “grey” literature. 
A search strategy was prepared for each study using defined keywords and reviewers inde-
pendently screened and selected potentially relevant articles that met the inclusion criteria. 
Once the articles were screened and selected for inclusion, the studies were assessed utilizing 
a standardized template and information.
Cross sectional study into the perceptions of healthcare regulation 
and self-reported compliance
The traditional viewpoint on the determinants of compliance behaviour has concentrated 
on instrumental motivations: people obey rules and laws because there are penalties and 
incentives. However, instrumental mechanisms have, at best, a small impact on compliance 
behaviour.110,111,112 An alternative viewpoint looks at the role of people’s social motivations 
in terms of the perceived legitimacy and fairness of the regulatory process76. The study 
focused on the factors that influence and determine healthcare professionals’ compliance 
with specific regulatory requirements by investigating the relationship between participants’ 
perceptions regarding the legitimacy and fairness of the regulatory process and the self-
reported compliance.
Natural field experiment into the effects of subtle behavioural cues
Influenced by behavioural economists, such as Daniel Kahneman and Amos Tversky113 and 
Richard Thaler114 and Cass Sunstein115, decision makers, politicians and researchers have 
increasingly investigated the role and impact of psychological, cognitive, emotional and 
social factors on decision-making. Behavioural approaches recognise that humans are not 
entirely rational and humans frequently misjudge decisions because of their inherent biases 
when making sense of information. The move towards this new approach is also influencing 
regulatory agencies115. In order to review the effects of behavioural cues, we conducted a 
field experiment to investigate the effects of cues of being observed by displaying a picture of 
Chapter 1
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human eyes in the area where the research is carried out. ‘Watching eyes’ experiments have 
been tested in a variety of different settings and areas. Previous studies116 have found that 
people complied with instructions or social norms better when eyes images were displayed, 
for example paying for coffee, clearing/sorting one’s litter, preventing bicycle theft, charitable 
donations and other pro social behaviour.
1.7 Outline of this Thesis
This thesis consists of a series of studies that contribute to a small but growing body of 
scientific evidence related to the role and impact of regulatory methods in the healthcare 
sector. Chapters 2 and 3 serve as an introduction and contextualization of the main body of 
research which is presented in the subsequent Chapters.
Chapter 2 sets the scene in terms of the context of the healthcare reform in the Emirate of 
Abu Dhabi, as part of the UAE where this study took place and Chapter 3 presents a more 
in-depth progress report on the reform progress within the country as a whole.
The findings of the specific role and compliance effects of healthcare regulatory methods are 
described in Chapters 4, 5, 6 and 7. In Chapter 4 we describe the findings from a literature 
review focused on one of the more prevalent regulatory methods, Clinical Practice Guide-
lines. This study looks at the development, implementation and evaluation of this regulatory 
tool in the Gulf Region.
In Chapters 5 and 6 we present the findings of a cross-sectional survey measuring the percep-
tions of students in medicine in the UAE and its influence on their actual and self-reported 
compliance. Chapter 7 describes the results of a field experiment with medical students in 
a natural setting in a medical faculty in the UAE, exploring the impact of simple behavioural 
cues on levels of regulatory compliance.
In the final chapter of this thesis, Chapter 8, we discuss the methodology, limitations of the 
research, the interpretation of the main findings and it describes a potential way forward to 
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The desire to achieve the best outcomes in the provision of healthcare has driven health 
system reforms in many countries across the globe, including the Emirate of Abu Dhabi, 
United Arab Emirates.
As a young state (the United Arab Emirates was founded as an independent state in 1971) 
with a diverse (with 78% expatriates) and young population (40.23% of the national Emirati 
population is under 15 years of age), the government of the Emirate of Abu Dhabi has 
embarked on a journey to reform their healthcare system. This reform focuses on the rede-
sign, financing, regulation and provision of healthcare with the aim of delivering accessible, 
affordable and high quality health care.
We will describe and review the health system reform in Abu Dhabi to date: its background, 
history and characteristics. The review looks at whether the main components of the reform 
(mandatory health insurance; enhanced competition and a centralized regulatory system) 
have had the desired effects in terms of improving quality, enhancing access and ensuring 
affordability.
Looking towards the future for the health system in Abu Dhabi we conclude that it is too 
early to tell whether the reform programme is having the desired effects in terms of achieving 
its goals of quality, access and affordability.
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2.2 Introduction
Since the beginning of the foundation of the United Arab Emirates (UAE) as an independent, 
sovereign state in 1971, the late founder and President of the UAE, His Highness Sheikh 
Zayed bin Sultan Al Nahyan, consistently expressed his vision of access to high quality health-
care for the entire community. Over the past four decades, realizing this vision has been one 
of the key drivers of reform in the provision of healthcare.
The United Arab Emirates (UAE) is a Federal union of 7 distinct State-Emirates. The Emirate 
of Abu Dhabi acts as the political capital for the Federation and, together with Dubai, the 
two Emirates account for more than two thirds of non-oil Gross Domestic Products (GDP) of 
the UAE1.
The Emirate of Abu Dhabi is rich in national resources and over 2.2 million of barrels of oil 
are produced annually in the Emirate of Abu Dhabi, of which over 90% is exported and 
half of the GDP of the Emirate of Abu Dhabi relates to oil1. One of the main objectives 
of the government of Abu Dhabi is to reduce its reliance on the oil exports by promoting 
diversification and targeting growth areas such as tourism, healthcare, telecommunications 
and aviation2. Abu Dhabi is the second largest federal state, population wise, within the 
United Arab Emirates, with an estimated total population of around 2.4 million in 20113. The 
population is multi-cultural, diverse and young: 22% of the population is Emirati, of whom 
two thirds are under the age of 30, 2.2% are over 65 years of age and only 8.8% of the 
labour force is Emirati. The majority of the expatriate population is male (70%) and almost 
half of expatriates are under the age of 301.
This vision for healthcare in the Emirate of Abu Dhabi has been outlined by the Executive 
Council’s (the executive authority or council of Ministers) Policy Agenda 2007-2008 and 
Economic Vision 2030 for Abu Dhabi2,4. These strategies have played a key role in focusing 
on the strengthening of a secure and stable society and a dynamic open economy based 
on pillars such as education, healthcare, enhanced privatization, sustainable development 
within a transparent regulatory environment. The main aims are to establish a sustainable 
economic development in Abu Dhabi and ensuring a balanced social and regional economic 
development approach that brings benefits to all.
In this introduction, we will describe the main characteristics of the health system reform in 
the Emirate of Abu Dhabi since 2007, when a major reorganization took place of the health 
system.
Since 2007, healthcare regulation in the Emirate of Abu Dhabi has been the responsibility 
of one central, statutory agency, the Health Authority – Abu Dhabi (HAAD). HAAD reports 
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directly to the Executive Council (the executive authority of the Emirate of Abu Dhabi) and 
sets regulatory requirements for healthcare providers, professionals and payers (insurance 
companies), operates a mandatory licensing system, monitors compliance with require-
ments and takes action to enforce compliance. In addition, HAAD plays a central role in 
health promotion campaigns and public health programs and strategic planning5. Since its 
establishment HAAD has set out to the achievement of affordable, quality healthcare that is 
accessible to all6.
Note: The term health system reform is used in this article rather than healthcare reform 
since the definition of health systems is broader and encompasses the resources, actors and 
institutions related to the financing, regulation and provision of all activities whose primary 
purpose is to promote, restore or maintain health7.
The population in the Emirate of Abu Dhabi has a number of interesting characteristics. The 
birth and death rates have declined rapidly over the last two decades. However, there is a 
marked difference between the death rates of the national and expatriate populations: the 
death rate for the Emirati (national) population was 2.2 per 1,000 in 2011, compared to 
3.8 in 1985 for the nationals. In comparison, the death rate for the expatriate population 
was 1.0 in 2011 and 1.8 in 19853. At the same time the birth rate amongst nationals has 
decreased from 46.9 per 1,000 in 1985 to 33.7 in 2011. During the same period, the birth 
rate amongst the expatriate community decreased from 29.1 in 1985 to 8.7 in 2011. The 
high rates of male expatriates (77% of all expatriates are male) and a young expatriate 
population (99.4% of the expatriate population is below the age of 65) are the most likely 
causes for these differences3.
Across the United Arab Emirates the infant mortality rate has dropped significantly from 15 
to 7 per 1,000 births between 1990 and 20093. In 2010, life expectancy at birth for Abu 
Dhabi Emirate was 74.9 years for males and 77.0 years for females1. Across all age groups, 
nationals accounted for 34% of all deaths. Nationals accounted for 59% of all the deaths 
above the age of 65. However, of all deaths of young adults (20 – 39 years) 14.4% were 
nationals3. The leading causes of death are diseases of the circulatory system, cancer and 
deaths due to road traffic injuries.
The Emirate has relative high rates of chronic diseases related to life style including obesity, 
diabetes and cardiovascular diseases5. Over the last three decades the prevalence of diabetes 
has increased fivefold from around 5% to almost 25% of the national Emirati population in 
Abu Dhabi8. According to preliminary analysis by the Health Authority Abu Dhabi, 21% of 
Emirati nationals are diabetics compared to 18% of expatriates3. In addition, cardiovascular 
diseases accounted for over a quarter of deaths in 2011, with obesity rates high for both the 
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national as well as the expatriate population (national: 33% for males and 38% for females; 
expatriates: 17% for males and 32% for females)3. One recent study of a sample of over 
500 Emirati women reported a prevalence of obesity (defined by body mass index > or = 
30) of 35% with many women (28%) reporting having a chronic disease (including obesity, 
diabetes, cardiovascular disease, respiratory disease)9.
By Emirati law employers are required to provide for health insurance coverage for its 
employees and their families. Residence status is generally contingent on being employed. 
Hence, there are very few retired or unemployed expatriates10. There are three insurance 
schemes in operation in the Emirate of Abu Dhabi: Thiqa cover, which is available only for 
Emirati nationals; Basic cover, mainly for unskilled labourers and lower paid employees and 
Enhanced cover, mainly for higher skilled expatriate workers. There are over 400,000 people 
insured through Thiqa; over 1.3 million insured with the Basic product and over 1 million 
policy holders with the Enhanced cover3.
The Thiqa and Basic schemes are provided by the National Health Insurance Company, Da-
man, a Abu Dhabi government owned entity that has a strategic partnership with Munich 
Re, a large German health insurance company. The Enhanced scheme is provided by 35 
licensed insurers, including Daman. Individual members of the different schemes have to 
make co-payments, which differs per insurance company and relates mainly to payments for 
pharmaceutics, optical and dental services.
As Figure 1 below shows, there are noticeable differences in the utilization of healthcare be-
tween different groups as reflected in the percentage of claims per health scheme: 15.7% of 
insured individuals hold a Thiqa card, compared to 47% who have Basic insurance. However, 
as a percentage of the amount claimed, Thiqa card holders represent 40.1% of the market, 
whereas Basic insurance card holders represent 26.5%. The higher utilization rate of Thiqa 
members can be explained by the differences between the expatriate and national, Emirati 
population. The expatriate population tends to be younger, predominantly male and more 
transient. In contrast, a higher percentage of the national population has is over the age of 
65 and there is a higher birth rate amongst the national population. Lifestyle characteristics 
may also play an important role with a high prevalence of diabetes amongst national. A 
recent study found that in one of the largest hospitals in Abu Dhabi, nationals accounted 
for 72.2% of all diabetes related inpatient encounters8. Finally, the lower number claims 
per member per year for workers on the basic insurance (average of 3 claims per year, as 
compared to 14 claims per year for Thiqa members) may also be due to the fact that the level 
of co-payment is higher for the Basic insurance product3.
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Figure 1 Membership market share versus expenditure market share (2011)
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There has been a noticeable growth in the provision of healthcare services in the United Arab 
Emirates over the last decade.  According to recent statistics, in 2010 the total number of patient 
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in 2008 22%3. It is difficult to explain the dip in the growth rate between 2008 and 2009, however at 
















There has been a noticeable growth in the provision of healthcare services in the United 
Arab Emirates over the last decade. According to recent statistics, in 2010 the total number 
of patient encounters had grown by 17.5% compared to 2009, whereas the growth rate 
in 2009 was 2.5% and in 2008 22%3. It is difficult to explain the dip in the growth rate 
between 2008 and 2009, however at the same time the Abu Dhabi economy contracted by 
24%1, mainly due to the global economic recession.
As Figure 2 below illustrates, the absolute growth for Outpatient Care between 2007 and 
2010 was 46.4% (12.2 million encounters in 2010, compared to 8.4 million in 2007). During 
the same period the absolute growth for Emergency Care was 28.2% and for Inpatient Care 
only 0.4%.
Figure 2 Number of patient encounters in Abu Dhabi, 2007 - 2010
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Inpatient discharges 173,331 174,587 177,428 174,099
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A further analysis of the encounters over the same time period1,3,5,6 indicates that, when 
expressed in relative terms, the growth has been less evident (see also Table 1 below). Whilst 
there has been a particular growth in outpatient encounters (an increase of 26.1% in just 4 
years), the relative growth in ED encounters was small and there was even a decrease in the 
discharge rates for inpatients over those 4 years.
Table 1 Number of patient encounters in Abu Dhabi per 1,000 population, 2007-2010
Number of patient episodes in Abu Dhabi, per 1,000 population
Year 2007 2008 2009 2010
Difference 
2007-10
Discharge rate per 1,000 population 102.21 95.58 92.61 88.48 -13.43%
ED encounters per 1,000 population 376.01 390.11 432.97 415.53 10.51%
Outpatient encounters per 1,000 
population
4,934.03 5,646.50 5,460.15 6,223.68 26.14%
Healthcare in Abu Dhabi is provided by over 22,000 licensed healthcare professionals who 
work in over 1,200 facilities, ranging from pharmacies, clinics, and rehabilitation centres to 
acute hospitals. In total there are almost 5,000 physicians, almost 1,000 dentists, over 8,000 
nurses and 5,000 allied health professionals3.
In terms of provision of healthcare, the establishment of a new state-owned company in 
charge of the management and contracting of healthcare services was established by law 
in 2007, with governmental support. This company, SEHA (Arabic for Health), provides 
inpatient and outpatient services and over 66% of all hospital beds are provided by or on 
behalf of SEHA (see Table 2 below). Prior to being established as a Government supported, 
private company, the facilities in the SEHA group were managed by the General Authority 
for Health Services, GAHS. SEHA manages its own existing facilities and has contracted the 
management of a number of large hospitals with international healthcare groups, such as 
John Hopkins Medicine and the Cleveland Clinic. The overall market share for SEHA is 56% 




Table 2 Provision of health services in the Emirate of Abu Dhabi
Provision of health services in the Emirate of Abu Dhabi: SEHA and non-SEHA
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In the next section we will review the health system reform program in Abu Dhabi.
2.3 Discussion: Health System Reform in the Emirate of 
Abu Dhabi
The provision of high quality, affordable and sustainable healthcare that citizens can freely 
access remains a dream for many politicians, providers, payers, policy and decision makers. 
In many countries, the gap between dream and reality has led stakeholders such as patient 
lobby groups, political parties, researchers, providers, insurers and policy makers to advocate 
for structural and lasting reform to address the multitude of persisting quality problems and 
financial concerns.
In the previous section we described some of the main characteristics of the health system in 
Abu Dhabi, in terms of population, payer and provider. We will now review the current situ-
ation in Abu Dhabi by looking at whether the different elements of the reform have had the 
desired effect in terms of achieving the projected outcomes: improving quality, expanding 
access and ensuring affordability6,11. Before we look at the three main elements of the reform 
in Abu Dhabi (mandatory health insurance, enhanced competition and a centralized regula-
tory system) we will briefly describe the international research into health system reform.
Even though international organizations such as the World Health Organization (WHO) and 
the Organization for Economic Cooperation and Development (OECD) have carried out 
many comparative reviews, the evidence of the impact of health system reforms remains 
inconclusive as healthcare costs continue to grow, disparities remain and health outcomes 
do not improve significantly. The WHO, following an extensive review of the available evi-
dence12, concluded that here is little evidence concerning the effectiveness of many reform 
policies. On behalf of the OECD Docteur and Oxley13 conducted a similar review six years 
later and drew as similar conclusion [page 8]: ‘choices about further reform are hampered by 
the insufficiency of information about the impact of the (numerous) reforms’.
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More recently the Australian Government mandated a Commission to review the health 
system and produce recommendations for reform. The Commission found that health sys-
tems are notoriously resistant to reform in a large part because of the competing objectives 
of access, quality and affordability14. Inherent to the process of reforming healthcare is that 
the goals cannot always be aligned and often compete with each other. For example, the 
objective of delivering of high quality healthcare can be expensive and therefore clash with 
the objective of delivering affordable healthcare.
More evidence has been found at an individual country level. In relation to England for ex-
ample, the King’s Fund reviewed the reform period under Labour government and concluded 
that considerable progress had been made. Particularly improvements had been made in 
reducing waiting times for treatment, reductions in rates of health care associated infections, 
improvements in areas of clinical priority such as cancer and cardiac care and progress in 
reducing rates of cigarette smoking15.
Pollitt16 concluded that one of the biggest assumptions is that there has been some well 
thought through and well-designed plan behind reform. However, reform is often the result 
of many compromises and systematic evidence is relatively sparse. The challenge is whether 
and how to attribute indicators of population health or specific outcomes to health service 
interventions.
Although Abu Dhabi’s health system reform is relatively young, after 5-6 years it is time to 
take stock and briefly analysing whether the three main characteristics of the reform have 
resulted in the desired outcomes.
Health insurance
As described earlier, the introduction of the mandatory health insurance system for all work-
ers is a key characteristic of the reform program. All employers are obliged to enrol and fund 
insurance for all eligible expatriate employees. The insurance requirements and the pricing 
are set by the regulatory authority.
In terms of access to health care, according to the regulatory authority, over 95% of the 
population is enrolled in one of three health insurance plans. However, this high level of 
enrolment has not led to an even distribution in terms of the utilization of healthcare. As 
noted in the Introduction, members of the Basic insurance access healthcare less frequently 
and have a higher level of co-payment. This could be an indication for underutilization and 
lower access for this particular group. However, it has to be considered that the age and 
sex distribution of this group is different. Furthermore, expats often leave the country when 
they become severely ill, which would lead to lower utilization numbers when compared to 
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the national population. Therefore the lower utilization in the Basic plan will require more 
attention and further analysis in the future. In addition, Emirati patients continue to use 
healthcare services outside of the United Arab Emirates. A Medical Board approved almost 
3,000 patients to avail of treatment abroad in 2010, an increase of 13% when compared 
to 200917.
Limited information is available regarding the affordability of healthcare. At a macro level, 
the most recent figures indicate that across the United Arab Emirates, 2.7% of GDP was 
spent on healthcare in 200918. The two largest insurance products, the Basic product and 
Thiqa scheme, are underwritten by the Abu Dhabi Government and limited data is avail-
able in relation to the overall costs to the Government. However, what is noticeable is a 
substantial increase in the number of payer submissions (claims) and the costs per insurance 
plan. Table 3 indicates the growth in payer submissions (claims), per insurance product, the 
overall growth is 42.1%, with the biggest growth (87.0%) in the Daman Basic product3,5,6.
Table 3 Health insurance in Abu Dhabi (2009-2011)
Payer claims and market share per insurance product, 2009-2011











Basic product (Daman) 2,132,354 20.1% 2,932,545 22.5% 3,987,477 26.5% 87.0%
Thiqa product (Daman) 4,475,578 42.3% 5,920,296 45.4% 6,029,795 40.1% 34.7%
Enhanced product 3,981,416 37.6% 4,200,514 32.2% 5,025,707 33.4% 26.2%
Total 10,589,348 100.0% 13,053,355 100.0% 15,042,979 100.0% 42.1%
At the same time, the average cost per claim is substantially lower for the Basic product, as 
shown in Table 4 below.
Table 4 Cost of average health insurance claim (2011)
Cost of average insurance claim, 2011 (in AED)
Inpatient Outpatients
Basic product (Daman) 8,792 152
Thiqa product (Daman) 12,727 362
Enhanced product 9,344 343
Recent research of the health insurance in Abu Dhabi19 has indicated that being covered by 
health insurance actually lowers per capita household’s health care spending to the extent 
that those benefiting from the introduction of mandatory health insurance experience a 
statistically significant increase in household’s disposable income. In comparison, in other 
Emirates, the original situation pre-2007 has remained with many low skill-low paid expatri-
ates who are either not insured at all or who are faced with out-of-pocket payments.
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It is difficult to ascertain what impact the introduction of a mandatory health insurance 
system has made on the quality of healthcare provision. The regulatory authority has also 
begun to implement a comprehensive pay for quality program. The first steps of establish-
ing an eClaims system, introducing a competitive market of insurance companies for the 
Enhanced product and a standardized new basic price list have been taken already. However, 
further evidence is required to review the effects of health insurance regulation on quality.
Enhanced Competition
Another important feature of the health system in Abu Dhabi has been enhanced competi-
tion through an increased privatization and the commissioning of large healthcare service 
contract to internationally recognised and well-established institutions such as the Cleveland 
Clinic and John Hopkins Hospital. With the establishment of the Abu Dhabi Health Services 
Company (SEHA) in early 2007, a mechanism was created to commission the delivery of 
critical care to external companies and with this create a quasi-market. SEHA manages the 
performance of contracted providers by monitoring a set of agreed key performance indica-
tors. This model includes financial penalties when the performance falls below the expected 
targets.
As described above, the private sector has expanded significantly and between 2009 and 
2010 the total number of healthcare facilities grew by 12.4%, with almost 90% of these 
facilities run by private companies5. It remains to be seen whether these changes have con-
tributed to an improvement in the quality of care provided as limited information is available 
on the quality of healthcare services.
The increase in number of facilities does not necessarily mean an improvement in terms of 
access to care. As we have noted above, the utilization rates differ starkly between different 
population groups. Also, worth noting is the increase in Emirati nationals travelling abroad 
for treatment, despite the increase in the number and range of healthcare facilities. In 2012 
the regulatory authority for healthcare, HAAD, launched a Capacity Master plan to ensure 
improved planning to address quality and access issues and stricter regulate the supply of 
healthcare services, in particular in areas where there appears to be oversupply (for example 
general/family medicine and dentistry) and undersupply (for example intensive care, psychia-
try and emergency medicine)3.
In terms of affordability of care, to date no concrete evidence exists to suggest that the 




The final characteristic of the health system reform in Abu Dhabi is the establishment of a 
centralized regulatory system, with one agency (Health Authority Abu Dhabi) responsible 
for the regulation of healthcare professionals, healthcare providers and healthcare insurance 
companies.
With the establishment of a regulatory authority, the government of Abu Dhabi created a 
mechanism to control costs and, indirectly, affordability, through a reimbursement mecha-
nism. The regulatory authority sets the level of reimbursement for all the different activities 
performed by healthcare providers. Since concrete evidence is not readily available, it still 
unclear what the effects have been on the affordability of care.
The introduction of the mandatory insurance system has led to an improved situation where 
virtually all residents are covered by insurance and therefore can access the basic healthcare 
that they require. The enforcement by the regulatory has indirectly contributed to improving 
access to care by all residents as heavy penalties are imposed on non-compliant employers 
[5]. Again the exact impact that this part of the reform has had remains unclear as further 
evidence is required.
In terms of quality, the regulatory authority is currently developing a quality rating system for 
all hospitals in Abu Dhabi, to provide relevant and trustworthy information about the quality 
of care. The Health Authority Abu Dhabi aims to create transparency and accountability in 
the healthcare industry by providing information about the quality of care to all stakeholders. 
As a first step the Health Authority Abu Dhabi introduced a rating system for pharmaceutical 
Facilities in 2011, with a view of expanding this to all healthcare facilities in 2012.
2.4 Conclusion: Reform in Abu Dhabi - what’s next?
Although in many countries stakeholders often hold different views on the most effective 
mechanism to implement reform, there appears to be a consensus on what the overall aims 
should be: affordable, high quality healthcare that citizens can freely access. The goals set by 
the Abu Dhabi government reflect the priorities of health system reform in other countries: 
ensure the provision of high quality, affordable and sustainable healthcare that can be ac-
cessed by the community.
To date research on the effects of the healthcare reform on the access, affordability and 
quality of healthcare in Abu Dhabi has been scarce.
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Despite this lack of evidence, a number of tentative conclusions can be drawn. In terms of 
the first goal: improving access to healthcare, great strides have been made as over 95% 
of the population (expatriates and nationals) are now members of a healthcare insurance 
scheme. However, the utilisation rates differ strongly between policy holders. Policy holders 
in the lower income groups underutilise the healthcare services and this discrepancy raises 
questions in relation to the achievement of an equitable distribution according to health 
needs
Even though the WHO estimated that the UAE’s expenditure on healthcare is relatively low 
(2.7% of GDP) compared to other countries, the Government of Abu Dhabi has made the 
sustainability of healthcare funding a key governmental priority4. However, no research has 
been conducted on the affordability of care from an individual insurance card holder and it 
remains to be seen what the impact of the health system reform has been as it is too early to 
tell whether they have had the desired effects on the affordability of care.
Finally, the regulatory authority has begun to measure the effects of the reform on the quality 
of healthcare have been measured in a number of different ways. For example, in 2010 the 
Health Authority Abu Dhabi contracted an external agency to conduct a comprehensive 
patient satisfaction survey. Over 34,000 people were interviewed and the study reported 
an overall satisfaction rating of 83% for outpatients and 86% for inpatients across all 37 
facilities participating5.
In conclusion, many challenges in terms of access, affordability and quality remain to be 
addressed in the Emirate of Abu Dhabi. The first steps have been taken under the leadership 
of the Health Authority Abu Dhabi but in order to effect sustainable, long-term change, the 
reform needs to continue in its efforts to ensure high quality, reliable excellence in healthcare. 
Creating transparency by publicly reporting on the performance and quality of healthcare 
is one of the major initiatives currently under way in Abu Dhabi. As part of their ongoing 
efforts to measure the impact of healthcare reform, the Health Authority Abu Dhabi has also 
established an ambitious research initiative to examine the relationship between regulatory 
approaches and compliance with regulatory requirements. Ayers and Braithwaite20 originally 
developed a theoretical model of ‘responsive regulation’ asserting that regulatory interven-
tions are more likely to succeed if they are responsive to the culture, context and conduct 
of the regulated organizations. The hypothesis behind this research study is that responsive 
regulatory interventions increase the likelihood of compliance with regulatory requirements, 
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The United Arab Emirates (UAE) government aspires to build a world class health system to 
improve the quality of healthcare and the health outcomes for its population. To achieve this 
it has implemented extensive health system reforms in the past ten years. The nature, extent 
and success of these reforms has not recently been comprehensively reviewed. In this paper 
we review the progress and outcomes of health systems reform in the UAE.
Methods
We searched relevant databases and other sources to identify published and unpublished 
studies and other data available between 01 January 2002 and 31 March 2016. Eligible 
studies were appraised and data were descriptively and narratively synthesized.
Results
Seventeen studies were included covering the following themes: the UAE health system, 
population health, the burden of disease, healthcare financing, healthcare workforce and the 
impact of reforms. Few, if any, studies prospectively set out to define and measure outcomes. 
A central part of the reforms has been the introduction of mandatory private health insur-
ance, the development of the private sector and the separation of planning and regulatory 
responsibilities from provider functions. The review confirmed the commitment of the UAE 
to build a world class health system but amongst researchers and commentators’ opinion 
is divided on whether the reforms have been successful although patient satisfaction with 
services appears high and there are some positive indications including increasing coverage 
of hospital accreditation. The UAE has a rapidly growing population with a unique age and 
sex distribution, there have been notable successes in improving child and maternal mortality 
and extending life expectancy but there are high levels of chronic diseases. The relevance of 
the reforms for public health and their impact on the determinants of chronic diseases have 
been questioned.
Conclusions
From the existing research literature, it is not possible to conclude whether UAE health sys-
tem reforms are working. We recommend that research should continue in this area but that 
research questions should be more clearly defined, focusing whenever possible on outcomes 
rather than processes.
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3.2 Background
The United Arab Emirates (UAE) is a young nation, established in 1971 as a federation of 
seven Emirates: Abu Dhabi, Dubai, Ajman, Umm Al Quwain, Sharjah, Fujairah and Ras Al 
Khaimah (Figure 1). This newness has allowed its leaders to deliberately plan for the develop-
ment of UAE society in order to strengthen national unity, promote continuous economic 
growth and personal health and wellbeing1.
Figure 1 Map of United Arab Emirates showing the seven Emirates
As recently as the late 1960s, in the UAE, it was reported that only half of new-born babies 
survived and one in three mothers died during childbirth2. Almost fifty years later many 
health outcomes are on par or even better than those seen in developed countries. The 
maternal mortality ratio (MMR) is now 8 per 100,000 live births (in contrast to an MMR of 
14 in the USA) and the infant mortality rate is 5.6 per 1,000 live births (5.8 in the USA)3. 
Healthcare in the UAE has benefited from rapid economic growth and there has been a 
significant increase in the number of healthcare facilities and healthcare professionals and in 
levels of service use. For example, between 2011 and 2015 healthcare spending in the UAE 
grew by 10% to US$ 11 billion4.
In 2014, the Vice President and Prime Minister of the UAE, His Highness Sheikh Mohammed 
bin Rashid Al Maktoum, launched an ambitious set of plans with the overall goal of making 
the UAE one of the best countries in the world by 2021, the 50th anniversary of its founda-
tion. The UAE National Agenda 2021 consists of a comprehensive set of key performance 
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indicators (KPI) with specific targets and clear pathways for achieving those targets5. For 
example, in 2016, the UAE Government announced the appointment of a Minister of Hap-
piness whose task it is to ensure that the UAE is ranked among the top five countries in the 
world according to the World Happiness Report6.
The improvement of the health of its citizens and the performance of the healthcare system 
form one of seven headings of the UAE national strategy. The KPIs include population health 
targets, such as increasing life expectancy and reducing tobacco consumption, as well as 
more structural and organizational targets, such as the regulatory requirement for all health-
care facilities to be externally accredited5. Overall, the UAE aims to be ranked amongst the 
top 20 countries in the world, according to the Legatum Prosperity Indicator. In 2015 the 
UAE was ranked 34th globally, an improvement from 37th place in 20147.
Given its starting point, it is remarkable what has been achieved in the UAE in the last 
four decades. However since the early 2000s the UAE has been involved with an ambitious 
program of health system reforms to further improve health and health services and to ad-
dress cost and quality challenges. These reforms have focused on the introduction of private 
health insurance and encouraging the growth of private health provision against a back-drop 
of rapid population growth and a rising prevalence of chronic disease and chronic disease risk 
factors including obesity, low levels of physical activity and diabetes8.
The purpose of this paper is to describe the main healthcare challenges and public health is-
sues in the UAE and review the progress and outcomes of health systems reform. This will be 
achieved by reviewing secondary data from peer-reviewed journal publications and reports of 
government agencies and related health organizations. Even though the term health system 
reform is regularly used, it is rarely defined in any operational way9. In this paper we have 
defined health system reform as “sustained, purposeful change to improve the efficiency, 
equity and effectiveness of the health care sector”10.
3.3 Methods
Data for this review were obtained by means of a systematic search of the published literature 
using defined keywords, conducted according to Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) guidelines11. MEDLINE (accessed by PubMed), EMBASE 
and PsycINFO electronic databases were searched covering the period from 2002 to April 
2016 using a combination of the following MESH terms, free-text words, and entry terms: 
UAE; United Arab Emirates; Dubai; Abu Dhabi; healthcare quality, access and evaluation; 
healthcare reform, health system reform, health sector reform.
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In addition, reference lists of published studies were searched manually for relevant articles. 
To minimize publication bias and improve the usefulness of our review we also conducted 
a thorough analysis of existing, publicly available “grey” literature by means of personal 
contact with senior officers at health authorities, government agencies and health sector 
organizations and a review of publications and reports from health policy centres, the 
healthcare business sector and key international sources. These sources included the World 
Health Organization (WHO) and its regional office for the Eastern Mediterranean (EMRO), 
the Organisation for Economic Co-operation and Development (OECD), the World Bank, and 
local sources such as the Health Authority Abu Dhabi (HAAD), Dubai Health Authority (DHA), 
Ministry of Health and the Federal Competitiveness and Statistics Authority.
Finally, a small number of other sources were reviewed from local “think tanks” and con-
sultancy and research firms. These included Ernst and Young, Colliers International, The 
Economist Intelligence Unit, US-UAE Business Council, Joint Commission International and 
Sheikh Saud bin Saqr Al Qasimi Foundation for Policy Research.
Eligible studies were those that focused on the UAE health system. Excluded studies were 
those that focused on healthcare in the wider region, studies that were published before 
2002, articles that were not available in English and duplicate studies or those that formed 
part of a larger study. Two reviewers (EK, IB) independently screened the titles and abstracts 
of identified studies and duplicates were removed. Studies considered eligible for full text 
screening were retrieved for full review. The reviewers independently assessed the papers for 
eligibility and quality, and then met to resolve any disagreements regarding eligibility and/or 
quality. The key features of the studies were summarized using a data extraction form that 
recorded first author name, year, study design, setting, theme and key findings. A descriptive 
and narrative synthesis of the studies was carried out.
3.4 Results
We screened 353 published articles and 17 met our inclusion criteria (Figure 2). Of these, 
three related to Dubai, eight to Abu Dhabi and six were UAE-wide and all were published 
after 2010. There were four cross-sectional studies, six policy reviews, three data reviews, 
two case studies and two literature reviews. From a careful reading of the selected papers it 
was possible to classify the content into six categories or themes. The six themes are: the UAE 
health system, population health, the burden of disease, healthcare financing, healthcare in-
frastructure and workforce and the impact of reforms (Table 1). The findings are summarized 
under these headings in the following sections. For the sake of clarity, while acknowledging 
the possible inferior quality, we have included the grey literature, appropriately referenced, it 
in our summary along with the published literature.
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Figure 2 Flow diagram of the search and selection process
Table 1 Summary of study characteristics included in the literature search
First author, 
Year
Study Design / 
Method
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1,605 USD, with complications 5,645 
USD
Burden of disease 
(diabetes)
61% of all diabetes patients in the 
cohort reported to have suffered poor 








Asthma treatment in the UAE costs 
around 200 USD per capita
Burden of disease 
(asthma)
Crude prevalence of asthma is 4.8%, 
much lower than expected
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The UAE health system
Ten of the included papers discussed the UAE health system. Improving the quality of health-
care as well as the actual health outcomes for its citizens has been a key strategic goal of the 
UAE government since its formation in 1971. Dubai and Abu Dhabi have their own health 
authorities for licensing, regulation and quality assurance. The Federal Ministry of Health 
(MOH) fulfils these functions in the other five emirates. In addition, the MOH carries out 
certain high-level functions for all Emirates17. In both Dubai and Abu Dhabi around 70% of 
outpatient visits are made to private healthcare facilities while for inpatient activity in private 
facilities the proportion is 40% in Abu Dhabi and 60% in Dubai28,29. In the remaining five 
Emirates, the Ministry of Health is both the regulator as well as the main provider of most 
healthcare services. According to the most recent data, in 2014, there were 36 government 
and 79 private hospitals in the UAE, an increase of 25% since 200930.
In 2006 the government of Abu Dhabi embarked on a significant health system reform pro-
gram with a clear focus on the redesign of the healthcare financing and regulatory system8. 
The regulatory function (the responsibility of Health Authority Abu Dhabi) was separated 
from service provision (the responsibility of the Abu Dhabi health service company, SEHA). 
Also, the new system required all persons to have private health insurance and provides a 
centralized platform for automated claims processing and an improved level of accountability 
and transparency because of market regulation27. One study reported large differences in 
healthcare utilization rates between UAE nationals who, on average, used outpatient clinical 
services once per month compared to expatriates where usage rates were 3-4 times less31.
In 2014, Dubai also began to introduce mandatory health insurance, with about one third 
of its residents currently estimated to be insured32. A recent review of the Dubai health 
system concluded that more effort should be made to move from curative to preventive 
services22. The same review also found that the current system of care encouraged excessive 
hospital utilization and recommended a reorientation towards outpatient, home based and 
day surgery services.
It has been reported that the rest of the UAE will follow soon with the introduction of man-
datory private health insurance but a final date has not been set33. The MOH is considering 
introducing health insurance but has not yet done so. In the northern Emirates, the private 
sector is less well developed than in Dubai and Abu Dhabi and the quality and cost of services 
varies between these two Emirates and the remainder of the country31.
Five of the studies examined the UAE health regulatory system with one highlighting the 
trend towards regulatory fragmentation as a serious challenge to the future of healthcare in 
the UAE32. A further study reported the lack of regulatory control and a lack of competition 
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between insurance companies as the two main obstacles to achieving greater cost efficiency 
in the healthcare market20. Researchers who evaluated the regulatory system for healthcare 
professionals concluded that the UAE had made significant progress in developing and 
implementing best regulatory practice17. Other research on the regulation of healthcare ser-
vices in Abu Dhabi concluded that several challenges remained to be addressed, in particular 
with respect to quality improvement32. Interestingly, Abu Dhabi’s healthcare regulator itself, 
HAAD, concluded in 2013 that “the current model of care in Abu Dhabi does not adequately 
support self-care or prevention and screening programs and diagnostic services are not in-
tegrated into care plans. Also, patients have undirected access to services and specialty care 
which leads to inappropriate use and, in turn, over-supply of services”29.
Population health
Five studies addressed this topic. The UAE population can be characterized as young and 
fast growing. The UAE population pyramid is remarkable in term its youthfulness and the 
high proportion of male expatriates14. Overall, the median age is 30 but amongst UAE 
nationals, who only account for approximately 11% of the population, 79% are aged less 
than 353,30. Expatriates are typically of working age but despite this the majority are aged 
35 or less. Population growth rate has also been remarkable. In 1950 the population was 
70,000, in 1968 it was 180,000 but this has now grown to 9.16 million34,35. Over the last 
10 years the population has more than doubled, mainly due to large net in-migration of 
expatriates. Since the population of nationals is small, the contribution of the birth rate 
amongst nationals to overall population growth is also small. For example, between 2010 
and 2014, the UAE population grew by over one million. However, during this four-year pe-
riod, the national population increase by only 126,609 (births minus deaths). In other words, 
population growth amongst nationals contributed only 11.7% of total population growth. 
By comparison, natural growth amongst expatriates contributed 19% of total population 
growth and net in-migration contributed the remaining 70%.
The great majority of the expatriate population in the UAE are male, young and originally from 
Asian countries. For example, it is estimated that approximately 2.6 million Indian nationals 
reside in the UAE36. The total fertility rate (average number of children that would be born to a 
woman over her lifetime) decreased from 4.4 in 1990 to 2.4 in 201023. During the same period, 
the average life expectancy improved from 72 years to 77 years37. The unique characteristics 
of the UAE population should play a major role in the development and implementation of 
health strategies and policies. Clearly child and maternal health services, youth services, health 
promotion and preventative services and occupational health services should be priorities31. A 
recurring theme from the studies that we reviewed is the need to improve health data collec-
tion and reporting14,31. For example, birth and death data are reported but not by nationality, 
making it difficult to determine what, if any, specific, targeted strategies are required.
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In summary, the demographic transition in the UAE is one characterized by declining birth 
and death rates which with high net in-migration has resulted in significant population 
growth24. There has been a second health transition in the UAE in recent decades, an epi-
demiological transition, characterized by a decline in communicable diseases and a rise in 
non-communicable or chronic diseases, such as heart disease, diabetes and cancer24. This is 
described in the following section.
The burden of disease
Eight studies discussed UAE mortality, morbidity and risk factors. As mentioned earlier, the 
UAE Government has set itself a number of challenging targets through its Vision 2021 strat-
egy5. Of particular relevance are the targets to reduce the number of deaths (per 100,000 
population) from cardiovascular disease from 297 to 158. Other targets relate to a reduction 
in the number of adults with diabetes (from 19% to 16%), a reduction of obesity amongst 
children (from 13% to 12%) and an increase in the healthy life expectancy (from 67 years 
to 73 years). Since its independence in 1971, the UAE has made significant progress with 
increased life expectancy and lower maternal and infant mortality rates19. However, despite 
these achievements, the UAE faces a number of challenges including rising rates of non-
communicable diseases such as diabetes, cardiovascular diseases and cancer23.
The UAE has made progress with the control and prevention of communicable diseases, 
through a strong focus on immunization, surveillance, mandatory reporting and effective 
treatment23. The mandatory screening of all expatriate workers linked to the visa application 
and renewal process has also had an effect38. The national neonatal screening program for 
new born babies has been successful with an increased uptake from 50% in 1998 to 95% 
in 2010 resulting in early detection, treatment and follow up16. The WHO currently estimates 
that world-wide around 67% of all deaths are now attributable to non-communicable 
diseases, with the leading causes of death reported as cardiovascular diseases, injury and 
cancer39. This is also the situation in UAE, where mortality from non-communicable diseases 
(NCDs) among those aged 60 years or younger is amongst the highest in the world. The 
leading causes of premature deaths in the UAE are road injury, cardiovascular disease and 
respiratory illnesses31. In the studies that we reviewed, authors identified the determinants 
of this health loss as unhealthy lifestyles (physical inactivity, high caloric intake) and a lack of 
health system focus on prevention, chronic disease management, early stage interventions 
and inadequate treatment options for NCDs and their complications. As solutions, these 
authors proposed further research, the establishment of reliable surveillance and monitoring 
programs and improved training and education for healthcare professionals12,16,23.
We found five studies that described interventions to address the UAE burden of NCDs. 
One such intervention is the Abu Dhabi Weqaya program that aims to screen adults for 
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cardiovascular disease risk factors followed by targeted follow up, treatment and secondary 
prevention18. Weqaya has confirmed a high prevalence of cardiovascular disease risk factors 
amongst the adult population. Following the successful implementation of screening in a 
small, high-risk population using newly agreed UAE screening guidelines other researchers 
have recommended a national diabetes screening program40. In the review we found a num-
ber of studies that reviewed the direct and indirect economic burden of selected diseases, 
including asthma and diabetes12,13. The economic burden of asthma was estimated at US$ 29 
million in Abu Dhabi and US$ 24 million in Dubai, an annual per capita cost of around US$ 
200, about half the cost compared to European or North American benchmarks.
One of the most cited articles in the review assessed the direct medical costs of diabetes care, 
the annual cost of diabetes without complications was US$ 1605, similar to the costs in most 
western countries but the treatment costs of diabetes mellitus with complications was up 
to 9.4 times higher12. The authors of these papers that reviewed the economic costs of high 
burden diseases typically recommended improvements in management including nationwide 
early screening and rapid implementation of best-practice clinical guidelines as a means to 
improve outcomes while controlling costs.
Healthcare financing
Seven studies discussed healthcare financing. Recently published WHO data indicates that in 
the UAE over the last 12 years, total expenditure on health as percentage of gross domestic 
product (GDP) has increased by over 36% (from 2.2% of GDP in 2000 to 3.0% in 2012)3.
In absolute terms, the UAE’s GDP rose from US $ 104.3 billion in 2000 to US$ 372.3 billion 
2012, meaning that health spending grew from US$ 2.3 billion to US$ 11.2 billion. More 
recent reports show a further increase to US$ 13.6 billion in 2014 with an expected budget 
of US$ 25.7 billion by 202441.
In Abu Dhabi, mandatory health insurance for all nationals and expatriates has been the major 
driver of its healthcare reform since 200621. There are three different insurance schemes: two 
for expatriates (Basic and Enhanced) and one for UAE nationals (Thiqa). In 2011 there were 
15.3 million insurance claims with an average cost per claim of $105 giving a total insurance 
bill of US$ 1.6 billion. This had grown to over 22 million claims and US$ 2.9 billion by 201429.
Even though there has been a steady rise in the number of claims (Figure 3) as well as the 
overall cost, some researchers have argued that this is appropriate because universal health 
insurance cover and transparent, standardized payment rules and regulation allow for better 
control of cost, ensure that health needs are met and offer patients the freedom to choose 
provider8,27.
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Figure 3 Health insurance claims by type of insurance scheme, Abu Dhabi, 2009- 2014
However, other researchers have concluded that increasing claims and costs signal the need 
for further changes to ensure long-term financial sustainability21. The WHO and other sources 
estimate that the UAE government spent almost a quarter of its total healthcare expenditure 
in 2010 to send its citizens abroad for medical care27,39.
Dubai Health Authority for example sponsored 2,717 patients in 2014 for treatment abroad, 
an increase of almost 2,000 in 10 years28 (Table 2). While in 2013, Health Authority Abu 
Dhabi sponsored over 1,400 patients29. There are also other referral sources for UAE nation-
als who wish to be sent abroad for medical treatment, including the Ministry of Health, 
Ministry of Defence, Abu Dhabi National Oil Company (ADNOC) and other large companies8.
Table 2 Funding of International Patient Care by Dubai Health Authority
Source: Dubai Health Authority’s Annual Reports42.
Year
No. UAE Patients who received 
medical treatment outside UAE
Average cost per patient (US$) Total cost (US$)
2004 808 40,436 32,672,262
2005 679 54,768 37,187,738
2006 863 57,221 49,381,471
2007 946 51,499 48,717,711
2008 850 75,204 63,923,706
2009 1073 59,128 63,444,414
2010 975 68,392 66,682,561
2011 1428 57,766 82,489,373
2012 1819 50,681 92,189,101
2013 2010 46,921 94,311,172
2014 2717 44,142 119,932,970
At the same time, the UAE is working to attract medical tourists to its healthcare facilities, in 
particular its highly specialized hospitals. For example in 2012, Dubai attracted over 500,000 
medical tourists, a figure that is expected to grow annually by 10-15%43.
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In the UAE the level of out-of-pocket (OOP) healthcare expenses is relatively low in compari-
son to other countries in the region and the rest of the world. At 20% the OOP is just above 
the OECD average of 17% indicating a reasonable level of financial protection44.
A number of studies have commented on the low levels (ranging from 4-15%) of generic 
prescribing and the high use of branded pharmaceuticals with the inevitable implications 
for increasing costs45,46. In the UAE, data on health care spending is not yet available in a 
standardized format. The claims based data for Abu Dhabi shown in Table 2 contains only 
the reimbursement cost not the actual cost. Denials, co-payments and sole payments are 
not included. Also cost estimates typically exclude capital expenditure, funding provided 
through other government institutions such as the Ministry of Defence and ADNOC and 
cash payments.
Table 3 gives a breakdown and estimate of the healthcare expenditure in the UAE based on 
our findings from this review22,42.
Table 3 UAE total healthcare expenditure (Billion US$), by Emirate, 2014




International Patient Care 3.6
Total 13.6
Healthcare infrastructure and workforce
Five studies addressed this topic. Hospital bed and physician and nurse numbers have in-
creased in the past decade generally keeping pace with the growth of the population (Table 
4). The total number of hospital beds has more than doubled and there has almost been a 
five-fold increase in the number of nurses and physicians30. A number of case studies have 
reviewed the current demand and supply and made recommendations for future configura-
tion and capacity. Few of these studies reported that additional increases in hospital beds and 
staff numbers were justified26,31,41.
However, the Health Authority Abu Dhabi estimated that a further 4,800 physicians and 
13,000 nurses would be required for Abu Dhabi alone to meet the projected 2022 de-
mand29. The goal for the UAE is to bring the level of nurses and physicians to a world class 
level, which means that the number of nurses need to be almost doubled and the number of 
physicians needs to increase by 20%5.
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Table 4 UAE healthcare infrastructure, by category, Government and private, 2005-2014
2005 2010 2014
Government*
Hospitals 26 34 36
Beds 4,273 7,029 7,493
Physicians 2,105 5,031 6,504
Nurses 6,132 10,875 16,547
Private
Hospitals 37 58 79
Beds 1,546 2,556 4,164
Physicians 1,143 7,866 10,165
Nurses 1,866 10,611 16,882
Total
Hospitals 63 92 115
Beds 5,819 9,585 11,657
Physicians 3,248 12,897 16,669
Nurses 7,998 21,486 33,429
* Includes Ministry of Health, Ministry of Interior, Ministry of Defence, Abu Dhabi Health Authority, Dubai 
Health Authority and ADNOC
Despite these reported shortfalls in capacity and resources, the authors were unable to find 
any studies that analysed the potential effects of the reported lack of manpower and hospital 
beds. On the contrary, a number of studies, as well as a report from the Abu Dhabi regulatory 
authority described potential oversupply in certain areas29,31. Another challenge is the high 
rate of turnover of clinical staff, with one report estimating that around 15% of physicians 
and 13% of nurses left their positions in the UAE in 2012 alone47.
The impact of reforms: quality
Only three of the studies focused on the impact of health system reforms. Although a num-
ber of researchers have commented that it is too early to say whether the UAE health system 
reforms that have been in place over the past 10 years have achieved the desired outcomes, 
there is evidence of a positive trend8,31. A recent study in a large hospital in Abu Dhabi found 
a decrease in reported clinically significant adverse events in one department (paediatrics) 
over a four year period48. This decrease coincided with the reform of its residency training 
program, leading to the researcher’s conclusion that “it is quite likely that our residents are 
providing better patient care”. In Abu Dhabi, a study into perceptions and attitudes towards 
medical research amongst focus group participants noted that the UAE has one of the best 
healthcare systems in the region49.
The UAE has also witnessed a significant growth in Joint Commission International (JCI) 
accreditation50. JCI accreditation has become increasingly important in the UAE, where a 
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growing number of providers have achieved JCI accreditation51 (Table 5). It is estimated that 
currently 47% of healthcare facilities are accredited and the UAE government’s ambition is 
to achieve 100% accreditation by 20215. In our review we found few studies that reported 
quality and outcomes of care. However, in one study in Dubai that reviewed the quality of 
care for diabetic patients, using a standardized assessment, the researchers found a num-
ber of differences when compared to the US benchmark and recommended a nationwide 
benchmarking program25. Another study found that while a private hospital maintained 
its performance following JCI accreditation, accreditation did not contribute to an overall, 
sustained improvement52. Finally, in our review, we found that studies that examined patient 
satisfaction generally reported consistently high levels compared to other countries8,31.
Table 5 Joint Commission International accredited facilities, UAE, 2007-2015
Source: Joint Commission International











This review has highlighted the ambition and commitment of the UAE to build a world class 
health system and has catalogued the major reforms that have been implemented in the 
past decade to achieve this. The paucity and limited scope of the studies means that it is not 
possible to conclude whether the reforms are working although patient satisfaction with 
services appears high and there are some isolated examples of quality improvement.
The UAE health system is not a single system, rather there are several systems and of these 
the three main systems are operated by the health authorities of Abu Dhabi and Dubai and 
the Ministry of Health (MOH). These systems have expanded in the past ten years in line with 
the growth of the population and increases in national income and have been subjected to 
major reforms aimed at improving public health and quality while keeping costs at sustain-
able levels, thereby achieving a world class health service.
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The main elements of the reforms have been a move to mandatory private health insurance 
for all citizens and expatriates, the development of the private sector to deliver services and 
the separation of planning and regulatory responsibilities from provider functions. These 
reforms have moved at different speeds, being most complete in Abu Dhabi, in the de-
velopment phase in Dubai and just commencing in the MOH. This patchy implementation 
has highlighted variations in access, affordability and quality across the Emirates. Amongst 
researchers and commentators opinion is divided on whether the reforms have been success-
ful. Few, if any, studies have prospectively set out to define and measure outcomes and while 
some researchers have expressed optimism others have been more critical. The relevance of 
the reforms for public health and their impact on the determinants of chronic diseases have 
been questioned with some researchers citing market failure and oversupply.
The UAE has a rapidly growing population with a unique age and sex distribution. There is an 
unusually high proportion of young people and expatriates of working age, small numbers 
of older persons and rapid year on year growth due to high net in-migration. It might be 
expected that the unique characteristics of the population would be a major factor to be 
considered when planning and implementing health services but there is little published 
research to support this. While child and maternal health services are well developed, there 
is little published evidence of needs analysis in the areas of youth services, health promotion, 
preventative services and occupational health services. Also health data is not collected and 
reported in a way that allows the health needs of these population sub-groups to be defined.
The UAE has passed through the epidemiological transition with impressive reductions in 
health loss from infections and neonatal and nutritional disorders but an increasing burden 
of non-communicable disease (NCD) notably cardiovascular disease (CVD), diabetes and road 
injury. The lifestyle risk factors for these diseases (obesity, low physical activity) are at high 
levels. From our review there is evidence of high level commitment to addressing these issues. 
The Abu Dhabi Weqaya program set out to identify and manage individual CVD risk factors 
but after the initial report describing the program and presenting baseline data there have 
been no updates on outcomes, effectiveness or recommendations to extend the program to 
the whole UAE adult population. There is good evidence for the considerable cost burden 
that NCDs place on health budgets and bench-marking has shown that the situation in the 
UAE is comparable to that in other high income countries. However there is also evidence 
that in the management of NCDs international best practice is not always followed.
Total expenditure on health has increased both in absolute terms and as a percentage of 
national income. As in all health systems these increases can be explained on the basis of 
population growth, aging of the population, advances in technology and price inflation. In 
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the UAE, the increases may also be justified if there was previously unmet need that is now 
being met.
In our review we found researchers who suspected over-use, waste and fraud and who ques-
tioned whether the increases in activity and cost were sustainable or whether further reforms 
were required. In the review, a recurring theme was the need to economize on drug costs 
by encouraging greater use of generic products. In our review we were surprised that, given 
the excellence of the UAE health system, substantial numbers of patients are funded to have 
medical treatment abroad at substantial cost. This is all the more noteworthy because the 
UAE health system is highly successful at attracting incoming medical tourists. The reasons 
for this curious state of affairs was not explored in depth but if the UAE’s ambition to have a 
world class health system is fully achieved then funding patients to receive routine treatment 
abroad would seem to be improvident. In the review we found discussion of the percentage 
of total health expenditure that is contributed by out-of-pocket (OOP) expenses, a widely 
used metric to indicate financial security. In the UAE, the OOP percentage is comparable 
to that seen in other countries with well-developed progressive health systems. This might 
appear surprising given the high levels of disposable income enjoyed by many UAE citizens 
and expatriates. However, once again our review highlighted the need to improve the quality 
of data collection and reporting and to make allowance for the fact that the UAE population 
is very heterogeneous
In this review, we found that a normative approach was typically adopted to plan and predict 
future capacity both for hospital bed numbers and numbers of doctors, nurses and other 
healthcare staff. The norms or benchmarks that are used are those from North America and 
Europe. It is not clear if there is shortage or oversupply or what, if any, are the consequences 
of this. What is clear from published evidence is the high staff turnover and poor retention 
rates.
From our review, it is not possible to say if the UAE health systems reforms are working. Some 
researchers have concluded that it is too early to expect to see any effect but mostly the 
research in this area has not focused specifically on this question. We found isolated reports 
of initiatives that have improved quality. UAE national policy is that all hospitals should be 
JCI accredited and good progress is being made towards this target. Again, there are a few 
reports of the beneficial effects of accreditation but this is an area that is poorly researched. 
We found isolated examples of where services or programs had been audited against inter-
national best practice benchmarks with mixed findings. Where researchers commented on 
patient satisfaction with services this was usually high.
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Despite the increased focus on healthcare reforms in many countries, it remains a concept 
lacking a clear definition9. According to one definition, health system reform can be described 
as a “significant purposive effort to improve the performance of the health care system”53.
With respect to the impact of reforms, several authors have cautioned against simplistic, 
cause-and-effect logic because of the complexities involved in overseeing and providing 
healthcare with multiple, demanding stakeholders, competing political priorities and high 
expectations54,55. However, despite this caution, over the last three decades, global institu-
tions such as the World Health Organization and the World Bank have stimulated national 
government to reform their health systems, with notable results56. For example, governments 
of developing countries, such as Brazil, Russia, India, China and South Africa have committed 
themselves to radical reform programs with the goal of achieving universal health cover-
age and China in particular has made significant progress in ensuring that its population 
has access to healthcare53,57. Similarly, the Affordable Care Act in the US has resulted in an 
impressive decrease in the percentage of uninsured adults58. Specifically to the Middle East 
and North Africa region, researchers have commented on the increased focus on building or 
reforming health insurance systems as a popular method of reform59.
This is the most complete summary, to date, of the evidence available on the progress and 
outcomes of health systems reform in the United Arab Emirates. Our study is not without 
limitations. We found a limited number of studies that addressed UAE health system re-
form and of those that did most lacked robust methodology and failed to focus on the 
outcomes of reform. Although our search strategy was broad and included both published 
and unpublished sources to minimize publication bias it is possible that papers meeting our 
inclusion criteria were missed and therefore, not included in the review. Nevertheless, the 
review provides a stock-take or baseline from which future researchers can plan and develop 
their research questions. We have identified some important gaps in knowledge that may 
inform future research.
3.6 Conclusion
The UAE government is committed to build a world class health system to improve the 
quality of healthcare health outcomes for its population. To achieve this, it has implemented 
extensive health system reforms in the past 10 years including the introduction of mandatory 
private health insurance, the development of the private sector and the separation of plan-
ning and regulatory responsibilities from provider functions.
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From the existing research literature, it is not possible to conclude whether the reforms are 
working although there are some positive indications including high patient satisfaction, 
increasing coverage of JCI accreditation and isolated examples of quality improvement. We 
recommend that research should continue in this area but that research questions should 
be more clearly defined focusing whenever possible on outcomes rather than processes. 
In addition, there is need for better quality data collection and reporting to allow the health 
needs and outcomes of specific population sub-groups to be defined. Finally, there is scope 
to align services and program more closely with international best practice and to benchmark 
UAE performance with that of similar highly developed, progressive health systems from 
around the world.
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Objective: Our aim was to examine and describe the current situation in Gulf Cooperation 
Council (GCC) member countries regarding the development, implementation and evalua-
tion of clinical practice guidelines. The objectives were to describe from where the studies 
originated, what the clinical focus was of each study and examine the methodology and the 
status of each study (i.e. development, dissemination, implementation and evaluation).
Methods: Review of literature – two stages: Stage 1: screening through an abstract review, 
followed by independent adjudicator. Stage 2: detailed assessment and classification.
Results: Considering the widespread acceptance that CPG’s are useful and effective tools for 
quality improvement in healthcare, it is worth noting that relatively few studies have been 
conducted in the GCC region that examine CPG. Furthermore, the reviewers found that 
the quality of the research methods used could be improved. However, the majority of the 
studies that were conducted evaluated the effects of guidelines and focused on the ‘lifestyle 
diseases’, in particular diabetes and cardiovascular diseases. It is also worth noting that there 
has been a steady increase in the number of publications over the 10 years period.
Conclusions: More attention needs to be given to developing, disseminating, implementing 
and evaluating CPG’s in the GCC region in order to improve the quality and safety of health 
care.
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4.2 Introduction
Concerns about patient safety, an increased focus on high quality, rising consumer expecta-
tions and increased healthcare costs have all highlighted the need to regulate and improve 
the quality of healthcare services. The term healthcare regulation is used to describe the 
collective function by an entity (regulator) to act in the interest of the public in order to 
achieve regulatory objectives1. In order to abate or control risks and provide assurances to 
the society, different regulatory interventions have been introduced to both deter particular 
non-desirable actions and behaviours and encourage compliance with desired actions and 
behaviours. Both forms of regulation (deterrence and compliance) are used extensively in 
healthcare regulation2.
Despite the best intentions of regulatory authorities, there still is a dearth of empirical evi-
dence of the overall effectiveness of regulatory interventions on the quality of health care3–5.
However, studies into the effectiveness of regulatory interventions have found moderate, 
positive results on the quality and safety of healthcare in relation to two regulatory interven-
tions in particular: accreditation6 and evidence based best practice guidelines such as Clinical 
Practice Guidelines7–9. The focus of this study is on one of these interventions in particular: 
This study will provide an overview of the availability, use and effects of guidelines in the Gulf 
Cooperation Council (GCC) region. This study forms part of a broader investigation into the 
relationship between regulatory approaches and compliance with regulatory requirements 
for healthcare organizations and professionals10.
In clinical practice, clinicians are encouraged to implement and adhere to evidence-based 
clinical practice guidelines (CPGs), as these are regarded as important tools for quality im-
provement and patient safety. Clinical practice guidelines are used to translate, adopt and 
implement best evidence into everyday clinical practice11.
The Institute of Medicine12 defines clinical practice guidelines as “statements that include 
recommendations intended to optimize patient care that are informed by a systematic review 
of evidence and an assessment of the benefits and harms of alternative care options”.
The aim of developing clinical guidelines is to produce explicit recommendations that are 
both scientifically valid and helpful in clinical practice13. Implementation can be described as 
‘a planned process and systematic introduction of innovations or changes of proven value; 
the aim being that these are given a structural place in professional practice, in the function-
ing of organizations or in the health care structure9. Finally, the evaluation of guidelines con-
siders whether the recommendations in the guideline and pathway are adhered to, whether 
practices have changed and whether the intended health outcomes have improved14.
Chapter 4
84
There is evidence that the use of standardized practice is associated with improvements 
in the quality and safety of care15–17, as well as cost savings18. Since the positive effects 
are widely acknowledged, healthcare regulatory authorities have regularly endorsed and 
mandated the development and implementation of guidelines4. The effectiveness of clinical 
practice guidelines in terms of improvement in the quality of care and patient outcomes has 
been well documented7,9 which has led to a proliferation of guidelines, often as part of a 
regulatory intervention.
This study analyses the current situation in one of the fastest changing regions in the world: 
The Gulf region in the Arabian Peninsula. Six countries in the Gulf region (the United Arab 
Emirates, the Kingdom of Bahrain, the Kingdom of Saudi Arabia, the Sultanate of Oman, 
the State of Qatar and the State of Kuwait) that shared a common language, religion and 
history in the Gulf region established a cooperative agreement in 1981, the Gulf Cooperation 
Council (GCC). The GCC countries collaborate on a variety of areas, including economic 
development, foreign policy and also healthcare. The GCC Council of Health Ministers is 
comprised of health ministers from each of the seven member states and convenes biannu-
ally. The total, combined population of the six GCC countries was 45 million in 2011, with 
astonishing population growth rates of up to 850% in the last 3 decades in Qatar and 780% 
in the United Arab Emirates19, mainly due to the increase of expatriate worker. During the 
same period, GCC countries witnessed a rise in life expectancy (for example life expectancy 
in the United Arab Emirates improved from 69 years in 1980 to 77 years in 2011) and sig-
nificant improvements in under-five mortality, achieving reductions ranging from 70% to an 
impressive 91% lower mortality in Oman. Another notable characteristic is the large number 
of expatriates: nationals are a minority in all GCC countries, except Oman and Saudi Arabia20.
4.3 Methods
The aims of this review were to investigate the stages of development, implementation and 
evaluation of clinical practice guidelines in the countries of the GCC region and to present 
the latest available information, per GCC country and clinical specialty.
Screening
A systematic literature review was conducted in Medline and PubMed databases and Co-
chrane Library on clinical practice guidelines in the GCC region. Searches included studies 
published between 2000 and 2013, in the English language. Two reviewers (EK and AA) 
independently screened the titles and abstracts and selected potentially relevant articles that 
met the inclusion criteria. Any differences between the two reviewers were referred to a third 
researcher (CA) for resolution.
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The following search strategy was deployed:
#1 Clinical practice guideline OR clinical guidelines OR evidence-based guidelines
#2 Develop* OR availab* OR implement* OR adopt* OR adher* OR compliance OR dis-
seminat* OR evaluat* OR promulgat* OR effect* OR impact
#3 Gulf Cooperation Countries OR GCC OR United Arab Emirates OR UAE OR Oman OR 
Sultanate of Oman OR Qatar OR Saudi Arabia OR Kingdom of Saudi ArabiaOR Kuwait 
OR Bahrain OR Kingdom of Bahrain
#4 (#1 AND #2 AND #3)
Data extraction and assessment
Once the articles had been screened and selected for inclusion, the studies were assessed 
utilizing a standardized template and information on the following was recorded by two 










The final search was conducted on 2 October 2013 and resulted in 229 articles. Two review-
ers independently reviewed the titles and abstract and key words to determine eligibility. 
Any disputes were referred to a third researcher. This resulted in the selection of 73 papers 
for further analysis and assessment. Among these 73 articles identified, 58 were selected 
following the detailed assessment of the studies. Out of these 58 articles, 24 (40.4%) were 
published by journals from the GCC Region, primarily from Saudi Arabia (32.78% of all 
articles).
Country or countries of origin
The majority of the publications originated from Saudi Arabia (27), followed by the United 
Arab Emirates (8), Kuwait (7), Oman (4), Bahrain (3) and Qatar (1). In addition, 2 articles 
covered the entire Gulf Cooperation Council (GCC) Region and a further six covered the 
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entire Middle East and North Africa Region (MENA Region). However, the overwhelming 
majority of articles refer to and compare their findings with international Clinical Practice 
Guidelines (50 out of 58 articles).
Topic of study: Disease or Condition
Table 1 below indicates what type of disease or condition the articles focused on. Unsurpris-
ingly, the majority of articles (30 out of 58 articles) dealt with the common lifestyle associated 
diseases in the GCC region (i.e. cardiovascular, diabetes, hypertension and cancer). However, 
quite a range of topics were studied, including pandemic influenza, smoking cessation, etc.






Infectious diseases 5 (8.6%)
Hypertension 4 (6.9%)
Communicable diseases 3 (5.2%)
Community Acquired Pneumonia 3 (5.2%)
Cardiovascular disease 2 (3.4%)
N/A 2 (3.4%)
Two articles did not deal with a specific topic, one article21 dealt with the attitudes and 
self-reported behaviours of healthcare professionals toward clinical practice guidelines in 
a hospital in Saudi Arabia and the second article22 described a brief background on clinical 
practice guidelines in Saudi Arabia.
Publication date
There has been a steady increase in the number of articles published over the last 15 years, 
as shown Figure 1 below, with a marked increase since 2010. Over 60% of all articles were 
published in the last 4 years.
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Figure 1 Publications by year













































































Stages and study design
A small number of publications simply reproduce the guidelines in an article format, for 
example the Osteoporosis Guidelines in Saudi Arabia23 and GCC Guidelines for Commu-
nity-Acquired Pneumonia24 and a larger number describe the entire process for developing 
guidelines. In total, 20 articles describe the development of a guideline, most often based 
on a literature review and expert consultation. However, only one study25 utilises the AGREE 
Instrument to evaluate the quality of the CPG. A number of articles also make reference 
to guidelines developed by regional GCC working groups, such as the GCC Community-
Acquired Pneumonia Working Group26–28 and the MENA Region–National Comprehensive 
Cancer Network Breast Cancer Guidelines29.
In total 7 publications focused solely on the implementation process and systematic introduc-
tion of the guidelines into practice, mainly using surveys as methodology, for example the 
implementation of Asthma Guidelines in Oman30.
In terms of publication productivity, it is difficult to infer anything from this number of articles, 
since there have been very few comparative studies. However, it appears to be lower than 
what could be expected, considering the population size. A study31 into the quantity and 
quality of biomedical publications between 2001-2005 found that the 12 countries selected 
from the Arab world (including the GCC region) producing significantly fewer biomedical 
publications of lower quality than other Middle Eastern countries (Turkey, Israel and Iran). 
Other studies have found similar results32,33.
Finally, the majority of the publications (31 out of 58) described findings from evaluating 
the adherence to guidelines or the effects of the implementation of guidelines. The research 
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methodology to evaluate adherence and effects included cross sectional studies, case series, 
retrospective reviews of medical records and in one study, a randomised controlled trial34. 
These evaluation studies are important as they attempt to discover whether practices have 
changed and whether the intended outcomes have been achieved.
A closer review of these evaluation studies indicate that out of the 31 studies, 25 concentrated 
solely on evaluating the adherence to the processes, for example the self-reported adherence 
of primary care physicians in Bahrain to the WHO-recommended guidelines for the manage-
ment of acute diarrhoea35. Two studies focused solely on the effects of the guidelines36,37 and a 
further six remaining studies focused on both the adherence to guidelines as well as the effects, 
for example, one study from the UAE looked at the physician’s adherence to diabetes guide-
lines and its effects on the health outcomes of patients38. Most of these studies used evaluation 
studies used methods such as chart reviews of patient files and reviews of medical records, such 
as26,39,40, and a smaller number used prospective cross-sectional reviews through observation, 
for example35,41,42 or surveys for healthcare professionals43 and patients44. A number of studies 
used a combination of methods, for example medical records reviews and physician surveys45.
The reviewers looked in particular at the methodological quality of the 31 studies that 
evaluated the adherence to and effects of Clinical Practice Guidelines. This part of the review 
focused on three criteria in particular: whether a standardized and validated evaluation 
tool with clear requirements based on an established Clinical Practice Guideline was used; 
whether the evaluation reflected existing international and national guidelines and whether 
the appropriate study design was used and clearly described. Table 3 summarizes the findings.
Table 3 Methodological quality of evaluation studies
Review Criteria Percentage
1 Standardized/validated evaluation tool was used reflecting CPG requirements 54.8%
2 Study refers to existing international and national guidelines 80.6%
3
Appropriate study design was used and clearly described, i.e. cross-sectional studies, 
intervention studies (RCT), cohort studies, reviews)
67.7%
In terms of the strength of the evidence (see Table 4 below), a high proportion of evaluation 
studies that looked at the effects of guidelines on patient outcomes showed strong positive 
results. Whereas only a small proportion of the studies that reviewed healthcare profes-
sional’s adherence showed strong levels of adherence with guidelines.
Table 4 Summary of the findings of evaluation studies
Strong/significant results Moderate results Poor results
Adherence 32.3% 19.4% 48.4%
Patient outcomes 75.0% 12.5% 12.5%
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4.5 Discussion
The main finding that emerged from this research is that the development, implementation 
and evaluation of Clinical Practice Guidelines is still in its infancy in the GCC Region. The 
relatively small number of studies that were found, screened and reviewed concentrated on 
evaluating the effects of particular guidelines and described the development and implemen-
tation process. The majority of articles originated from Saudi Arabia and the studies focused 
on the lifestyle diseases most prevalent in the region.
Quantity: Publication productivity
The underlying premise of this study is that the publication of articles on the development, 
dissemination, implementation and evaluation of Clinical Practice Guidelines is an indicator 
or proxy for the current situation in the GCC region in terms of evidence-based healthcare 
practice.
It is essential that Clinical Practice Guidelines are adapted to the complex social, cultural and 
economic situation in a region in order for the guidelines to have optimal effect46. However, 
the total number of articles found, screened and selected, 58 in total, is relatively small, con-
sidering the combined population of the entire GCC region. Other researchers, such as24,47, 
also found a scarcity of studies into the development, dissemination and evaluation of Clinical 
Practice Guidelines from the Gulf Region. It is worth noting that according to the SJR-SCImago 
Journal & Country Rank48, the six counties are ranked as follows in term of the number of cite-
able documents in the subject area of Medicine: Saudi Arabia (41st in the world), Kuwait (60), 
United Arab Emirates (62), Oman (77), Qatar (82) and Bahrain (92). In comparison, countries 
such as the US have seen a proliferation of guidelines with over 700 guidelines accepted by its 
national guideline authority, the National Guideline Clearinghouse, in 2008 alone12.
Apart from a few initiatives such as the MENA – NCCN Breast Cancer Guidelines network, 
there appears to be a shortage of professional associations and regulatory authorities involved 
in guidelines development, review and adoption. It is worth pointing out that out of 98 
member organizations of the Guidelines International Network (G-I-N) only 2 hail from the 
GCC Region49. In comparison, in many countries the efforts to standardize healthcare and 
improve quality and patient safety agencies have resulted in the establishment of national 
repositories of guidelines, such as the National Institute for Health and Care Excellence (NICE) 
in England that has published over 100 pathways and almost 200 guidelines to date50. In the 
US the National Clearinghouse has published almost 3,000 guidelines and internationally, 
the Guidelines International Network’s database currently lists almost 4,000 Clinical Practice 




Quality: Implementation and Adherence
Considering the widespread evidence of the positive effects of the implementation of Clinical 
Practice Guidelines on the process and outcome of healthcare, it is encouraging that recently 
there has been a significant increase in the number of publications coming from the GCC 
Region, in particular since 2010.
It has been estimated that around 70% of the population of the GCC Region is overweight 
and around one third of the population obese19. Therefore, it is important to note that the 
majority of the publications address the clinical needs associated with the so-called ‘life style 
diseases’ in the region (diabetes, hypertension, etc.).
Whilst it is encouraging that a significant number of research publications attempted to 
review and evaluate the effects and adherence to guidelines, there is room for improvement 
of the methodological quality of these studies. Only a small majority of the evaluation studies 
(54.8%) used a standardized and validated evaluation tool with clear requirements based on 
an established Clinical Practice Guideline and around one third of the evaluation studies used 
an appropriated research method.
In addition, the actual published results have been mixed. In Qatar, for example, adherence 
to diabetes guidelines was classified as intermediate, with an overall adherence rating of 
68.1%51. Compliance with paediatric asthma guidelines in a large emergency department 
in Saudi Arabia was considered to be poor, with only 3 out of 8 recommendations applied 
consistently40. Adherence to community-acquired pneumonia guidelines in Oman was the 
subject of another study26, which found very poor adherence to local guidelines. Similarly, a 
study in Kuwait52 found the adherence to antibiotic prescribing guidelines was low, with only 
30.4% of prescriptions fully adhering to the guidelines. In terms of hypertension manage-
ment in one region in Saudi Arabia53, the study concluded that most physicians did not 
adhere to the guidelines and lack the necessary knowledge. A study in the United Arab 
Emirates43 found that whilst physicians have favourable attitudes towards smoking cessa-
tion counselling guidelines, their actual practice fell below recommendations. However, in 
another study from Saudi Arabia21, both the physician’s attitude towards the guidelines as 
well as the self-reported adherence was high, which was attributed to the credibility and 
respectability of the source of the guidelines.
These findings in relation to a weak adherence to guidelines by healthcare professionals 
confirms the mixed findings from other studies7,51 and can be explained by the fact that the 
development of Clinical Practice Guidelines often does not meet the required standards set 
by international and national organizations such as the US Institute of Medicine or UK based 
National Institute for Clinical Excellence (NICE).
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In addition, many evaluation studies reviewed adherence and outcomes against non-specific 
best practice requirement, such as medical nutritional treatment based on recommendations 
from the American Diabetes Association34, rather than Clinical Practice Guidelines developed 
regionally or locally. Other explanations for the lack of adherence include lack of education 
and training53, absence of clear implementation strategies17,18, poor access to the evidence12 
and lack of awareness and familiarity amongst healthcare professionals54. Interestingly, the 
lack of perceived credibility of the guidelines was also cited as an explanation for poor adher-
ence to the guidelines21,40.
In terms of the effects on patient outcomes, it should also be noted that the studies that 
evaluated the effects of guidelines on health outcomes showed a largely positive, strong 
impact. Out of the 8 studies that looked at the effects of the adherence with the guidelines 
on patient outcomes, five reported significant positive results38,41,55–57. It is worth noting 
however, that only a small number (8 out of 58) evaluated effects on patient outcomes.
In terms of research methodology used, there is still a lot of room for improvement. Only 
one study34 [34] used a Randomised Control Trial (RCT) and a large number of studies simply 
described the process for developing a guideline. Furthermore, the research methodology 
used was often descriptive and seldom were the guidelines appraised for their quality. This 
finding is consistent with other recent reviews of international guidelines, which found that 
the quality scores against the AGREE appraisal instrument were moderate to weak25,58.
4.6 Conclusion
The overall goal of the research was to review how countries in the GCC region have 
developed, implemented and evaluated clinical practice guidelines. The GCC region has 
seen unprecedented economic and demographic growth, as well as social and cultural 
change. As a consequence, the prevalence of lifestyle diseases such as diabetes and car-
diovascular diseases is widespread51. It is therefore encouraging that many of the Clinical 
Practice Guidelines developed and implemented in the GCC Region focus on these diseases 
in particular.
As described above, the relatively small number of research articles published in the GCC 
Region over the 13-year period raises concerns about the likelihood to successfully address 
any evidence gap and attain better quality outcomes. This is a particular concern to the 
GCC region since the healthcare sector relies on the experience and expertise of health-
care professional from a wide variety of different backgrounds. In addition, whilst some 
evaluation studies were methodologically robust, many studies focused on generic practice 
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requirements rather than evaluating the effects of and adherence to specific, relevant Clinical 
Practice Guidelines. A more rigorous approach to the development and evaluation of Clinical 
Practice Guidelines needs to be established to address these methodological weaknesses.
Despite all this, a number of positive signs may indicate that there is a gradual change 
occurring, as evidenced by the recent increase in number of studies, as well as an emphasis 
on evaluating the effectiveness and a focus on lifestyle diseases.
Further in-depth research exploring the reasons behind non-adherence to Clinical Practice 
Guidelines is needed as this will enable regulators, healthcare providers and healthcare 
professionals to apply the required clinical practice in a consistent manner, resulting in bet-
ter outcomes for patients. In particular, further research need to look at the application of 
regulatory mechanisms using a procedural justice approach towards regulatory requirements 
that support the argument that when health care authorities use fair procedures rather than 
sanctions, health care professionals are more likely to overcome barriers to achieving adher-
ence to guidelines59.
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Although healthcare regulation is commonplace, there is limited evidence of its impact. 
Making sure that healthcare professionals comply with the regulatory requirements is a 
prerequisite to achieving effective regulation. Therefore, investigating factors that influence 
compliance may provide better insights into how regulators can be more effective. This study 
aimed to find out if medical students’ perceptions of regulation in the United Arab Emirates 
are associated with self-reported regulatory compliance.
Methods:
In the cross-sectional study, we administered a structured questionnaire to students of medi-
cine with different statements concerning their perceptions of healthcare regulation and self-
reported compliance. The statements included statement regarding the legitimacy, fairness 
and regulatory performance, as well as the risk to getting caught and being punished. The 
association between perceptions and self-reported compliance was analysed using multiple 
regression models.
Results:
One hundred and six Year 3 and 4 pre-clinical medicine students (56.4% response rate) 
completed the survey. Almost 40% of the students rated their level of awareness and un-
derstanding of regulation as Good or Very Good., despite their lack of direct contact with 
the regulatory authorities (less than 10% reported monthly or more frequent contact). Self-
reported compliance was high with almost 85% of the students either agreeing or strongly 
agreeing with the four compliance statements (mean score 4.1 out of 5). The findings sug-
gest that positive perceptions of the regulator’s performance (β 0.27; 95% CI 0.13 – 0.41), 
fairness of the regulatory processes (β 0.25; 95% CI 0.11 – 0.38) and its legitimacy (β 0.23; 
95% CI 0.05 – 0.41), are stronger associated with compliance than the perceived risks of 
getting caught and being punished (β 0.10; 95% CI -0.04 – 0.23).
Conclusions:
To improve compliant behaviour, healthcare regulators should pay more attention to their 
own perceived performance, as well as the perceived fairness and legitimacy of their regula-
tory processes rather than focusing on more traditional methods of deterrence, such as 
perceived risk of getting caught and being published.
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5.2 Background
One of the central tenets within the study of public service delivery is the notion that public 
services should deliver the greatest benefit to the maximum number of people1. Regulation 
plays an important role in this as it aims to oversee the quality and performance of services2. 
In the healthcare context, regulation consists of mandatory requirements, such as standards, 
laws or directives and tends to focus on basic safety elements to protect public health3 and 
improve quality of care4. The assumption is that a positive effect will be realized if these 
regulatory requirements are complied with in full4.
However, researchers have reported a lack of empirical evidence regarding the effects of 
regulatory interventions on the level of compliance as well as the actual quality of healthcare 
and patient outcomes5,4,6. A study undertaken by the RAND Cooperation into the regula-
tory mechanisms of six countries concluded that the overall evidence of the effectiveness of 
regulatory strategies towards ensuring care quality and safety at system level is still scarce7. 
One of the biggest challenges in this context is the healthcare professionals’ lack of compli-
ance with requirements which contributes to a poor quality of care and put patients at risk8. 
Even a simple requirements such as appropriate hand hygiene is known to be one of the 
most effective ways of improving patient safety9 and it is widely endorsed by regulators as a 
mandatory requirement10. Despite these efforts, actual compliant behaviour is lower than the 
recommended guidelines, around 40%11.
Regulation involves rules that must be followed but in the healthcare context very few em-
pirical have looked at why some organizations or individuals display compliant behaviour and 
others do not6,4. This study will take a closer look at the reasons why some people comply 
with regulatory requirements and others do not by focusing on the role of perceptions of 
procedural justice and deterrence.
The traditional viewpoint of compliance with regulation has primarily concentrated on deter-
rence: people are thought to obey rules and laws because there are penalties and incentives2. 
From this point of view, people are “amoral calculators”, interested and motivated by their 
self-interest. This view supports the notion of a regulatory approached characterized by the 
strict application of formal enforcement mechanisms12. However, studies across different 
settings have found that deterrence with penalties and rewards has a small influence on 
people’s compliance behaviour13 and sometimes even the opposite effect14.
In contrast, several studies have found that a regulatory process that is procedurally fair is an 
important motivating factor for compliance in different areas, such as residential homebuild-
ers’ compliance with regulations15, business firms’ compliance with environmental protection 
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regulation16, taxpayers’ compliance with taxation rules17 and even patients’ adherence to 
doctors’ medical recommendations18. As Healy6 puts it “the evidence is that most people and 
most organizations respond well to a respectful and supportive approach”.
In his seminal work on compliance and regulation in the 1980s, Tom R. Tyler studied people’s 
self-reported compliance with the law. In the so-called Chicago study, Tyler19 looked at what 
factors shape compliance and what make people obey laws and regulatory requirements. One 
of his main findings was that when people are treated fairly by authorities, they are more likely 
to comply with requirements, because there is a relational bond. This is also known as the 
procedural justice model which leads to legitimacy, the belief that rules and regulations should 
be obeyed by virtue of who made the decision or how the decision was made20. The perceived 
fairness of the procedures and processes involved in regulatory decision making, as well as the 
perceived treatment one receives, are known to be important factors influencing compliance17.
There is growing empirical evidence that this regulatory approach focused on cooperation 
has a stronger impact than the more traditional, deterrence based approach21. This emphasis 
on legitimacy also influenced Ayers and Braithwaite22 to propose the theory of ‘responsive 
regulation’ that focuses on regulation based on trust and asserts that regulator should be 
flexible and decide to utilize a range of regulatory measures and strategies depending on 
what is required. These regulatory measures and strategies can range from persuasion all the 
way to legal penalties.
The Figure below (based on Sunshine and Tyler’s original model23) explains the predictive 
model for compliance in a conceptual manner. We propose two antecedent conditions of 
legitimacy: the regulator’s performance and the perceived procedural fairness24. Legitimacy 
itself, together with the perceived risk of getting caught and punished are considered to be 
the strongest antecedents to the self-reported compliance.
Figure 1 Conceptual model
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The study took place in one of the main medical and health sciences university of the United 
Arab Emirates (UAE). The UAE is a federal union of seven states (Emirates), established in 
1971. The country has seen a huge economic and population growth, from an estimate of 
287,000 inhabitants in 1971 to around 9.1 million population in 2017.25 The UAE consists of 
a large portion of expatriates workers (around 88.5%) and a small number of UAE Nationals 
(around 11.5%)26,27. In terms of healthcare regulation, the UAE is quite fragmented28 and 
the two largest emirates, Dubai and Abu Dhabi, have their own regulatory authorities that 
are responsible to provide oversight and control over the facilities and professionals in their 
respective jurisdictions.
At a Federal level the Ministry of Health is responsible for regulating the activities of the 
remaining facilities and professionals29. The UAE has a relatively well performing healthcare 
systems in the region, for example, Legatum Prosperity group ranked the UAE 28th out of 149 
countries30 and it has made significant progress in establishing major academic and research 
institutions31.
The hypothesis of this study is that a more favourable perception of regulation in terms 
of legitimacy is associated with higher levels of self-reported compliance with regulatory 
requirements in the healthcare context. The objective of this study was to explore and in-
vestigate medical students’ perceptions of the healthcare regulatory environment. This was 
carried out by assessing the perceptions of medical students across a range of legitimacy 
related constructs such as procedural fairness, performance, risk and empowerment and the 
self-reported levels of compliance.
5.3 Methods
Study design
To test the association between legitimacy and other factors and self-reported compliance, a 
cross-sectional survey was designed to elicit the views and perceptions of the participants. All 
students in the medical school were invited to participate in the study. The research proposal 
received approval from the relevant Research and Ethics Committee in January 2016 and the 
study was carried out over a two-day period in April 2016.
The survey instrument focused on the general views and perception of regulation in health-
care rather than specific personal experiences. The survey instrument was developed in 
consultation with the university’s Faculty of Medicine and it was prepared after a thorough 
review of the medical literature, identifying distinct items that have been used in other stud-




The country’s relevant educational authority has accredited the university to provide the 
medical education program34. The faculty offered a six-year Doctor of Medicine, M.D. Pro-
gram to UAE Nationals. The medical faculty ranked amongst the best medical schools in 
the GCC region and the university took in around 100 new medical students annually in 
2016/2017. At the time of this study the university served as the primary source of medical 
education for citizens of the UAE35. The first two years of the six-year curriculum included 
a clinical foundation module that provided students with basic knowledge of the principles 
underlying clinical practice. Even though medical education in the UAE has received national 
accreditation, the undergraduate program has been characterized as being too focused on 
classroom based education, rather than hands on training36
As part of the university’s first year curriculum for medical students, the university offered 
a short, general orientation into the health care service provision in the UAE, including the 
regulatory role and function of the relevant authorities. Despite this it was assumed that 
students had a limited experience and understanding of the regulatory context and the 
survey briefly described the role of the regulatory authorities in healthcare, with a clear short 
description of the main regulatory functions.
Data Collection
All third, fourth, fifth and sixth year medical students (333 students in total) received an 
invitation by email from the Assistant Dean of the Medical Faculty to participate in the 
research study. However, the students were required to visit the Research Lab in person, as 
the research study formed part of a wider study into regulatory compliance. This meant that 
final year students (fifth and sixth year, 145 students) were unable to take part as they were 
enrolled in residency programs in various hospitals and clinics across the UAE. The total (third 
and fourth year) student population was therefore 188. Upon registration, each participant 
received a unique identifier and each student was asked to complete the Consent form. 
Once consent was granted, the participants were brought to a classroom by a Research 
Assistant where the students could complete the survey.
Study variables
The survey consisted of two sections – the first section dealt with measuring the students’ 
views and opinions regarding regulation as well as their self-reported compliance and the 
second section asked general, background questions about the students’ experience as well 
as their self-reported compliance rating. In the first section students were asked to indicate 
their level of agreement on a five-point Likert scale with eighteen statements. The scales 
ranged from one (Strongly Disagree) to five (Strongly Agree). The survey items assess the 
medical students’ appraisal of the healthcare regulatory authority in the UAE across the main 
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facets of legitimacy: perceived risk of detection, performance and empowerment of regula-
tory authority and fairness. The survey also contained numerous questions about students’ 
self-reported awareness and understanding of regulatory requirements.
In our study the dependent variable, compliance with regulatory requirements, is measured 
by the medical students’ self-reported compliance. The independent variables, related to 
the students’ perceptions, are measured using statements describing statements relating 
to legitimacy, fairness, risk (the perceived likelihood of being caught and punished for not 
complying with the regulatory requirements) and the regulatory authority’s performance or 
empowerment (views regarding the authority and power of the regulatory authorities).
In addition to this, the students’ prior knowledge, understanding and experiences with regu-
latory authorities was measured. In this study, we explored medical students’ perceptions of 
four independent variables (perceptions of the regulator’s legitimacy, fairness, performance 
and estimates of risks) and one dependent variable (self-reported compliance). The different 
statements (see Appendix I) were derived from other studies into the relationship between le-
gitimacy and compliance in the fields of compliance with taxation, justice and policing24,23,17.
Compliance
Four questions were devised to assess the dependent variable, self-reported compliance 
(Cronbach’s Alpha: .393). These items included statements such as “My friends and family 
would describe me as somebody who complies with rules and regulations”, “I try very hard 
to follow relevant guidelines and requirements from regulatory authorities” and “In general, 
I tend to comply with what is expected of me by regulatory authorities”.
Legitimacy
Legitimacy is defined as the property of an authority or institution that leads people to feel 
that authority or institution is entitled to be deferred to and obeyed32. Put simply, legitimacy 
is the perception that one “ought to obey” another. The independent variable related to 
the theory that people are more inclined and willing to follow rules and regulations if they 
believe these are legitimate, i.e. the regulations are desirable, proper and appropriate in line 
with societal norms, values and beliefs37.
This study measured legitimacy as the perceived obligation to obey and trust in regulatory 
authorities, with five items (Cronbach’s Alpha: .475), such as “You should accept the deci-
sions made by the regulatory authority, even if you think they are wrong” and “The laws 





The survey instrument contained four items relating to the fairness of the decision-making 
and treatment (Cronbach’s Alpha: .799) such as “The regulatory authorities in the healthcare 
field make their decisions based on facts, not opinions” and “Regulatory requirements are 
applied to all people consistently”. The two key dimensions of procedural fairness judgments 
are fairness of decision making (voice, neutrality) and fairness of interpersonal treatment 
(trust, respect)19.
Performance and Empowerment
The students’ perceptions of the performance of the regulatory agencies was measured by 
asking how effective they perceive regulatory authority is and the effects of the regulatory 
actions. Two items (Cronbach’s Alpha: .635) were included: “Regulations such as standards, 
directives and policies are needed because they have a strong, positive impact on the quality 
of care delivery” and “In my opinion, the regulatory authorities are effective in improving the 
quality of health care delivery”. The students were also asked to what extent they agreed 
that the regulatory authority should be autonomous and have power to make decisions: 
“The regulatory authority should have the power to decide which regulatory requirements 
are the most important”.
Risk of getting caught or punished
The survey included two items (Cronbach’s Alpha: .303) that looked at the students’ per-
ceptions regarding the likelihood of being caught and punished for not complying with 
regulatory requirements, including “It is likely that you get caught and penalized if you break 
any rule or regulation”.
Statistical analysis
The students’ responses were coded and the data was analysed using SPSS (v22, IBM Inc.) 
software.
In order to analyse the relationship between the independent and dependent variables, the 
scores were calculated for each item by allocating a weight between 1-5, with a weight of 
1 for “Strongly Disagree” and 5 for “Strongly Agree”. The scores for each item were added 
up and divided by the total number of completed items. Missing data were excluded from 
the calculation. In total 106 surveys were completed and each survey included 23 items 
(see Appendix 1). Seven surveys were incomplete with no more than one item not filled in. 
The average score for each variable was calculated by adding up the average score for the 
relevant items and then dividing this score by the number of items for the variable.
In order to test what factors influenced self-reported compliance, we performed an ordinary 
least squares regression analysis using the indexes of legitimacy, risk, performance evalua-
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tion, procedural fairness, awareness and understanding, as well as the frequency of contact, 
self-assessed clinical skills evaluation and demographic variables. From the regression model’s 
beta and 95% confidence intervals were derived. P-values of <0.05 were considered to be 
significant.
5.4 Results
A total of 106 students agreed to participate in the study (response rate 56.4%, 106/188), 
83 participants were female (78.3%) and 23 were male (27.1%), see Table 1 below. All 
participants were UAE nationals, 23% male and 77% female.
Table 1 Participation rates amongst male and female students
Year
Male Female
No. Participated Response Rate No. Participated Response Rate
3 18 75% 37 47%
4 5 25% 46 70%
Total 23 52% 83 58%
In terms of the frequency of contact with the regulatory authority, a high percentage of 
students (62.3%) had never dealt directly with a regulatory authority, whilst 27.4% had 
infrequently dealings with the regulators, see Table 2 below.
Table 2 Frequency of contact with the regulatory authorities (n=106)
Never Infrequent Monthly Weekly Daily
In the past 12 months, how often 
you have been in direct contact with 
regulatory authorities such as HAAD, 
DHA or the UAE Ministry of Health?
62.3% 27.4% 8.5% 1.9% 0.0%
The respondents were also asked a number of background questions. Overall, the majority of 
students rated their own clinical skills and competencies as “good” (55.7%) or “very good” 
(9.4%), see Table 3 below. Furthermore, over 60% of respondents indicated that they had 
an average or above average understanding and awareness of the regulatory requirements.
Table 3 Clinical skills and awareness/understanding of regulatory requirements (n=106)
Very Good Good Average Poor Very Poor
Overall, how would you rate your awareness 
and understanding of the current regulatory 
requirements in the UAE?
8.5% 31.1% 21.7% 17.9% 20.8%
I would rate my own clinical skills and 
competencies as…..
9.4% 55.7% 26.4% 6.6% 1.9%
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The highest mean on the four independent variables was the performance and empower-
ment of the regulatory authority: 4.1 out of 5. The legitimacy variable had the lowest mean 
score, 3.3, followed by perceived fairness (mean: 3.8) and the perceived likelihood of being 
caught and penalized for breaking a rule or regulation (mean: 3.8). In order to measure 
the dependent variable, self-reported compliance with regulatory requirements had a mean 
score of 4.1 out of 5.
An average of almost 85% of all respondents either agreed or strongly agreed with the four 
compliance statements, see Figure 2 below.
Figure 2 Self-reported compliance amongst medical students in the UAE (n=106)
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Finally, this analysis enables us to estimate the strength of the relationship between each 
independent variable and the dependent variable. The results of our analysis are shown in Table 4 
below.  
 






Legitimacy 0.23* 0.05 – 0.41 
Fairness 0.25** 0.11 – 0.38 
Performance & Empowerment 0.27** 0.13 – 0.41 
Risk 0.10 -0.04 – 0.23 
Contact with regulator 0.09 -0.05 – 0.23 
Regulatory awareness and understanding 0.04 -0.04 – 0.12 
Clinical skills and competencies rating -0.05 -0.18 – 0.07 
* p <.05 
**p < .001 
The strongest relationship was between legitimacy and compliance (b 0.23; 95% CI 0.05 – 0.41), 
fairness and compliance (b 0.25; 95% CI 0.11 – 0.38) and regulatory performance and compliance  (b 
0.27; 95% CI 0.13 – 0.41) 
  
0% 10% 20% 30% 40% 50% 60% 70% 80% 90%100%
My friends and family would describe me as
somebody who complies with rules and
regulations
I try very hard to follow relevant guidelines
and requirements from regulatory authorities
I normally bring concerns about safety
immediately to the attention of people who
are in charge
In general, I tend to comply with what is
expected of me by regulatory authorities
Disagree or Strongly Disagree Neither agree nor disagree Agree or Strongly Agree
Finally, this analysis enables us to estimate the strength of the relationship between each 
independent variable and the dependent variable. The results of our analysis are shown in 
Table 4 below.
The strongest relationship was between legitimacy and compliance (β 0.23; 95% CI 0.05 – 
0.41), fairness and compliance (β 0.25; 95% CI 0.11 – 0.38) and regulatory performance and 
compliance (β 0.27; 95% CI 0.13 – 0.41)
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Legitimacy 0.23* 0.05 – 0.41
Fairness 0.25** 0.11 – 0.38
Performance & Empowerment 0.27** 0.13 – 0.41
Risk 0.10 -0.04 – 0.23
Contact with regulator 0.09 -0.05 – 0.23
Regulatory awareness and understanding 0.04 -0.04 – 0.12




Considering that one of the core objectives of regulation is to oversee or control activities 
that are socially valued38, it is important to find out more about how the people who are the 
subject to the regulatory requirement perceive the regulations. As noted, there is growing 
empirical evidence that a positive perception of the regulatory authorities’ fairness, perfor-
mance and legitimacy increases the likelihood of compliance in fields such as law and order 
and taxation24. This procedural justice model of compliance has remained almost entirely 
based on research evidence from the United States39 and has only been used in a small 
number of areas40. Using the extensive body of evidence19, this is the first ever study con-
ducted exploring the relationship between the perceptions of regulation and self-reported 
compliance amongst medical students.
We would like to make three general observations about the results before we look at the 
extent to which deterrence and procedural justice have an influence on compliance with 
regulatory requirements.
First of all, in terms of the UAE’s regulatory context, researchers28 have commented on the 
consequences of a fragmented regulatory system leading to confusion and complicated rules 
governing each Emirate. However, over 60% of all respondents rated their awareness and 
understanding of current regulatory requirement as average or above average. This is even 
more remarkable considering the high number of students (more than 90%) that had limited 
or no contact with the regulatory authorities.
It is also noteworthy that the majority of medical students rated their own clinical skills and 
competencies highly (more than 66% of students rating their skills and competencies as very 
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good or good, see also Figure 1), considering that other studies observed that in the UAE 
“undergraduate medical education continues to be comprised of long hours in the classroom 
and frequent written examinations, but limited hands-on training”36. Other studies have 
found similarly high self-reported skills rating41,42, with a negative relationship between years 
of experience and self-assessment ratings of clinical skills and competencies. One possible 
explanation could be that the lack of experience has impacted the overestimation of their 
own skills and competencies as well as the compliance levels.
Finally, another interesting observation is the participants’ high average compliance score. 
For example, almost 90% either agreed or strongly agreed with the statement “My friends 
and family would describe me as somebody who complies with rules and regulations”. In 
contrast, several researchers have found suboptimal levels of compliance in similar settings in 
the UAE such as adverse drug reporting43, over the counter sales of antibiotics44 and adher-
ence to diabetes medication45. Since these are self-reported ratings, it may not necessarily 
translate into actual compliant behaviour.
These three observation are interesting from al regulator’s point of view, as it indicates the 
high level of support for healthcare regulation, as well as high scores on self-reported com-
petencies and compliance. A team of researchers who evaluated the regulatory system for 
healthcare professionals concluded that the UAE had made significant progress in develop-
ing and implementing best regulatory practice27. Our study supports this view insofar that 
medical students had a largely positive view of the performance of the regulatory authorities 
in the UAE, with almost 86% of all students agreeing with the statement that regulatory 
authorities in the UAE are effective in improving the quality of health care delivery. A recent 
study exploring UAE medical students’ perceptions of international accreditation for medi-
cal education found a similarly high level of support34 for this particular type of regulatory 
intervention.
In terms of the factors influencing compliance, the results described in the previous section 
support our hypothesis that procedural justice related variables have a stronger effect on 
compliance than deterrence as measured by the perceived likelihood of getting caught and 
being penalized.
As Figure 3 below indicates, both regulatory performance and fairness are also associated 
with legitimacy, a finding similar to other studies32,46,17. The other variables, such as gender, 
clinical skills, regulatory awareness and understanding, etc. do not have a significant associa-
tion with the compliance ratings and there are no discernible trends between these variables 
and the self-reported compliance.
Similar to other studies23, procedural fairness was the primary driver of perceptions of legiti-
macy (beta=0.36). The perceived likelihood to get caught or be punished (beta=0.10) does 
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not have a significant association with compliance rates. These findings are consistent with 
studies in other fields, such as policing47 and law.17
Figure 3 Our findings, using the conceptual model
In terms of measuring this relationship in a healthcare context, our research has found similar 
results as two other studies. The first study18 found strong support for the argument that 
when healthcare authorities use fair procedures, patients are more likely to accept their 
recommendations. The second study33,48 concluded that the satisfaction of nursing home 
owners is more strongly associated with the fairness of the inspection process than the actual 
favourableness of the regulatory outcomes.
Obviously, it should be noted that the largely positive attitudes towards regulation as well as 
the high levels of self-reported compliance may not necessarily be sustained over time and 
result in positive behaviours and attitudes of physicians in the future. It is encouraging to note 
the positive attitude and intention to comply amongst current students. Other researchers49 
have found that healthcare professionals’ intention to comply appears to have a reasonably 
strong relationship with actual compliance. In terms of medical education, more attention 
could be given to ensuring that medical students are empowered to comply with regulatory 
requirements and meet the healthcare needs of the society.
Limitations of study
The overall response rate was reasonably high (56.4%) and a number of students who had 
intended to participate contacted the medical school beforehand to explain that they were 
unable to attend in person due to other commitments. The response rate may have been 
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higher if an additional, online survey option had also been made available to the students. 
The medical school is the primary source of medical education in the UAE35 and each year 
around 80-100 students graduate from this particular school and only around 130 students 
apply for residency programs in the UAE every year34. Therefore it could be argued that par-
ticipants are reasonably representative of the slightly larger population of medical students. 
The sample did not differ from the total Year 3 and 4 population in terms of gender (sample: 
78% female vs. 77% female for the total population).
The study assessed the self-reported rather than the observed compliance levels. However, 
self-reported compliance in the healthcare field is not always associated with actual compli-
ance50. In other words, a high level of self-reported compliance may not translate into a high 
level of actual, observed compliance making it difficult to draw any major conclusions from 
surveys based on self-reported compliance levels.
Another limitation of this study is the lack of students’ exposure to regulatory authorities, 
over 60% indicated that they never had any contact with the regulatory organizations. Since 
the students were only in their third and fourth year we would not have expected them 
to be overly engaged with the regulatory authorities as their professional licensing process 
would only commence after graduation. At the same time, students did indicate a high level 
of awareness and understanding of the regulatory requirements, perhaps as a result of their 
pre-clinical, practice based training, involving learning courses focused on real life examples.
Since the medical students were relatively unfamiliar with the regulatory requirements, they 
may have tended to provide responses which they deemed to be socially desirable. The 
high, self-assessed scores on awareness, clinical skills and compliance may be an indication 
of a high level of social desirability51. Other studies in the UAE with similar self-assessment 
methods found equally high rating in terms of competency42. These high scores may indicate 
that the medical students responded in a socially desirable way and some of the study results 
should be interpreted with caution.
Finally, the medical students had limited clinical experience and exposure to regulations or 
regulatory authorities. This may have resulted in a overestimation of the importance and 
impact of regulation.
5.6 Conclusion
Regulation based on trust and fairness is often more effective than more traditional, rational 
choice approach33, with a focus on deterrence. This study aimed to contribute to the growing 
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body of knowledge5,52 into the role of procedural justice and its effects in healthcare. As 
we have seen in this study, negative motivations arising from a fear of the consequences 
of violating regulatory requirements is not as strong a factor when it comes to influencing 
compliance compared to positive or affirmative motivations such as creating a sense of trust 
in the regulatory authority’s work and the obligation to comply53.
Considering that a lack of compliance with regulations may have serious and sometimes 
catastrophic consequences, policy makers, educators, regulators, providers and researchers 
need to be aware of these factors influencing compliance. Similar to studies in other fields, 
such as policing, our findings support for the hypothesis that people’s law-related behaviour 
is strongly shaped by their judgments about the legitimacy, fairness and performance of 
the regulatory agency54, a proposition that was initially viewed as counterintuitive but has 
received widespread confirmation, initially from psychologists and more recently from a 
broad range of social scientists.
Based on these insights we postulate that regulatory agencies should spend further efforts 
in enhancing their legitimacy as it has a strong association with (self-reported) compliance 
behaviours. The regulatory authorities in the UAE have the opportunity to change the 
perceptions of their workforce and more can be done to raise awareness and improve the 
understanding of the role and function of the regulator. A suggested way forward is for 
the regulatory agencies to conduct a regular self-assessment, at least once per year, with 
an opportunity feedback for all participants in order to make the necessary changes and 
improve compliance.
Even though there is relatively limited empirical evidence which regulatory approaches work 
best55, this research may assist regulatory agencies to expand their regulatory toolkit56 and 
experiment with alternative ways of setting direction, monitoring compliance and enforce-
ment. To truly measure the effects of a regulatory approach based on the procedural justice 
model, healthcare researchers should make use of randomized control trails to find out 
whether this has a meaningful impacts on perceptions and compliance. A small number of 
researchers57,58 have attempted to conduct trials in other regulatory contexts, such as polic-
ing and law. Regulatory agencies should attempt to present themselves as trustworthy and 
reliable actors in the healthcare field by ensuring that their directive approach is accessible 
and understandable, their monitoring is logical, transparent and fair, and their enforcement 
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Competency-based education and training has become a key component of healthcare 
systems across the globe. Ensuring that healthcare professionals are able to assess their own 
competencies is critical for continued professional development and the delivery of high-
quality care.
The aim of this study was to assess how medical students perceive their performance on an 
objective structured clinical examination. Using a cross-sectional study design, a sample of 
Emirati third and fourth year (preclinical) medical students (N=106; 56.4% response rate) 
was recruited from the United Arab Emirates University in Al Ain, United Arab Emirates. 
Medical students completed a short non-invasive clinical task (i.e. measuring and recording 
blood pressure and performing hand hygiene) followed by a structured survey to self-assess 
their performance and skills. Trained assessors used a clinical skills observation checklist tool 
to score each student’s performance.
According to the observed performance, 27.36% of medical students performed the objec-
tive structured clinical task adequately. In contrast, 69.52% rated their own performance 
as adequate. Furthermore, only 8.43% of medical students rated their own clinical skills as 
below average. This study did not find evidence that medical students can accurately assess 
their own clinical skills and performance.
In order to support the delivery of high-quality healthcare, it is important that medical stu-
dents develop their ability to accurately assess their own clinical skills and performance early 
in their medical careers. Teaching and appraising self-reflection is an important component 
of any undergraduate or postgraduate medical degree program.
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6.2 Introduction
Medical education plays an important role in maintaining and improving the quality of a 
country’s healthcare system1. Many competencies are defined for medical students that 
must be acquired before graduation, such as clinical knowledge and expertise, professional 
integrity, empathy, communicative skills, and conceptual thinking2,3. To achieve these desired 
competencies, future doctors need to be able to accurately self-assess and appraise their 
multiple skills, also in addition to recognizing their limitations3.
In this paper, we assumed that a competency involves multiple skills. Healthcare providers 
and educators are moving towards competency-based education and assessment skills, and 
the lack of self-assessment skills from healthcare professionals can act as a barrier for self-
paced learning4. Self-assessment has multiple definitions in the literature and the term has 
also been used to describe self-reflection or self-evaluation. Andrade and Du (page 160) 
define each of these concepts independently, and in this paper we used their self-assessment 
definition as the “process of formative assessment during which students reflect on and 
evaluate the quality of their work and their learning, judge the degree to which they reflect 
explicitly stated goals or criteria, identify strengths and weaknesses in their work and revise 
accordingly”5. Studies have found that physicians often assess themselves as being more 
competent than they actually are6. Therefore, introducing self-assessment for medical stu-
dents may assist them to accurately assess their own skills and competencies in the future. 
Accurate self-assessment of personal and professional capabilities are now seen as essential 
for success7 as healthcare professionals and essential for delivery of high quality care.
The Objective Structured Clinical Examination (OSCE) is a comprehensive evaluation tool that 
has been used to assess the competencies of medical students in the majority of medical 
schools worldwide8. The OSCE assesses clinical skills, counselling, and communication-based 
competencies through direct observation8. The OSCE has been widely used over the past 
two decades and can be defined as a “timed examination in which medical students interact 
with a series of simulated patients in stations”8. The OSCE comprises several clinical stations, 
usually 10-12, where the student performs tasks including history-taking, physical examina-
tions, counselling or patient management, and clinical procedures. The student is required 
to complete the task within a set time limit and according to well-defined criteria for each 
specific clinical skill. These clinical tasks are normally assessed by trained assessors from the 
medical faculty8,9.
This study took place in the United Arab Emirates (UAE), an independent federation, consisting 
of seven Emirates with a total population of approximately 9.1 million people, in 201610. It is 
a relatively young, high-income country, established in 197111 with a strong government-led 
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desire to build a world-class healthcare system to improve the health of its population12. The 
World Health Organization described the Eastern Mediterranean Region, where the UAE is 
located, as a region facing major challenges regarding the healthcare workforce. Specifically, 
the UAE faces major challenges related to the shortage of UAE national healthcare workers, 
a high reliance on expatriate staff, limited health professionals’ production capacity, and a 
high turnover of expatriate healthcare workers13. In this context, the present study focuses 
on one of these challenges: the capacity deficit to educate and train an adequate number of 
appropriately educated and trained UAE nationals’ healthcare professionals.
The main objective of the study was to explore the differences between self-assessment and 
trained-assessors OSCE score. Our hypothesis was that a medical student who rates their 




A cross-sectional study was used to investigate the relationship between self-perceived 
performance from medical students and trained-assessor rated OSCE performance. The 
STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) Statement 
was used to structure this paper14.
Setting
The study was conducted at the clinical skills simulation centre of the College of Medicine 
and Health Sciences of the United Arab Emirates University, the largest public university in 
the UAE. Data collection occurred over two consecutive days in April 2016. This study was 
approved by the institution’s Social Sciences Research Ethics Committee (ERS_2015_3212).
Participants
Medical students from the Doctor of Medicine (M.D.) six-year program at the College of 
Medicine and Health Sciences were the study population. Pre-clinical students (third and 
fourth year) were invited to participate in the survey and to perform a specific non-invasive 
clinical task (measure blood pressure).
Variables
The study variables were overall OSCE score, student self-assessed performance, and self-
reported clinical skills. These two last variables were measured by statements in the survey, 
ranked by a Likert scale ranging from one to five. The variable self-assessed performance was 
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defined through the survey sentence “Overall, I think that I performed the OSCE to the best 
of my abilities” measured by the Likert scale as strongly disagree (1), disagree (2), neither (3), 
agree (4) and strongly agree (5). The variable self-reported clinical skills was defined through 
the sentence “I would rate my own clinical skills and competence as” categorized into (1) 
poor, (2) fair, (3) average, (4) good and (5) very good.
The dependent variable overall OSCE score was created by summing the scores of the clinical 
skills observation tool that was completed by the observers. The trained observers were 
faculty and staff from the College of Medicine. They were considered eligible to assess the 
clinical task of collecting blood pressure by their qualifications, and they were profession-
ally trained on how to evaluate the quality of hand hygiene practice, having successfully 
completed a two hour long online hand hygiene course from Hand Hygiene Australia and 
through a bespoke two-hour face-to-face practical course prepared by the authors.
Data sources/measurements
To accomplish our research objective, we used a cross-sectional survey and a clinical observa-
tion tool to collect the data. The survey was designed specifically for this study and the 
designing process took into consideration a review of other papers and surveys15–18. The 
survey formed part of a larger study exploring medical student’s perceptions of healthcare 
regulation19 and included questions regarding the two above mentioned variables (self-
perceived performance and self-reported clinical skills).
The clinical skills observation tool was designed in consideration of other observation tools 
used to assess OSCE, for example, the OSCEstop20. This observation tool included data collec-
tion on four major parts: preparation, including introducing self to the patient, hand hygiene 
including the WHO hand hygiene standards (before and after the clinical task), and blood 
pressure measurement (clinical task performed at OSCE). These four parts were assessed 
by observers using a Likert scale ranging from one to three (one – performed adequately, 
two – attempted, but performed inadequately and three – not attempted).
Eligible medical students received an email invitation to participate in the research study one 
week before the study took place. Students were informed and asked to perform a clinical 
task and to complete the survey. Students who were willing to participate booked a slot or 
‘walked in’ at the clinical skills simulation centre during the two days of the data collection. 
Upon arrival, the students received a brief description of the study and consent process, 
and they were requested to read and sign a consent form. A research assistant explained 
the study as follows: the participant was asked to perform a short non-invasive clinical task 
– measuring and recording a person’s blood pressure – and complete the survey afterwards. 
Students were randomly assigned to one of the four available clinical skills simulation rooms. 
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One of the observers played the role of the “standardized patient”, and the other one pre-
tended to be completing a Sudoku book, but observed the student performing the OSCE 
and completed the clinical skills observation tool. Usually the OSCE is a circuit of stations, 
but as this OSCE was designed specifically for this study, it comprised only one station with 
one clinical task. At the end of the task, the participant was asked to complete the survey 
and earned a Certificate of Attendance. All students had received the same training on 
performing the clinical task and were aware of the key steps involved in completing the task 
correctly and in accordance with the UAE health regulations.
Bias
To minimize potential bias in our study, the observers were not known to the students, they 
were always of the same gender as the participants and they were trained and experienced in 
observing students’ OSCE performance. In addition, each participant was randomly assigned 
to the clinical room where the OSCE was carried out. The layout of the clinical observation 
rooms was identical. Students were unaware (blinded) to the covert assessor role of the 
research assistant who pretended to complete the Sudoku book whilst they performed their 
clinical task. This method of blinding was used to minimize any possible Hawthorne effect 
(i.e. observer effect that causes reactivity in which an individual modifies their behaviour in 
response to awareness of being observed).
Study sample size
All undergraduate medical students from the third and fourth year (N=188) were invited 
to participate in the study. From the 188 students, 106 participated in our study (56.38% 
response rate).
Quantitative variables/Statistical methods
Descriptive statistical techniques were used to describe the dependent variable (trained as-
sessor rated overall OSCE score) and the two independent ones under analysis: self-perceived 
performance and self-reported clinical skills. A t-test was used to test the difference between 
genders and the dependent variable. An ANOVA was used to determine the difference be-
tween the categories of the independent variables and the OSCE overall score. All the tests 
were performed using α=5%.
6.4 Results
Participants
A total of 106 medical students participated in our study representing 31.80% of all un-
dergraduate medical students in the university. All university students from the College of 
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Medicine and Health Sciences at the United Arab Emirates University are UAE nationals, and 
77.40% were female. The proportion of male/female in the study sample is similar to the 
gender distribution of the medical student population in the college.
Main results
When asked if they performed the OSCE to the best of their abilities, the majority (69.52%) 
of students answered agree or strongly agree, while nearly a third (30.48%) of students self-
assessed their performance as neutral (neither) or negative (disagree or strongly disagree) 
(Figure 1).
Figure 1 Medical students self-perceived performance after OSCE.
Half of the students (55.66%) self-reported their clinical skills as ‘good’ and only 8.49% 
considered their clinical skills below average (Figure 2). None of the students rated their 
clinical skills and competencies as ‘poor’.
The observed score shows that the OSCE overall score was performed ‘adequately’ by 
27.36% of students, while 72.64% were rated as ‘attempted, but performed inadequately’. 
None of the students did not attempted. The mean (±SD) of the trained-assessor observed 
OSCE overall score was 1.7±0.0, minimum of 1.0 and maximum of 2.6. The mean (±SD) 
of the trained-assessor observed OSCE score for females was 1.7±0.0 and for males was 
1.6±0.0 (Figure 3). This difference was not statistically significant (p=0.794).
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Figure 2 Medical students self-reported clinical skills
Figure 3 OSCE overall score per gender
The students that ‘strongly disagreed’ and the students that ‘neither agreed nor disagreed’ to 
performing the OSCE at their best had a mean OSCE overall score of 1.6±0.1 and 1.6±0.0, 
respectively (Figure 4). The students that ‘strongly agreed’, ‘agreed’ and ‘disagreed’ revealed 
same mean OSCE overall score with a decimal difference amongst them. ANOVA was calcu-
lated to assess the difference between the students’ perceived performance categories and 
there were no statistically significant differences (p=0.763).
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Figure 4 OSCE overall score and medical students self-perceived performance.
The students that reported their clinical skills as ‘fair’ showed the highest mean (±SD) OSCE 
overall score (1.8±0.1). While the students who reported their clinical skills to be ‘good’ or 
‘very good’ presented mean (±SD) overall OSCE score of 1.7±0.0 and 1.7±0.1, respectively. 
There was no statistical significance between how students reported their clinical skills and 
OSCE overall score (p=0.6). The intragroup variance between gender, self-perceived perfor-
mance and self-reported clinical skills is not statistically significant (p=0.492).
Figure 5 OSCE overall score and medical students self-reported clinical skills
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The intragroup variance between gender, self-perceived performance and self-reported clini-
cal skills is not statistically significant (p=0.492).
6.5 Discussion
Key results
The key result is that this study did not find evidence to support the hypothesis that medical 
students in the pre-clinical phase can accurately self-assess their own skills, competencies 
and performance. In other words, the lack of a statistically significance between the mean of 
overall OSCE score the two self-rated variables may indicate that medical students in the pre-
clinical phase have not yet developed the necessary self-reflection skills to accurately appraise 
their own performance compared to their assessed performance. There was no difference 
between the gender of the medical students regarding self-assessment and trained-assessor 
observed overall OSCE score. These findings were similar to Andrade and Du’s study that 
explored the attitudes toward and beliefs about self-assessment in undergraduate teacher 
education students in the United States and did not find differences in the responses of male 
and female students5.
Limitations
The undergraduate preclinical medical students that participated in the present study rep-
resented nearly a third (31.80%) of the total medical students at the United Arab Emirates 
University. One of the limitations of this study is that it represents a convenient sample from 
one of six medical universities in the UAE, and includes only third and fourth-year preclinical 
medical students.
Interpretation
Only one-quarter of preclinical medical students performed the OSCE adequately. However, 
the majority of the students reported a positive self-assessment when asked if they performed 
the OSCE to their best ability. In Oman, a similar study compared the difference between the 
student’s self-assessment and the trained-assessor OSCE score in 60 medical students and 
the results show that the students consistently overestimated their performance in four of 
the 12 items while underestimating their performance in the remaining eight items21.
Almost 70% of participants self-reported their clinical skills as good or very good and that 
they had completed the OSCE to the best of their ability. This is in stark contrast with the ac-
tual trained-assessed OSCE appraisal which found that only 27% of students performed the 
OSCE task adequately. Other studies have found similar discrepancies. In a systematic review 
including 20 studies on the accuracy of physician self-assessment compared with observed 
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assessments, the results showed that physicians did not accurately self-assess themselves 
in the majority of the studies6. In addition, the systematic review reported only weak or no 
associations were found between self-rated assessment and external observed assessments6. 
The inaccuracy of self-assessment is also reported in medical students as being frequent and 
across several specialities or levels in the graduating program3,4,22.
The timing of assessment has been shown to play a role in student self-reflection. A study 
examining the self-rated competencies of 168 medical students pre- and post-OSCE showed 
that students decreased their self-rating after the family medicine objective examination, 
but not significantly for family medicine specific skills4. A study of 244 medical students 
for the specialization in general practice revealed that the method of self-assessment was 
experienced and perceived as useful, but only 57% of the sample opted for self-assessment 
combined with individual feedback on their strengths and weaknesses3. Self-assessment is 
a complex process of internalization and self-regulation5, and many medical students may 
not have developed the necessary cognitive skills and reflective practices during their medical 
undergraduate degrees to provide a realistic self-appraisal. Therefore, providing sufficient 
time for students to develop their self-reflection skills is an important component of any 
undergraduate or postgraduate medical degree programme.
Some authors have questioned the reliability of self-assessment4,6,23. It has been reported 
by medical students that if the subjective self-rating is to be used as a formal aspect of the 
medical education program, then it should be complemented with formative feedback from 
the supervisors3. As such, several researchers advise the development of all-inclusive con-
tinuing professional education programs including portfolios, documenting practice-based 
learning and improvement activities, and creating less general and more detailed learning 
objectives3,6. In this case, it is important to include direct observation in clinical training which 
has also been a standard in medical education as it is linked to students self-confidence in 
their final year23. For future studies including medical students, we would suggest including 
a third way of measuring clinical competencies: peer review, this would ensure a triangulated 
measurement: self, peer and external assessments24.
6.6 Conclusion
The self-assessment of medical students is not related to trained-assessed OSCE score in this 
study. To achieve good practices in future healthcare professionals, specifically physicians, it 
is important to understand the discrepancies between the medical student’s self-perception 
and their actual observed performance. Further research is required to provide a deeper 
understanding of the factors related to the discrepancy between student self-assessment 
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and trained-assessed performance. Such detailed information would allow educators to cre-
ate better learning environments with more effective self-assessment strategies. This paper 
contributes to the understanding of the current production of Emirati medical students in the 
UAE, to achieve the UAE Vision 2021 and to the 2030 agenda of the Sustainable Develop-
ment Goals and Universal Health Coverage.
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The degree of altruistic behaviour among strangers is an evolutionary puzzle. A prominent 
explanation is the evolutionary legacy hypothesis according to which an evolved reciprocity-
based psychology affects behaviour even when reciprocity is impossible, i.e., altruistic be-
haviour in such instances is maladaptive. Empirical support for this explanation comes from 
laboratory experiments showing that surveillance cues, e.g., photographs of watching eyes, 
increase altruistic behaviour.
A competing interpretation for this evidence, however, is that the cues signal the ex-
perimenter’s expectations and participants, aware of being monitored, intentionally behave 
more altruistically to boost their reputation. Here we report the first results from a field 
experiment on the topic in which participants are unaware they are being monitored and 
reciprocity is precluded. The experiment investigates the impact of surveillance cues on a 
textbook example of altruistic behaviour – hand hygiene prior to treating a ‘patient’. We 
find no evidence surveillance cues affect hand hygiene, despite using different measures of 
hand-hygiene quality and cues that have been previously shown to be effective. We argue 
that surveillance cues may have an effect only when participants have reasons to believe 
they are actually monitored. Thus they cannot support claims altruistic behaviour between 
strangers is maladaptive.
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7.2 Introduction
The degree of altruistic behaviour among strangers in modern societies is a major evolution-
ary puzzle1,2. A prominent explanation is the ‘evolutionary legacy hypothesis.’ It posits that 
the human brain evolved in ancestral conditions that differed radically from those in modern 
environments3,4. Although nowadays many encounters are with anonymous strangers, for 
much of our evolutionary past, humans interacted repeatedly in small social groups where 
one’s reputation was constantly at stake, leading to the evolution of cognitive mechanisms 
to automatically identify reputation-building opportunities5,6,7. According to the evolutionary 
legacy hypothesis, individuals may behave altruistically in anonymous one-shot interactions 
due to an uncontrolled, automatic reaction aimed to bolster one’s good reputation in antici-
pation of positive reciprocity, even when such opportunities do not exist; i.e., the observed 
altruistic behaviour between anonymous strangers is maladaptive8,9.
Empirical support for this hypothesis comes from laboratory experiments showing that 
reputation-related surveillance cues such as displaying photographs of watching eyes promote 
altruistic behaviour, i.e., actions which benefit another individual at a personal cost10,11,12. Since 
the cues do not affect one’s reputation, participants are anonymous to each other and direct 
reciprocity is precluded by design, the effect has been attributed to the automatic activation 
of one’s reciprocity-based psychology8,9. A problem with this interpretation, however, is that 
participants are not anonymous to the experimenter who may be observing their choices 
or can easily infer them from their earnings. A competing interpretation therefore is that 
the increase in altruism is due to an ‘experimenter effect’13,14,15: surveillance cues signal the 
experimenter’s expectations to participants who intentionally react to the stimulus in a way 
they believe would boost their reputation with him/her. In other words, even though direct 
reciprocity between participants is precluded, indirect reciprocity concerns may still play a role. 
In line with this interpretation, survey evidence shows the effect on altruistic behaviour is me-
diated by participants’ expectation of reward by “a third party who was monitoring them”16.
One way to eliminate the possibility of an experimenter effect is to conduct field experi-
ments such that individuals are unaware they are participating in a study. In order to provide 
clear evidence that altruistic behaviour is maladaptive, however, certain conditions need to 
be satisfied such that alternative explanations are ruled out. In particular, it is critical that 
all encounters in the experiment are anonymous, one-shot and reciprocity of any kind is 
precluded. It is also desirable that exposure to the cues is brief as habituation with the 
false stimulus may attenuate the effect through intentional brain processes7,12. If surveillance 
cues are found to increase altruistic behaviour in such circumstances this would support the 
hypothesis that altruistic behaviour between anonymous strangers is maladaptive. If surveil-
lance cues have no effect, it would suggest that previous findings may have been due to 
Chapter 7
138
an intentional decision taken to bolster one’s reputation with the experimenter. Here, we 
present the first evidence from such a field experiment.
We take advantage of a unique opportunity to study altruistic behaviour in a setup which 
meets all the aforementioned requirements. This distinguishes our experiment from previous 
field studies in which surveillance cues were displayed in public spaces over an extended 
period of time17–25. As we explain in the last section of our paper, these studies were designed 
to address different research questions. As such, the positive effect of surveillance cues on al-
truistic behaviour in these studies suggests a potentially useful, low-cost, policy intervention, 
but it cannot support the claim that altruistic behaviour among strangers is maladaptive as 
many of the aforementioned conditions are not satisfied and indirect reciprocity opportuni-
ties exist.
In our experiment we investigate how two distinct surveillance cues impact the quality of 
hand hygiene by medical students before treating a ‘patient.’ Hand hygiene (HH) is a general 
term used to describe the process of removing microorganisms with a disinfectant agent 
such as alcohol, or soap and water26. Appropriate HH among healthcare workers is consid-
ered by some to be the most effective measure to prevent healthcare-associated infections27, 
which are associated with 50,000 and 99,000 deaths each year in Europe and the USA, 
respectively28, and annual hospital costs between $28.4 to $33.8 billion USD26. It is estimated 
that a one-percent improvement in the quality of hand hygiene could save approximately 
$40,000 USD per year in a 200-bed hospital for a single type of infection29. That is, how 
one washes his or her hands is critical. Accordingly, compliance with HH guidelines has been 
identified by the World Health Organization (WHO) as a first priority in health-care facilities28.
Appropriate HH prior to treating a patient is a textbook example of altruistic behaviour. 
According to WHO’s guidelines, when contact with a patient is not invasive – as is the case in 
our experiment – a healthcare provider must follow a specific technique to thoroughly wash 
his/her hands both before and after contact, for 40 to 60 seconds each time (when contact 
is invasive, the duration should be between 120 to 300 seconds)28. HH prior to treating a 
patient is not only costly, taking time and effort, but also it does not benefit the healthcare 
provider directly, only the patient whose chances of a healthcare associated infection are esti-
mated to decrease between 15 and 30%30. Both the cost to the practitioner31 and the lack of 
individual benefits32 from HH prior to treating a patient have been cited as prime reasons for 
why compliance with WHO’s guidelines is low. In support of the idea that HH prior to treating 
a patient constitutes an altruistic act is the evidence that compliance with HH guidelines is 
substantially higher after contract with the patient31,33. In the concluding section, we present 
results from a survey showing that concerns for the welfare of the patient indeed appear to 
be the primary reason for washing hands prior to treating a patient in our experiment.
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7.3 The experiment
The experiment was conducted in a large university, which is well-regarded locally for its 
medical program: the United Arab Emirates University (UAE). Participants were advanced 
undergraduate students in the Doctor of Medicine (MD) program who had completed train-
ing modules in the basic principles of clinical practice, including infection prevention and HH 
in accordance with WHO guidelines. For the experiment, we took advantage of a unique 
opportunity offered by the program for students to privately practice their clinical skills – a 
Practice Objective Structured Clinical Examination (POSCE). The official OSCE is a critical part 
of all MD programs aimed to formally evaluate one’s clinical competence. Medical students 
in the OSCE are observed and evaluated by faculty members as they go through a series of 
stations, interviewing, examining and treating different standardized patients who present 
some type of medical problem. The POSCE was identical to the OSCE, with two crucial 
differences: (i) faculty members were not present to observe or evaluate the competence of 
the students, and (ii) participants remained anonymous throughout the process. Students 
were fully aware that the purpose of the exercise was for them to practice their skills without 
being judged or evaluated.
A note outside the ‘patient’s room’ informed students that their main task was to take the 
blood pressure of a standardized patient. Medical students are aware that, whenever they 
are having physical contact with a standardized patient, there is a real risk of contaminat-
ing him/her. Participants therefore know that best clinical practice requires they wash their 
hands carefully immediately prior to measuring the standardized patient’s blood pressure, 
following the WHO’s HH guidelines. At the same time, participants are not monitored and, 
like with the OSCE, each practice slot lasts ten minutes – this is signified by automated bells 
in the corridors, which were meant to reinforce the fact that the POSCE was not monitored. 
During this time, they had to briefly interview the standardized patient, wash their hands, 
measure blood pressure, wash their hands again, and provide feedback to the patient. Given 
their limited experience with the blood measurement instruments, participants had an incen-
tive to take advantage of this one-off opportunity and spend most of their time practicing 
measuring blood pressure as it is likely to be relevant in the official OSCE. Therefore, there is 
a non-trivial cost for participants from properly washing their hands, but incurring the cost 
benefits the standardized patient. It should be noted that students could not benefit patients 
by expediting HH as each POSCE slot lasted exactly ten minutes, i.e., they could leave neither 
earlier nor later.
The experimental treatments varied the surveillance cues which were displayed, approxi-
mately at eye-level, above a wash basin (see Fig.1) and underneath the standard HH poster 
by WHO explaining in detail appropriate HH. Due to the HH guidelines and the limited 
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time of the session, exposure to the surveillance cue was necessarily brief (<60 seconds). 
Participants were randomly assigned to treatments/cues. The Baseline condition, like previ-
ous studies, consists of a non-reputation-related image – the picture of a tree. In the Eyes 
treatment, a pair of stern-looking male eyes was displayed. This particular image was chosen 
as it has been previously associated with a large positive effect on HH, i.e., a 122% increase 
relative to a baseline condition when the cue was placed in a public space over an extended 
time period25. This was important as it was uncertain ex ante how large a sample we could 
hope to attract. Ultimately, the turnout was substantial and higher than we had expected: 
114 students out of an eligible student population of 330. With this sample size, our tests 
have sufficient power to detect treatment differences substantially smaller than those in 
King et al.25 Note that in order to be exposed to the treatment manipulation, participants 
had to go to the wash basin to wash their hands. Some participants in our sample had to 
be prompted to do so by the standardized patient. Our results are unaffected if we exclude 
these participants from the analysis.
Figure 1 Picture of the wash basin in the private examination room featuring the watching eyes
The Camera treatment is the first of its kind in the literature. In this treatment, the picture of 
a CCTV camera was placed over the wash basin. Such CCTV cameras are omnipresent in the 
country of our study, although none was available in the examination room. If people have 
developed cognitive mechanisms to automatically identify reputation-building opportuni-
ties through millennia, and this is the cause for the changes in altruistic behaviour when 
reputation-related cues are presented, then we would expect to observe an effect in the Eyes 
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but not in the Camera treatment [8]. A difference in HH between our Camera and Baseline 
conditions could be interpreted as evidence participants are concerned about actually being 
watched.
Apart from informing students they would need to measure blood pressure, the briefing 
note outside the room explained that the only people inside the room will be two simulated 
patients that will take turns being the ‘patient’. (Rooms were spacious: approx. 25 square 
meters or 270 square feet). This is standard practice as a person should not have his/her 
blood pressure measured repeatedly. The simulated patients (RAs) were trained to appear 
indifferent to the actions of the medical students. At any given point, one RA waited for 
his/her blood pressure to be measured, and the other –seated at a faraway corner of the 
room – waited for his turn, while filling out a Sudoku book. In actuality, this individual was 
covertly monitoring the student’s HH practice. All RAs had been professionally trained on 
how to evaluate the quality of one’s HH. Crucially, the simulated patients were selected such 
that they were completely unknown to the students (with one exception).
Like in previous studies, direct reciprocity is prevented by design: not only were standardized 
patients in a passive role, but they were also trained to appear bored and indifferent to 
the POSCE. To preclude indirect reciprocity, encounters had to be anonymous such that 
reputational concerns could not affect altruistic behaviour. For this reason, students and 
simulated patients were explicitly instructed not to share their identities. As both ‘patients’ 
would remain in the room at the end of the session to receive the next medical student, 
while the practicing student would leave, it was clear to participants that encounters were 
one-shot and that there would be no opportunities for the ‘patients’ to reciprocate, either 
directly or indirectly. Further, to ensure observers were blind to our treatment manipulation, 
the RA who acted as the patient changed the poster before the next participant entered the 
room so that the observer was not aware which poster was displayed at any point in time.
7.4 Results
Our measure of altruistic behaviour is the quality of hand hygiene prior to treating the patient. 
As mentioned, how a medical practitioner washes his/her hands is of critical importance for 
minimizing the risk of an infection. The survey evidence presented in the concluding section 
suggests that participants were well aware of this. In order to evaluate the quality of hand 
hygiene amongst participants, we use three distinct measures from the WHO guidelines 
about HH. First, we consider the time spent washing hands. Second, we study the quality of 
hand coverage, i.e., the extent to which a participant washed all surfaces of his/her hands. 
Third, we consider compliance with a rule prescribing participants use a tissue to switch off 
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the tap, after finishing washing their hands. For simplicity and brevity, we present the means 
of these variables in the figures below.
Fig. 2 shows that, across treatments, participants on average washed their hands for slightly 
more than 20 seconds. While this may be more than the time spent by many adults washing 
their hands, it falls considerably short of the minimum recommended duration stated by 
WHO (40 seconds). This implies that there are good conditions for our treatments to increase 
the quality of hand hygiene and, in this instance in particular, the time spent washing. 
However, we find no statistically significant differences across treatments (Eyes vs. Baseline: 
P=0.69, N=71; Camera vs. Baseline: P=0.64, N=79; Mann-Whitney Test, two-tailed).
Figure 2 Average time spent washing hands across treatments (with 95-percent confidence intervals)




Our measure of altruistic behaviour is the quality of hand hygiene prior to treating the patient. As 
mentioned, how a medical practitioner washes his/her hands is of critical importance for minimizing 
the risk of an infection. The survey evidence presented in the concluding section suggests that 
participants were well aware of this. In order to evaluate the quality of hand hygiene amongst 
participants, we use three distinct measures from the WHO guidelines about HH. First, we consider 
the time spent washing hands. Second, we study the quality of hand coverage, i.e., the extent to 
which a participant washed all surfaces of his/her hands. Third, we consider compliance with a rule 
prescribing participants use a tissue to switch off the tap, after finishing washing their hands. For 
simplicity and brevity, we present the means of these variables in the figures below.  
 
Fig. 2 shows that, across treatments, participants on average washed their hands for slightly more 
than 20 seconds. While this may be ore than the time spent by many adults washing their hands, it 
falls considerably short of the minimum recom ended duration stated by WHO (40 seconds). This 
implies that there are good ditions for our treat ents to increase the qu l ty of hand hygiene 
and, in this instance in particular, th  ime sp nt washing. However, we find no statistically 
significant differences across treatme ts (Eyes vs. Bas li e: P=0.69, N=71; Camera vs. Baseline: 
P=0.64, N=79; Mann-Whit ey Test, two-tailed). 
 
Figure 2 Average time spent washing hands across treatments  
(with 95-percent conf dence intervals) 
 
 
Fig. 3 presents the average quality of hand coverage across treatments. As mentioned, the RAs were 
professionally trained to evaluate the extent to which participants followed the WHO guidelines and, 
in this instance, covered adequately all hand surfaces. Performance was coded as 0 if the participant 
did not attempt to cover multiple surfaces (e.g., did a simple rub of the palms against each other), as 
1 if the participant covered multiple but not all surfaces (e.g., did not wash thumbs), and 2 if the 
participant covered all surfaces.  
 
As can be seen in Fig. 3, average coverage is very similar in Eyes and Baseline, and statistically 
indistinguishable (P=0.99, N=71; Mann-Whitney Test, two-tailed). Although the quality of coverage is 
slightly higher in the Camera treatment, the difference with Baseline is statistically insignificant 



























Fig. 3 presents the average quality of hand coverage across treatments. As mentioned, the 
RAs were professionally trained to evaluate the extent to which participants followed the 
WHO guidelines and, in this instance, covered adequately all hand surfaces. Performance 
was coded as 0 if the participant did not attempt to cover multiple surfaces (e.g., did a 
simple rub of the palms against each other), as 1 if the participant covered multiple but not 
all surfaces (e.g., did not wash thumbs), and 2 if the participant covered all surfaces.
As can be seen in Fig. 3, average coverag  is very similar in Eyes and eline, and statistically 
indistinguishable (P=0.99, N=71; Mann-Whitney Test, two-tailed). Although the quality of 
coverage is slightly higher in the Camera treatment, the difference with Baseline is statisti-
cally insignificant (P=0.18, N=79; Mann-Whitney Test, two-tailed).
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Figure 3 Average quality of hand coverage across treatments (with 95-percent confidence intervals)
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Fig. 4 presents the extent to which participants across treatments turned off the tap after washing 
their hands using a paper towel. This is critical in HH because a lot of bacteria can be found on the 
water tap. Participants have therefore been trained that not using a towel reduces considerably the 
efficacy of HH at combating disease transmission. Performance was coded as 0 if the participant did 
not use a paper towel at all, as 1 if the participant used a paper towel but improperly (e.g., used 
paper towel but also touched tap with bare hands), and 2 if the participant used properly a paper 
towel. Average compliance with this rule is lower in Eyes than in Baseline, although the difference is 
again statistically insignificant (P=0.39, N=71; Mann-Whitney Test, two-tailed). Compliance is similar 
in Camera and Baseline and statistically insignificant (P=0.90, N=79; Mann-Whitney Test, two-tailed). 
Neither the fraction of participants using a paper towel properly differs significantly across 
treatments (Eyes: 17.1%, Camera: 20.9%, Baseline: 16.7%; Eyes vs. Baseline: P=1.00, N=71; Camera 
vs. Baseline: P=0.78, N=79; Fisher Exact Test, two-tailed) nor the fraction of participants not using a 
towel at all (Eyes: 65.7%, Camera: 53.5%, Baseline: 52.7%; Eyes vs. Baseline: P=0.37, N=71; Camera 
vs. Baseline: P=1.00, N=79; Fisher Exact Test, two-tailed). 
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Fig. 4 presents the extent to which participants across treatments turned off the tap after 
washing their hands using a paper towel. This is critical in HH because a lot of bacteria can 
be found on the water tap. Participants have therefore been trained that not using a towel 
reduces considerably the efficacy of HH at combating disease transmission. Performance was 
coded as 0 if the participant did not use a paper towel at all, as 1 if the participant used a 
paper towel but improperly (e.g., used paper towel but also touched tap with bare hands), 
and 2 if the participant used properly a paper towel. Average compliance with this rule 
is lower in Eyes than in Baseline, although the difference is again statistically insignificant 
(P=0.39, N=71; Mann-Whitney Test, two-tailed). Compliance is similar in Camera and Base-
line and statistically insignificant (P=0.90, N=79; Mann-Whitney Test, two-tailed). Neither the 
fraction of participants using a paper towel properly differs significantly across treatments 
(Eyes: 17.1%, Camera: 20.9%, Baseline: 16.7%; Eyes vs. Baseline: P=1.00, N=71; Camera 
vs. Baseline: P=0.78, N=79; Fisher Exact Test, two-tailed) nor the fraction of participants 
not using a towel at all (Eyes: 65.7%, Camera: 53.5%, Baseline: 52.7%; Eyes vs. Baseline: 
P=0.37, N=71; Camera vs. Basel ne: P=1.00, N=79; Fisher Exact T st, t o-tailed).
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Figure 4 Average compliance with turning-off-tap-with-paper-towel rule across treatments (with 
95-percent confidence intervals)
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Our paper presents the first empirical test of the impact of surveillance cues on the altru-
istic behaviour of anonymous strangers when reciprocity is precluded and participants are 
unaware they are being studied. These conditions are critical to obtain clear support for the 
evolutionary legacy hypothesis – a prominent explanation for altruistic behaviour between 
strangers – according to which costly altruistic behaviour in anonymous encounters is an 
anomaly, owning to our ancestral past and the development of automated, involuntary 
mechanisms for boosting one’s good reputation. Despite using cues that have been suc-
cessfully used previously in the literature, we find no evidence surveillance cues increase the 
degree of altruistic behaviour in our experiment. That is, our findings do not support the 
hypothesis that altruistic behaviour among strangers is maladaptive.
One concern with all studies reporting null results is that this is due to the statistical tests 
being underpowered. This is clearly not the case in our experiment. Not only do we find 
no evidence across three distinct measures that the picture of eyes has a significant impact 
on altruistic behaviour in our experiment, but the effect itself is sometimes zero (Fig. 3) or 
negative (Fig. 4). By comparison, the effect of posting a picture of a camera over a wash 
basin – which as we argued could not be considered as supportive of the evolutionary legacy 
hypothesis – is also always insignificant and small in size, but at least it is always positive. 
Therefore, the overall lack of a significant effect cannot be attributed to insufficient statistical 
power.
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Another concern may be that the lack of a positive effect is due to the fact that our experi-
ment investigates the impact of surveillance cues on the quality of hand hygiene (intensive 
margin) but not on the decision to wash hands (extensive margin). Indeed, early evidence 
from dictator game experiments – in which an individual is assigned an amount of money 
and must decide how much of it to share with a passive recipient – suggested that surveil-
lance cues may have a greater impact on the likelihood a ‘dictator’ shares a positive amount 
(extensive margin) than on the actual amount they share (intensive margin); combining 
margins the effect was often zero11. A recent meta-analysis of laboratory studies however 
contradicts these earlier results, finding no differential effect of cues on the extensive and the 
intensive margin34. Further, some field studies find the opposite result, i.e., that the impact of 
the cues is stronger on the intensive margin19 or that a positive effect on charitable donations 
is obtained even when there are no differences in the proportion of donors responding to 
the cues13. Therefore, there exist neither clear empirical evidence nor theoretical reasons to 
expect the automatic activation of the reciprocity-based psychology will operate differently 
on the decisions on the extensive and intensive margins.
Although our design precludes both direct and indirect reciprocity by ensuring encounters 
are one-shot and all individuals involved (both participants and standardized patients) are 
unknown and anonymous to each other, we cannot rule out the possibility that, despite 
our efforts to avoid this, the presence of the standardized patients may have activated par-
ticipants’ reciprocity-based psychology already in the Baseline treatment, making it difficult 
to identify a treatment effect. However, it is worth emphasizing that similar concerns apply 
in laboratory environments. In fact, they are arguably greater: not only there are several 
participants in the lab at the same time – some of whom subjects may know personally – but 
their decisions are recorded by a computer and possibly observed by the experimenter. Even 
if this is not the case, participants – who often partake repeatedly in lab experiments – should 
anticipate that their final payment will ultimately reveal the extent of their altruistic behaviour 
to the experimenter. If the reason for not observing a surveillance-cue effect in our experi-
ment is the activation of the reciprocity-based psychology already in the Baseline condition, 
then it follows that the lab evidence on “watching eyes” cannot provide clear support either 
that altruistic behaviour among strangers is maladaptive.
It should also be noted that behaviour across measures in our experiment falls considerably 
short of that described in the WHO guidelines. If participants were concerned about their 
reputation, one might have expected higher compliance with the guidelines than observed.
An altogether different concern with our study could be that hand hygiene prior to treating 
a patient is in fact not an altruistic act as we claimed. Although similar claims are common in 
the medical literature31,33, one might wonder whether hand hygiene is regarded as altruistic, 
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i.e., as conferring a benefit to the patient, in our particular context by medical students such 
those participating in our experiment. To address this concern, we administered a survey to 
100 medical students with the same level of training and background as those who partici-
pated in our experiment. Respondents were presented with a vignette designed to mimic 
the situation and incentives in our experiment, and asked whether they would wash their 
hands prior to treating the patient or not, and the reasons for their decisions.  The survey also 
included a question to evaluate our claim that the quality of hand-hygiene matters when it 
comes to reducing infection by asking participants whether they agree that washing hands 
for longer reduces the risk of infection for the patient.
Of the survey respondents who stated they would wash their hands prior to taking the blood 
pressure, 96.6% agreed with the statement that they would do so to avoid doing harm to 
the patient. We can reject the hypothesis that respondents neither agree nor disagree with 
the statement in favor of the alternative hypothesis that they agree with it (P<0.01, N=87, 
Wilcoxon signed rank, two tailed). This supports our interpretation of hand hygiene prior to 
treating a patient as being an altruistic act as it is driven by a concern for the welfare of the 
patient. Participants were also more likely to agree with this reason for hand washing than 
with any of the other reasons (P<0.01 for all pairwise comparisons, N=87, Wilcoxon signed 
rank, two tailed) indicating that the desire to do no harm to the patient is the main concern 
driving hand hygiene prior to contact with the patient.
Perhaps unsurprisingly, we find that other concerns also appear to play a role, implying that 
hand hygiene prior to treatment is not driven exclusively by altruistic concerns for everyone. 
This, however, does not invalidate our analysis which only requires that altruistic motives are 
an important determinant of behaviour in our experiment. We can also reject the hypothesis 
that respondents neither agree nor disagree with this statement in favor of the alternative 
hypothesis that they agree with it (P<0.01, N=93, Wilcoxon signed rank, two tailed).
At first pass, our findings appear to contradict those in previous field studies finding a strong 
positive effect of surveillance cues on altruistic behaviour in natural environments17–25. Such 
interpretation of our findings however would be wrong. A critical difference between these 
studies and ours, stemming from the different research aims, is that the cues in these stud-
ies were placed in public spaces such as university cafeterias17,18, public car parks20, super 
markets13,21 or hospital entrances25, over an extended period of time. This implies that real 
reputational concerns were at play.
For example, participants in all these studies could self-select into several treatments, more 
than once, suggesting that individuals may be aware of the treatment manipulations and 
thus suspect they are being monitored. Similarly, since the manipulations occurred in places 
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frequented by the participants, many of the encounters were likely to be neither anonymous 
nor one-shot, implying that reciprocity is not precluded by design. For these reasons, these 
studies suggest a potentially useful, low-cost, policy intervention (as was intended by the 
authors) but the evidence cannot inform the debate of whether altruistic behaviour between 
strangers is maladaptive.
Taken together, the field evidence suggests that surveillance cues may be effective in promot-
ing altruistic behaviour in circumstances in which there are real opportunities to build a good 
reputation. In these instances, the cues may serve as a signal of what the expected behaviour 
is and that behaviour is monitored. In line with this is the finding that the surveillance-cue ef-
fect appears to be strongest when peer effects are modest13,18, possibly due to the increased 
difficulty of monitoring behaviour in large groups. Additional studies can help explore the 
underlying mechanism through which surveillance cues operate. Our findings indicate that 
surveillance-cues effects should not readily be interpreted as evidence that altruistic behav-
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This final chapter discusses the main findings and limitations of this study and the implica-
tions for research policy and practice, followed by the overall conclusions.
This study focused on what methods healthcare regulatory agencies can deploy in order 
to achieve their objectives. Research into the effectiveness of healthcare regulation can be 
challenging due to the complex nature of healthcare provision, as well as the interconnected 
relationships between regulatory methods, the targeted behaviours and the ultimate out-
comes of concern. The aim of this research was to explore the role and effects of healthcare 
regulation by investigating the factors that influence compliant behaviour. The central ques-
tion guiding this research was:
How can regulators utilize regulatory methods to improve healthcare regulatory compliance?
The research objectives are:
1. Review the role and impact of health system reform in the United Arab Emirates (UAE) 
with a specific focus on Abu Dhabi;
2. Review the current availability, use and effects of a healthcare regulatory intervention 
(Clinical Practice Guidelines) in the Gulf region;
3. Examine the explanatory powers of several independent variables (instrumental and so-
cial motivations, as well as self-reported compliance) on compliance-related behaviours;
4. Test whether a simple behavioural cue can be effectively deployed as a regulatory method 
to improve compliance.
This study consisted of a systematic review of the overall context of the health system reform 
in the UAE and the Emirate of Abu Dhabi as well as a review of one particular regulatory 
method and its application in the local environment. We conducted a survey into how people 
who are required to comply with healthcare regulation perceive these requirements and 
what can be done to improve their compliance. Finally, we evaluated regulatory compliance 
by conducting a field experiment to measure how future healthcare professionals respond 
to behavioural cues.
This research study took place in the UAE, a fast developing country with relatively new 
healthcare system. The systematic reviews focused on first two research objectives and 
charted the progress and outcomes of health system reform in Abu Dhabi and the UAE, as 
well as the role and impact of one particular regulatory method throughout the Gulf Region, 
over the last decades.
Chapter 8
156
The setting of the research was the UAE’s oldest and best established medical school, ranked 
amongst the best medical schools in the Gulf Region. The medical school is the primary 
source of medical education for UAE nationals1 and as such it plays an important role in 
the UAE healthcare system. For example, it has been estimated that only around 13% of 
all physicians licensed in Abu Dhabi are Emirati (around 1,200 in total)2, many of whom 
graduates from the medical school involved in our study.
8.2 Research findings
This research used a mixture of methodologies to answer the research question and address 
each research objective. Our research study used the so-called effect chain3 as the conceptual 
model in combination with the regulatory toolkit taxonomy designed by Freiberg4, to present 
and explore our empirical findings
We conducted systematic literature reviews to provide an insight into the local context of 
health system reform in Abu Dhabi, the UAE and the wider Gulf region, with a focus on 
healthcare regulation. We started with a review of the recent health system reform in the 
Emirate of Abu Dhabi, following the introduction of a mandatory healthcare insurance 
system and the establishment of a regulatory authority in 20065. In this review, we evaluated 
whether the health system reform program (including the establishment of a centralized 
regulatory system in Abu Dhabi) had achieved the desired effects. The study found that the 
new mandatory health insurance system had led to an improved situation where virtually 
all residents had access to the required care. However, we found no clear evidence that the 
introduction of a centralized regulatory system had made much impact on the quality and af-
fordability of healthcare in Abu Dhabi (Chapter 2). Research studies conducted subsequently 
reached similar conclusions regarding inappropriate overutilization6 of healthcare services, 
lack of information about the quality of care7 and concerns about the long term financial 
sustainability8.
As part of this phase, the research expanded into an evaluation of the entire UAE healthcare 
system. We conducted a systematic review, based on the AGREE tool9, to evaluate the na-
ture, extent and impact of the  healthcare system reform since the early 2000s. The UAE, as 
a relatively new federation of seven independent Emirates, has made substantial progress 
since its establishment, with an ambitious set of plans to create one of the best countries in 
the world before the country celebrates its 50th anniversary in 202110. The review did not find 
enough substantial evidence to conclude that the health system reform program, including 
the regulatory reform, had achieved its objectives and resulted in the desired improvements. 
Our study identified a number of areas that needed improvement11, such as the lack of 
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regulatory integration7, poor data collection and reporting12 and the increased prevalence of 
lifestyle related diseases, such as diabetes and cardiovascular diseases13 (Chapter 3).
In order to address the second research objective, we examined and reviewed the role and 
impact of one regulatory tool, Clinical Practice Guidelines (CPGs), in the wider Gulf region. 
By conducting another systematic literature review, our research study analysed the develop-
ment, implementation and evaluation of Clinical Practice Guidelines over a 13-year period. 
We concluded14 that, in the wider Gulf region, there had been a lack of proliferation and 
implementation of evidence based clinical guidelines, raising concerns about the ability of 
different healthcare systems to address the growing public health concerns regarding non 
communicable diseases15 (Chapter 4). Our study did not find robust evidence of widespread 
proliferation of CPGs or evidence that the implementation of this regulatory tool had resulted 
in quality improvements. A small number of published research studies (8 studies, out of a 
total of 58) had evaluated the effectiveness of the introduction of CPG as an intervention. 
Out of these effectiveness studies, 5 reported positive results. However, for many of these 
studies CPGs formed part of a series of interventions, such as the introduction of specialized 
clinics and awareness raising activities, making it difficult to draw any conclusions about the 
role and effects of CPG as a regulatory instrument.
There are several regional and local characteristics that play an important role in this research. 
First, the healthcare system in the UAE, and the rest of the Gulf region, is relatively young 
compared to other, developed countries and regions. Up until the late 1960s and early 
1970s, most of the Gulf region was relatively underdeveloped in terms of healthcare provi-
sion and infrastructure. In terms of medical education for example, the UAE only opened 
its first medical school in the mid 1980s16. It is worth bearing in mind that the Gulf society 
has changed dramatically over the last 40 – 50 years, with huge demographic and societal 
changes accompanied by strong economic growth17.
Whereas some countries such as the United Kingdom, France, Germany and The Netherlands 
have had some type of healthcare regulation in place since the mid-19th century18,19, many 
countries in the Gulf region established their regulatory system more recently, towards the 
end of the 20th century. The healthcare regulatory infrastructure in the UAE was controlled at 
a federal level until 2006 when, at an Emirate level, Dubai and Abu Dhabi established their 
own regulatory systems, resulting in a more complex healthcare infrastructure20. Taking this 
into consideration, our systematic reviews summarized the progress made in a relatively short 
period of time as well as identifying a number of areas for further improvement.
In addition to the challenge of building capacity within the healthcare system over a short pe-
riod of time, there are indications that the region also encounters capability challenges, such 
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as a lack of awareness around mandatory adverse event reporting21, a limited contribution to 
medical research22 and a lack of technical efficiency of its hospitals23. This local context with a 
relatively new healthcare system with a number of capacity as well as capability gaps, creates 
a challenging environment for the effective provision of oversight.
Our research also looked at factors influencing compliance (self-reported and observed). In 
this part of the study24, medical students were asked for their opinions and perception of 
healthcare regulations as well as their levels of compliance with regulatory requirements. 
Our findings supported the hypothesis that an individual’s compliance level is shaped by 
their perceptions of the legitimacy, fairness and performance of the regulatory agency. At 
the same time, our cross-sectional study found that deterrence factors, such as the perceived 
likelihood of getting caught, had no effect on the reported compliance levels (Chapter 5).
Our follow up study25 (Chapter 6) found a discrepancy between self-reported and observed 
performance: Nearly 70% of participants reported that they had performed the clinical task 
to the best of their abilities. However, from our observations, we found that the majority of 
the medical students (more than 75%) did not adequately perform the clinical tasks during 
the clinical skills simulation. We concluded that the self-assessed performance of medical 
students is not related to their observed compliance and therefore may be an unreliable 
predictor of observed compliance. Other studies found similar discrepancies between self 
assessed and observed performance.26,27 One study, involving nursing staff in Kuwait, found 
a self-reported compliance of 90% with hand hygiene requirements and an observed com-
pliance of 33%.28 It is worth noting that actual, observed hand hygiene compliance scores 
amongst healthcare professionals are frequently below 40%29 and our participants’ ability to 
rate their own performance may have actually been accurate, considering that the expected 
observed compliance level is below 40%.
The final part of our study included a natural field experiment (Chapter 7), involving medi-
cal students who were faced with a task to demonstrate their clinical skills (hand hygiene 
performed before and after blood pressure measurement). Compliance with regulatory 
requirements was measured by observing clinical practice. Compliance with hand hygiene 
requirements was chosen as it can be viewed as an example of altruistic behaviour since the 
action does not benefit the actor directly or immediately. The evolutionary legacy hypothesis 
postulates that actors may display complaint (altruistic) behaviour if it is viewed as a reputa-
tion building opportunity. Our study did not find evidence that exposure to visual behavioural 
cues resulted in improved compliance30 and concluded that further research needs to be 




To ensure scientific rigor we used several research models, in accordance with the study 
design outlined in Chapter 1. This section describes the most relevant aspects of the research 
methodologies deployed in our study and discusses the potential impact on the findings.
Design of studies evaluating the health care systems in Abu Dhabi 
and UAE
We reviewed the progress of the healthcare system in Abu Dhabi and the UAE between 
2002 and 2016 (Chapters 2 and 3). These reviews were based on an extensive search and 
evaluation of the available evidence.
We faced a number of methodological challenges conducting this research. First of all, it was 
difficult to draw firm conclusions due to the overall lack of high-quality research evidence 
into the impact of health system reform in Abu Dhabi and the UAE. We conducted two 
studies, five years apart, in order to investigate whether improvements in the health system 
research had been made between our first study in 2011/2012 and the second study in 
2015/2016. To improve the usefulness of our reviews we conducted a thorough analysis of 
‘grey’ literature, including reports issued by local government agencies, international bodies, 
such as the World Health Organization (WHO). We also used the Preferred Reporting Items 
for Systematic Reviews and Meta Analyses (PRISMA) guidelines for the second systematic 
review to ensure that we conducted a thorough and comprehensive search of all available 
literature. A final challenge concerned the lack of uniformity when it comes to complex 
interventions aimed at improving healthcare quality.31 We addressed this by including a large 
number of different search terms and by conducting the second review. However, the paucity 
and limited scope of the studies means that it is difficult to draw any major conclusions as to 
whether the reform programs in Abu Dhabi and the UAE have achieved the desired impact.
Design of a study to evaluate the development, implementation 
and impact of Clinical Practice Guidelines
A number of international studies have found a moderate, positive effect of CPGs on the 
quality and safety of health care independent of geographical location.32,33 We therefore 
conducted another systematic review to investigate the development, implementation and 
evaluation of one particular healthcare regulatory instrument, Clinical Practice Guidelines 
(CPGs), in the wider Gulf region (Chapter 4). Many healthcare regulatory agencies have 
attempted to steer and direct the behaviour of healthcare professionals by developing and 
disseminating CPGs34 and our research examined the availability, use and effects of these 
regulatory instruments in the Gulf region.
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The first challenges related to the relevancy and paucity of the research: research evidence 
can rapidly become outdated as more and more research is published35. To address this, we 
only included recent literature (between 2000 and 2013) and confined our search to one 
geographical area (GCC). We also designed and followed a comprehensive search strategy, 
including two different screening stages, in order to ensure that all relevant studies were 
included in the review.
Perhaps a bigger limitation is that many systematic reviews are unable to draw clear conclu-
sions due to the a lack of scientifically sound primary research studies.36 For example, a 
Cochrane review on the effectiveness of one widely implemented regulatory method, exter-
nal inspection, found only two high quality, controlled evaluations that met the researchers’ 
review criteria.37,38 We had a similar findings in our review: research studies lacked robust 
methodology. For example, we only came across one randomized control trial, the remaining 
studies were largely descriptive, making it harder to draw clear conclusions.
Design of a cross sectional survey to ascertain the perceptions of 
medical students
We designed a cross-sectional survey to elicit the views and perceptions of the medical 
students (Chapter 5) in order to assess the relationship between factors such as perceived 
legitimacy, fairness and regulatory performance and self-reported compliance. Over 100 
medical students took part (response rate 56.4%) and completed the survey. Considering 
the 56.4% response rate, there may have been a selection bias with some students opting 
out. However, the participants did not differ from the total population on variables such as 
gender, nationality and age.
Perhaps a more important limitation is the potential social desirability bias that can occur 
when participants do not answer based on their own beliefs or experiences, but rather by 
what they think is socially appropriate or expected from them. We undertook a number 
of steps to remedy this. Participants were informed that their responses would be kept 
confidential and their participation would not affect their grades. Secondly the participants 
completed the survey in a neutral environment with no interaction with fellow students, 
researchers or university staff.
Cross-sectional survey data rarely point directly at a causal relationship, since there are often 
many variables of interest that obscure the relationship between the variables.39 In our study, 
variables such as age, sex, frequency of contact with regulator, etc. were included to address 
such concerns and the findings indicated that these contextual factors had limited effect on 
the self-reported compliance behaviours.
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The survey measured self-reported compliance and it could be argued that self-reported 
compliance is not necessarily linked to actual compliant behaviour.40 We therefore conducted 
a separate analysis to investigate this further (Chapter 6).
Design of a natural field experiment to test the effects of a simple 
and subtle behavioural cue
We conducted a field experiment to find out whether surveillance cues have an impact on 
the altruistic behaviour among anonymous strangers. This type of research methodology 
has rarely (if ever) been used in the field of healthcare regulation and several researchers 
have recommended the use of experimental designs to investigate the impact of regula-
tory methods31,38. Influenced by the so-called effect change model3, we tested whether the 
intended behaviour (hand hygiene) can be affected by different behavioural cues. Students 
involved in this study volunteered to participate, signed a consent form and were randomly 
assigned to one of four examination rooms. In addition to this, the practice slot and room 
was randomly assigned into one of three treatments. This experimental study design is the 
most scientifically rigorous available to establish a causal relationship between two variables, 
in this case behavioural cues and observed compliant behaviour.
One potential methodological concern was the potential changes in participant’s behaviour 
due to their awareness of being observed (observer or Hawthorne effect). This concern 
was particularly relevant because the study took place in the same university where the 
medical students received their clinical training. Although we cannot completely rule out 
this potential bias, it is worth emphasizing four points. First, participants were randomly 
assigned to different private examination rooms located in an isolated wing of the university 
that students normally do not access. Participants were then asked to perform a relatively 
simple clinical practice task and observers were not known to the participants. In order to 
further minimize potential bias, the observers were trained and experienced in observing 
students’ performance and used a standardized observation checklist. Furthermore, one 
of the research assistants covertly monitored the participant’s behaviour by acting bored 
pretending to complete a Sudoku book. Finally, if participant had been concerned about 
their reputation, their compliance score would have been higher than observed. As noted, 
the actual observed compliance behaviour fell considerably short of the WHO guidelines.
The second methodological concern was the statistical significance of the sample size. Since 
our study was the first to explore the impact of surveillance cues on compliance behaviour 
in a natural field setting, we had no benchmark for the potential sizes of the different 
treatment groups. To remedy this, we based our statistical calculations on other numerous 




Even though this study can be classified as a natural field experiment, the replicability of 
these findings to a real life setting might be challenging43. Having conducted this study 
in a well-controlled environment with only two “bystanders” provides the methodological 
assurances of the validity of our findings. However, it has been argued that the effects of a 
subtle behavioural cue may actually be stronger in a real life environment as people are more 
sensitive to social consequences of one’s actions in public spaces such as bus stops and super 
markets44. Replicating this study in a real life setting certainly has merits even though our 
study showed no evidence behavioural cues improve regulatory compliance.
8.4 Implications for healthcare regulatory research, policy 
and practice
In this study we reviewed the potential impact of three regulatory tools in particular: 
guidelines, behavioural cues and perceptions. This section discusses the implications of this 
research study, in terms of further research and future policy and practice.
Implications for further research
This study contributes to the research into healthcare regulation in two important ways. First 
of all, there are several research implications within the geographical context and secondly 
the study also identified areas for improvement in the broader context of the study into 
healthcare regulation.
Firstly, this research study has provided new insights into the role of healthcare regulatory 
methods in a rapidly developing region. Further research is required to study the role and 
impact of regulatory methods. The unique healthcare regulatory context in the UAE provides 
a number of opportunities for further research. As the healthcare system in the UAE is evolv-
ing, it may be an opportune time to conduct interrupted time series or even randomized 
controlled trials, in order to measure the effects of various regulatory methods. For example, 
a recent interrupted time series analysis study in a UAE hospital45 reviewed the impact of ac-
creditation and found that improvement achieved from accreditation was maintained during 
the three year accreditation cycle. Healthcare regulatory agencies in the UAE have introduced 
new regulatory initiatives in recent times, such as mandatory health insurance, electronic 
medical records and health information exchanges46. As these interventions are being imple-
mented, regulatory agencies and research institutions should conduct effectiveness studies 




Secondly, a taxonomy of regulatory methods can help to focus the research activities and al-
low regulatory agencies to concentrate on day-to-day activities that can influence compliance 
behaviour. At the same time, regulatory agencies need to support further research into the 
relationship between the behaviour and the ultimate outcomes of concern. Whilst further 
research using the effect chain would help to create a better understanding of the impact 
of regulation, it should not become a goal in itself. Several researchers have argued that, in 
practice causality might be impossible to prove47 due to the complexity of the ‘phenomena‘ 
being studied and the data limitations18.
Our study found an association between perceptions of legitimacy and fairness and reported 
compliance. Using experimental research designs can help researchers to conduct simple, 
cost effective, observational studies into compliant behaviours that investigate what part 
of the regulation works, for whom and in what circumstances48. The paucity of high-
quality research evidence into the effectiveness of healthcare regulation38 can be addressed 
by breaking down the regulatory processes and its methods into smaller chunks that allow a 
regulatory authority to examine which parts work and which do not49.
Future research on the optimal utilization of regulatory methods should concentrate on con-
tinuing using low-cost research studies using a mixture of different methodologies, including 
natural field experiments and surveys, as well as population based surveys to measure the 
views and perceptions of the general public50,51.
Implications for policy and practice
This research study presents a number of findings which have implications for policy and prac-
tice. First, regulatory agencies need to take into consideration how regulated organizations 
and their staff perceive characteristics such as fairness, performance and legitimacy when 
performing their regulatory functions. The future physicians who participated in our study 
are more likely to display compliant behaviour when they perceive the regulatory agency as 
being fair, competent and legitimate. These findings provide further evidence in support of 
the responsive regulation paradigm as postulated by Ayres and Braithwaite52. The responsive 
regulation theory argues that better regulatory outcomes can be achieved if the regulatory 
agency is responsive to the needs of the regulated persons and organizations. Considering 
the costs of regulation and impact of non-compliance, combined with the lack of evidence 
for a deterrence approach, policy makers and regulatory agencies should focus more on 
creating a regulatory environment that reflects the principles of responsive regulation.
A taxonomy of regulatory methods will help regulatory agencies and researchers to gain 
more granular insights into the role and impact of a variety of methods. Regulatory agencies 
need to concentrate their research activities on the intended overall impact of the regulatory 
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activities, broken down into smaller steps or processes47. Each process within the effect chain 
should have its own, measurable goals and regulatory methods. This way the regulatory 
authority can direct its energy and efforts towards methods that are within their locus of 
control, helping the regulatory authority to show its added value53. For example, in our 
study, we were able to show that simple behavioural cues did not have a significant impact 
on compliant behaviours.
Regulatory agencies need to be flexible and explore, adapt, design and implement the most 
appropriate regulatory methods at their disposal to target relevant compliant behaviours 
that will ultimately lead to better outcomes. Even though many regulatory agencies have a 
wide arsenal of regulatory methods available to them, there is limited evidence how, when 
and if these methods achieve the desired effects in a healthcare setting. A taxonomy of 
relevant methods may help in identifying the most suitable method in order to achieve the 
regulatory objectives. In his seminal book about regulation, The Regulatory Craft, Malcolm 
Sparrow articulated this regulatory strategy as follows: “Pick an important problem. Fix it. 
Tell everyone”47.
Implications for local policy
Despite its many achievements, the UAE health system remains fragmented and in need of 
further reform54. The UAE Government has acknowledged this and set out a clear vision for 
the future with the ultimate goal to create a world-class health system55.
To address the fragmentation of the UAE health system, the UAE should consider establish-
ing a single, independent statutory healthcare regulatory authority dedicated to overseeing 
the performance of the overall health system, building on the best international practice 
available. Our research evidence points towards a need to collect more reliable data on 
healthcare outcomes and benchmark the performance globally56. Compared to other health 
systems with a more mature health care system, the UAE appears to be on the right track 
with its focus on market reforms through privatization, rates setting and public-private 
partnerships2. In the first instance, the UAE healthcare regulatory agencies could review their 
existing regulatory methods at their disposal and formulate new ways of implementation. For 
example, the healthcare professional licensing system in the UAE is now harmonised across 
the entire country57 and this harmonised system could provide a useful platform for further 
cooperation between the regulatory authorities.
As a rapidly growing and developing country, the UAE could build on the combined ex-
perience and knowledge from regulatory agencies from other countries. The OECD has 
developed a monitoring framework and effect chain to measure regulatory progress3 and 
at a national level the UAE could utilize this framework as well as subsequent versions and 
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iterations58,59 to conduct periodic reviews. In addition, the UAE is in an ideal position to learn 
from and put in practice the most relevant, up to date evidence when it comes to effective 
regulatory methods.
8.5 Conclusion
This research looked at how healthcare regulators can best utilize regulatory methods in 
order to improve compliance. To answer the research question, we identified a suitable 
taxonomy and a broader effect chain framework that we could use. Predicting whether and 
how healthcare providers and professionals will respond to different regulatory methods and 
comply with regulatory requirements is a fundamental prerequisite to improve regulatory 
compliance. We used the taxonomy proposed by Freiberg4 as a tool to identify and select 
regulatory methods.
In our study we reviewed the potential use and impact of three such regulatory methods: 
Legal (Clinical Practice Guidelines), Structural (behavioural nudges) and Informational (per-
ceptions).
Our systematic review of CPGs in Gulf countries over a 13-year period found a small number 
of studies that had evaluated an impact on outcomes. A number of these studies had found 
positive effects, but it was unclear how the actual CPG compliance had contributed to this 
because CPG compliance formed part of a larger intervention, often including activities such 
as awareness raising, clinic redesign and training. Our overall conclusion is that CPGs have 
potential as a regulatory tool and regulatory authorities should consider using CPGs as tools 
to improve patient outcomes.
Changing the choice architecture by introducing behavioural nudges did not lead to a sig-
nificant change in compliant behaviour. In our study we conducted a field experiment and 
found no difference in compliance behaviours between participants exposed to different 
behavioural cues. However, this regulatory method is relatively inexpensive to implement and 
in a different environment with an extended exposure it may help to improve compliance.
Our survey measured the perceived fairness, legitimacy, risk of getting caught or punished 
and performance of the regulatory agency and its relationship with self-reported compliance. 
We concluded that regulation based on trust and fairness is more likely to be effective than 
regulation with a focus on deterrence. Our research findings may help regulatory agencies 
to concentrate their efforts on building trust by ensuring that its regulatory processes are fair 
and transparent. It should be noted that in a follow up study we could not find a relationship 
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between the self-reported compliance and observed compliance. However, recent evidence 
also suggests that inspectors judgements and observations are not as reliable as often as-
sumed60 . Regulatory agencies need to realize that a complex and multidimensional reality 
cannot be measured by one tool alone and it is often a multitude or hybrid of tools that will 
give an accurate reflection of compliance.61
As noted in the introductory Chapter, the so-called effect chain assumes that an increase in 
compliance leads to improvements in the healthcare performance.62 Our research looked at 
the first part of the effect chain: the relationship between particular regulatory methods and 
compliant behaviour. This research found limited evidence of this relationship, but it can be 
used as an impetus for regulators to introduce new and innovative regulatory methods that 
can improve compliance and deliver positive results.
In response to the paucity of evidence regarding the effectiveness of healthcare regulation, 
combined with the growing concerns over quality and safety of care (i.e. do nothing is not 
an option), regulatory agencies have a bigger chance to make an impact if they regularly 
reviewed the regulatory methods at their disposal and design a regulatory approach accord-
ingly. By starting to acknowledge and address the limitations of their endeavours, regulatory 
agencies can establish a productive effect chain.
Finally, it may also guide and inspire future researchers, practitioners and policy makers 
to develop, test and implement new and innovative regulatory methods that will improve 
compliance and support the overall achievement of regulatory objectives. Well executed 
research projects, no matter how small, will help to build legitimacy and ultimately trust in 
the healthcare system. In turn, this legitimacy and trust will have an impact on compliance 
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Healthcare systems face numerous challenges such as rising consumer expectations, increas-
ing costs and patient safety concerns. Governments establish regulatory systems in an attempt 
to steer or direct events, activities and behaviours in order to improve the quality of care, 
provide assurance that minimum standards are achieved and ensure accountability. Regula-
tion covers a wide range of interventions and seeks to change behaviour in order to produce 
desired outcomes. The objectives of regulation are varied and range from protecting citizens, 
regulating social problems, exercising control over regulated activities or organizations and 
improving the overall quality of public service delivery. Healthcare regulatory agencies aim to 
provide oversight over the quality, safety, access and price of healthcare services using a wide 
range of regulatory methods.
Despite the important role of a well-functioning healthcare regulatory system, limited re-
search has been conducted into how regulation works in practice and what impact it makes. 
This study aims to contribute to a better understanding of healthcare regulation by taking 
an in-depth look at three different regulatory methods used to regulate the conduct and 
performance of healthcare professionals and organizations. Our study was carried out in 
the United Arab Emirates (UAE), a federation of states (Emirates) in the Persian Gulf region. 
We use a mixture of methodologies (systematic reviews, a survey and a field experiment) to 
answer the following research question:
How can regulators utilize regulatory methods to improve 
healthcare regulatory compliance?
Predicting whether and how healthcare providers and professionals will respond to different 
regulatory methods and comply with regulatory requirements is a fundamental prerequisite to 
improve regulatory effectiveness. Healthcare regulatory agencies are often given a broad and 
rather generic remit to oversee numerous heterogeneous organizations, markets and profes-
sionals. As a result, a regulator’s approach often consists of a mix of regulatory interventions 
with high levels of variance in context (i.e. the setting), contents (i.e. the characteristics of 
the intervention) and the application (i.e. the methods used and the process through which 
the intervention is delivered).
This research looked at how healthcare regulators can best utilize regulatory methods 
in order to improve compliance. To answer the research question, we firstly identified a 
suitable taxonomy and a broader framework that we could use and develop further. This 
taxonomy, developed by Arie Freiberg, can help regulators to focus on day-to-day factors 
that influence compliance and produce regulatory outcomes. Freiberg’s regulatory toolkit is a 
non-hierarchical taxonomy of regulatory methods, based on the premise that the responsive 
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regulation model, with its gradual escalation from persuasion to punishment, is not a suit-
able way to deal with all regulatory challenges.
In this research we have focused on the recent changes to the healthcare regulatory context 
in the UAE. This local context, with a relatively new healthcare system, creates a challenging 
environment for healthcare regulators.
From our systematic reviews, we conclude that the new mandatory health insurance system 
in Abu Dhabi has led to an improved situation where virtually all residents have access to 
the required care. However, we find no clear evidence that the introduction of a centralized 
regulatory system has made a similar positive impact on the quality and affordability of 
healthcare. We conducted a second systematic review to evaluate the nature, extent and 
impact of healthcare system reform since the early 2000s. This second review does not find 
enough substantial evidence to conclude that the health system reform program, including 
the regulatory reform, has yet to fully achieve its stated objectives.
In our study, we review the potential use and impact of three regulatory methods: legal 
(Clinical Practice Guidelines, CPGs), structural (behavioural nudges) and informational (per-
ceptions of healthcare professionals).
Our systematic review of CPGs in Gulf countries over a 13-year period yields a small number 
of studies that have evaluated the impact of CPGs on health outcomes. A number of these 
studies describe positive effects but it is unclear how actual CPG compliance contributes 
to this because CPG compliance formed part of a number of interventions, such as aware-
ness raising, service redesign and training. We conclude that regulatory authorities should 
consider using CPGs as tools to improve patient outcomes.
Changing the choice architecture by introducing behavioural nudges does not lead to a 
significant change in compliance behaviours. Using a field experiment, we find no differ-
ence in compliance behaviours between participants exposed to different behavioural cues. 
However, this regulatory method is relatively inexpensive to implement and in a different 
environment with extended exposure, may help to improve compliance.
In our survey involving medical students in the UAE we measure different self-reported fac-
tors related to compliance. These factors include perceived fairness, legitimacy, the risk of 
getting caught or punished and performance of the regulatory agency. We conclude that 
regulation based on trust and fairness is more likely to be effective than regulation with a 
focus on deterrence. Our findings support the hypothesis that an individual’s compliance 
level is shaped by their perceptions of the legitimacy, fairness and performance of the regula-
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tory agency. At the same time, our cross-sectional study finds that deterrence factors, such as 
the perceived likelihood of getting caught, has no effect on the reported compliance levels.
A number of important findings emerge for policymakers and researchers. In terms of the 
geographical context, this research study provides a unique perspective on healthcare regula-
tory methods in a rapidly developing region. Our research shows a scarcity of research, not 
just in Abu Dhabi, but also in the UAE and the wider Gulf region and further research is 
required to study the role and impact of regulatory methods. An evidence-based taxonomy 
of regulatory methods can help to focus research activities and allow regulatory agencies to 
concentrate on methods that have been proven to improve compliance behaviour.
Healthcare regulatory agencies should take into consideration how the regulated organiza-
tion and their staff perceive the regulatory agency when it comes to fairness, performance 
and legitimacy. Considering the costs of regulation, the potentially negative consequences of 
non-compliance and the lack of evidence for a deterrence approach, policymakers and regu-
latory agencies should focus their energy on creating legitimate and transparent processes to 
support policies and regulation.
Regulatory agencies need to be flexible and explore, adapt, design and implement regulatory 
methods that improve compliance level. Even though many regulatory agencies have a wide 
arsenal of regulatory methods available to them, there is limited evidence on how, when 
and if these methods achieve the desired effects in the healthcare setting. A taxonomy of 
relevant methods may help in identifying the most suitable approach in order to achieve the 
regulatory objectives. In his seminal book about regulation, The Regulatory Craft, Malcolm 






De gezondheidszorg staat voor tal van uitdagingen: hoge verwachtingen van patiënten en 
zorgverleners, toenemende kosten en zorgen over de veiligheid van de patiënt. De overheid 
zet systemen op in een poging om activiteiten en gedrag van zorgverleners aan te sturen en 
te regelen en zodoende de kwaliteit van zorg te verbeteren, zekerheid te bieden dat minimum 
normen worden bereikt en verantwoordelijkheid voor kwaliteit en veiligheid te waarborgen.
Toezicht bestrijkt een breed scala aan interventies en probeert gedrag te veranderen om 
gewenste resultaten te bereiken. De doelstellingen van regelgeving zijn uiteenlopend en va-
riëren van het beschermen van burgers, het reguleren van sociale problemen, uitoefenen van 
controle over gereguleerde activiteiten of organisaties tot het verbeteren van de algemene 
kwaliteit van de openbare dienstverlening. Toezichthoudende instanties in de gezondheids-
zorg streven ernaar toezicht te houden op de kwaliteit, veiligheid, toegankelijkheid en prijs 
van de gezondheidszorg met behulp van diverse methoden.
Ondanks de belangrijke rol van een goed functionerend toezicht in de gezondheidszorg, is 
er beperkt onderzoek verricht naar de manier waarop toezicht in de praktijk werkt en welke 
impact dit heeft. Deze studie heeft als doel bij te dragen aan een beter begrip van toezicht op 
de gezondheidszorg door onderzoek naar drie verschillende methoden die worden gebruikt 
om het gedrag en de prestaties te beïnvloeden. Onze studie is uitgevoerd in de Verenigde 
Arabische Emiraten (VAE), een federatie van staten (Emiraten) in de Perzische Golf. We 
gebruiken een mix van onderzoeksmethoden (systematische reviews, een enquête en een 
veldexperiment) om de volgende onderzoeksvraag te beantwoorden:
Hoe kunnen toezichthouders toezichtsmethoden gebruiken 
om naleving van de regelgeving door de gezondheidszorg te 
verbeteren?
Het voorspellen of en hoe zorgaanbieders en professionals zullen reageren op verschillende 
methodes en voldoen aan wettelijke eisen, is een fundamentele voorwaarde om de effectivi-
teit van het toezicht te verbeteren. Toezichthouders in de gezondheidszorg hebben vaak een 
brede en nogal generieke taak om toezicht te houden op tal van heterogene organisaties, 
markten en professionals. Als gevolg hiervan bestaat de benadering van een toezichthouder 
vaak uit een mix van verschillende instrumenten die verschillen qua context (de setting), 
inhoud (de kenmerken van de interventie) en toepassing (de gebruikte methoden en het 
proces waarmee de interventie wordt geleverd).
In dit onderzoek is onderzocht hoe toezichthouders op de gezondheidszorg het beste 
hun methoden en instrumenten kunnen gebruiken om de naleving te verbeteren. Om de 
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 onderzoeksvraag te beantwoorden, hebben we eerst een geschikte taxonomie en een breder 
raamwerk geïdentificeerd en verder ontwikkeld. Deze taxonomie, ontwikkeld door Arie Frei-
berg, kan toezichthouders helpen om zich te concentreren op factoren die van invloed zijn 
op de naleving en de naleving bevorderen. De toolkit van Freiberg is een niet-hiërarchische 
taxonomie van methoden, gebaseerd op het uitgangspunt dat “responsive regulation”, met 
de geleidelijke escalatie van overtuiging naar sancties, geen geschikte manier is om alle 
uitdagingen aan te pakken.
In dit onderzoek hebben we ons gericht op de recente wijzigingen in de gezondheidszorg 
in de Verenigde Arabische Emiraten. Deze lokale context, met een relatief nieuw zorgstelsel 
creëert een uitdagende omgeving voor toezichthouders. Uit onze systematische reviews 
blijkt dat de nieuwe, verplichte ziektekostenverzekering in Abu Dhabi heeft geleid tot 
verbetering: vrijwel alle inwoners hebben nu toegang tot de vereiste zorg gebruiken. We 
vinden echter geen duidelijk bewijs dat de introductie van een gecentraliseerd systeem van 
toezichthouden een vergelijkbare positieve impact had op de kwaliteit en betaalbaarheid van 
de gezondheidszorg. We hebben daarom een tweede systematisch onderzoek uitgevoerd 
om de aard, omvang en impact van de hervorming van het zorgstelsel vanaf het jaar 2000 
verder te evalueren. Dit onderzoek vindt niet genoeg substantieel bewijs om te concluderen 
dat het hervormingsprogramma voor de gezondheidszorg, inclusief de hervorming van het 
toezicht, zijn doelen al heeft bereikt.
In onze studie hebben we de potentiële toepassing en impact van drie toezichtsmethoden 
onderzocht: wetgevend toezicht (Clinical Practice Guidelines, CPGs), structureel toezicht 
(behavioural nudges) en informatieve toezicht (percepties van professionals).
Onze systematische review van CPG’s in de Golfstaten gedurende een periode van 13 jaar 
levert een klein aantal studies op die de impact van CPG’s op gezondheidsresultaten hebben 
geëvalueerd. Een aantal van deze onderzoeken heeft positieve effecten gevonden. Het is 
onduidelijk hoe de naleving van CPG’s aan het effect heeft bijgedragen. De naleving van de 
CPG’s maakt deel uit van een bredere interventie, zoals training van patiënten, hervorming van 
het zorgstelsel en de opleiding van zorgverleners. We concluderen dat toezichthouders moe-
ten overwegen om CPG’s te gebruiken als hulpmiddel om de patiëntresultaten te verbeteren.
Het veranderen van de keuzearchitectuur, door de introductie van nieuwe signalen die het 
nalevingsgedrag kunnen beïnvloeden, leidt niet tot een significante verandering in nalevings-
gedrag. In een veldexperiment vinden we geen verschil in het gedrag tussen deelnemers die 
werden blootgesteld aan verschillende signalen. Deze toezichtsmethode kan op een relatief 
goedkope manier worden ingevoerd en heeft in een andere omgeving met een langere 
blootstelling mogelijk wel een positief effect op de naleving.
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In ons onderzoek onder medische studenten in de VAE zijn verschillende factoren gemeten 
in relatie tot de zelfgerapporteerde naleving. De factoren zijn: rechtvaardigheid, legitimiteit, 
het risico om gepakt of gestraft te worden en de prestaties van de toezichthouder. We 
concluderen dat toezicht gebaseerd op vertrouwen en eerlijkheid effectiever is dan toezicht 
met een focus op afschrikking. Onze bevindingen ondersteunen de hypothese dat het nale-
vingsniveau wordt bepaald door de perceptie van legitimiteit, rechtvaardigheid en prestaties 
van de toezichthouder. Tegelijkertijd blijkt uit onze cross-sectionele studie dat afschrikwek-
kende factoren, zoals de kans om gepakt te worden, geen effect heeft op de gerapporteerde 
nalevingsniveaus.
Uit het onderzoek volgen aanbevelingen voor beleidsmakers en onderzoekers. Wat de geo-
grafische context betreft biedt dit onderzoek een uniek perspectief op toezichtsmethoden 
voor de gezondheidszorg in een zich snel ontwikkelende regio. Ons onderzoek toont een 
gebrek aan soortgelijk onderzoek. Er is meer onderzoek nodig in Abu Dhabi, maar ook in 
de VAE en de bredere Golfregio om de rol en impact van methoden van toezichthouden 
te bestuderen. Een empirisch onderbouwde taxonomie van methoden kan helpen met het 
focussen van onderzoeksactiviteiten en stelt toezichthouders in staat zich te concentreren op 
effectieve methoden om naleving te bevorderen.
Toezichthouders in de gezondheidszorg moeten rekening houden met de beoordeling van 
de toezichthouder door de ondertoezichtstaande organisatie en hun personeel. Het gaat 
hierbij om rechtvaardigheid, prestaties en legitimiteit van de toezichthouder. Gezien de 
kosten van toezicht, de mogelijk negatieve gevolgen van het niet-naleven van regelgeving 
en het gebrek aan bewijs voor toezicht gebaseerd op afschrikking, moeten beleidsmakers en 
toezichthouders hun energie richten op het creëren van transparante en legitieme procedu-
res in beleid en toezicht.
Toezichthouders moeten flexibel zijn en hun methoden onderzoeken, aanpassen, ontwerpen 
en implementeren om het nalevingsgedrag te bevorderen. Hoewel veel toezichthouders over 
een breed arsenaal aan methoden beschikken, is er beperkt bewijs hoe, wanneer en waarom 
deze methoden de gewenste effecten in de gezondheidszorg bereiken. Een taxonomie van 
relevante methoden kan helpen bij het identificeren van de meest geschikte aanpak om 
de doelstellingen van toezicht te bereiken. In zijn baanbrekend boek over toezicht, The 
Regulatory Craft, verwoordde Malcolm Sparrow deze strategie als volgt: “Pick an important 
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Propositions to accompany the PhD thesis
Improving compliance with healthcare regulatory 
requirements in the United Arab Emirates
By Erik Koornneef
1. Healthcare regulatory agencies should spend more resources to explore and experi-
ment with a variety of regulatory methods (This PhD Thesis).
2. For a rapidly developing country such as the UAE, it is imperative that it regularly 
reviews and benchmarks its healthcare performance and takes action to improve its 
performance (This PhD Thesis).
3. A positive perception of the healthcare regulatory agencies’ fairness, legitimacy and 
performance increases the likelihood of compliant behaviour (This PhD Thesis).
4. Medical universities need to investigate how medical students can acquire the 
necessary reflective skills to accurately assess their own clinical performance (This 
PhD Thesis).
5. Surveillance cues, such as watching eyes, may be effective in promoting compliant 
behaviour in situations where there are real opportunities to build and enhance a 
good reputation (This PhD Thesis).
6. Innovative methods using Artificial Intelligence (AI) can help to improve the quality 
of healthcare by providing accurate, real-time and comprehensive insights into the 
performance of providers and professionals (Griffiths and Leaver, 2018).
7. A reliable way to make people believe in falsehoods is frequent repetition, because 
familiarity is not easily distinguished from truth. Authoritarian institutions and 
marketers have always known this fact (Kahneman, 2011).
8. Online access to medical records by patients has the potential to improve the quality 
of patient-centred care and patient satisfaction (Mold et al, 2015).
9. More prospective validation should be conducted into tasks that machines could 
perform to help clinicians or predict clinical outcomes that would be useful for 
health systems (Topol, 2019).
10. In order to achieve better healthcare outcomes, healthcare policies should focus 
on changing the strongest determinants of health, in particular behavioural pat-
terns and social circumstances, rather than changing the actual healthcare delivery 
(McGinnis, Williams-Russo and Knickman, 2003).
11. Governments should “regulate the regulators” by obliging healthcare regulatory 












ith healthcare regulatory requirem





















Healthcare is one of the most challenging, 
resource intensive and complex areas of public 
sector reform. Many countries have established 
healthcare regulatory systems to provide as-
surance that standards are complied with and 
to improve the quality of care. This research 
focused on the healthcare system in the United 
Arab Emirates (UAE), a young, modern state 
with an ambitious healthcare reform program. 
This study takes an in-depth look at three dif-
ferent methods used to regulate the conduct 
and performance of healthcare professionals 
and organizations. Using a variety of methodol-
ogies, this research offers practical insights and 
recommendations for policy makers, regulators 
and researchers.
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